
































































































































Brain-derived	 neurotrophic	 factor	 (BDNF)	 is	 one	 of	 the	 key	 modulator/mediator	 molecules	 for	
synaptic	 plasticity	 in	 the	 adult	 nervous	 system	 and	 also	 coordinates	 neural	 development,	 survival,	
differentiation	 and	 axon	 growth	 during	 development	 in	 the	 central	 and	 the	 peripheral	 nervous	
system.	 The	 understanding	 of	 our	 brain	 critically	 depends	 on	 the	 detailed	 understanding	 of	 the	
regulatory	mechanisms	of	molecules	like	BDNF.	
Recent	 research	 has	 implicated	BDNF	 in	 synapse-specific	 strengthening	 of	 active	 synapses,	
but	 if	 BDNF	 is	 recruited	 specifically	 to	 active	 synapses	 to	 modulate	 their	 function	 is	 not	 known.	
Additionally,	 it	 is	 debated	 whether	 BDNF	 is	 released	 from	 post-	 or	 presynaptic	 sites	 and	 if	 BDNF	
affects	exclusively	neurons,	or	other	cell	types,	like	astrocytes,	in	addition.	
Here	we	 propose	 and	 investigate	 a	 novel	 strategy	 to	 achieve	 focal	 stimulation	 of	 neurons	
using	optogenetics,	with	the	ultimate	goal	to	study	the	influence	of	activity	on	the	recruitment	and	
release	of	the	neurotrophic	factor	BDNF.	We	demonstrate	the	utility	of	current	optogenetic	tools	to	
achieve	 highly	 focal	 depolarization	 and	 further	 examined	 a	 proof-of-principle	 of	 nanoscale	
optogenetic	activation	using	an	initial	macroscale	approach.	
Using	dissociated	and	organotypic	hippocampal	cultures	from	the	rat,	in	which	we	co-express	
BDNF-mRFP1	 and	 a	 cytosolic	 fluorophore	 to	 identify	 the	 cell	 of	 origin,	we	 tested	 the	 influence	 of	
focal	optogenetic	 activation	of	 specific	 sites	on	 intracellular	BDNF	 trafficking	and	 further	extended	
the	study	to	investigate	the	intercellular	transfer	of	BDNF	to	neighboring	cells.	We	found	that	BDNF	
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°C	 	 	 degree	Celsius	
aa	 	 	 amino	acids	
AAV	 	 	 adeno-associated	virus	
AF488	 	 	 Alexa	Fluor	488		 	
AMPA	receptor		 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic	acid	receptor	
ApE		 	 	 A	plasmid	editor	
APV	(AP5)	 	 2-amino-5-phosphonopentanoic	acid	
BDNF														 	 Brain-derived	neurotrophic	factor	
BIOS	 	 	 basic	input/output	system	
bp	 	 	 base	pair	
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CMV	 	 	 promotor	derived	from	cytomegalovirus	
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CO2	 	 	 carbon	dioxide	
DCVs	 	 	 dense	core	vesicles	
dH2O	 	 	 deionized	water	
DIV	 	 	 day	in	vitro	
DMEM	 	 	 Dulbecco’s	modified	Eagle	media	
DMSO	 	 	 dimethyl	sulfoxide	
DNA	 	 	 deoxyribonucleic	acid	
DPBS	 	 	 Dulbecco's	Phosphate-Buffered	Saline	
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g	 	 	 gram	
GABA	 	 	 gamma-aminobutyric	acid	(γ-aminobutyric	acid)		
GFAP	 	 	 glial	fibrillary	acidic	protein	 	 	
HBSS	 	 	 Hank’s	balanced	salt	solution	
HEK	 	 	 human	embryonic	kidney	
Hz	 	 	 hertz	
i.e.	 	 	 that	is,	id	est	
Iba1	 	 	 ionized	calcium-binding	adapter	molecule	1	
ITR	 	 	 internal	tandem	repeat	
kDa	 	 	 kilodalton	
kHz	 	 	 kilohertz	
	4	
LB	 	 	 lysogeny	broth	
LSM	 	 	 laser	scanning	microscope	
LSSmOrange	 	 large	stokes	shift	mOrange	
LTD	 	 	 long	term	depression	
LTP	 	 	 long	term	potentiation	
M	 	 	 molar	/	molar	concentration	
Map2	 	 	 microtubule-associated	protein	2	
MEM	 	 	 minimal	essential	medium	 	 	
min	 	 	 minutes	
ml	 	 	 milliliter	
mm	 	 	 millimeter	
mM	 	 	 millimolar	
mol	 	 	 mole	
mOsm	 	 	 milliosmole	
mRFP1	 	 	 monomeric	red	fluorescent	protein	1	
mRNA	 	 	 messenger	ribonucleic	acid	
mV	 	 	 millivolt	
mW	 	 	 milliwatt	
MΩ	 	 	 megaohm	 	
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NaOH	 	 	 sodium	hydroxide	
ng	 	 	 nanogram	
NGF	 	 	 nerve	growth	factor	
Nh4Cl	 	 	 ammonium	chloride	
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nM	 	 	 nanomolar	
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Ø	 	 	 diameter	
OD	 	 	 optical	density	
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P0	or	P4	 	 postnatal	day	0	or	4	
p75NTR	 	 p75	neurotropin	receptor	
pA	 	 	 piccoampere	
PBS	 	 	 phosphate-buffered	saline	
PEI	 	 	 polyethylenimine	
PFA	 	 	 paraformaldehyde	
Ph.D.	 	 	 Philosophiae	Doctor	(doctor	of	philosophy)	
pi		 	 	 injection	pressure	
PSD-95	 	 	 postsynaptic	density	-95	
rcf	 	 	 relative	centrifugal	force	
RESOLFT	 	 reversible	saturable	optical	(fluorescence)	transitions	
RFP	 	 	 red	fluorescent	protein	
rpm	 	 	 revolutions	per	minute	
s	 	 	 seconds	
SDS	 	 	 Sodium	dodecyl	sulphate	
SFO	 	 	 step-function	opsin	
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TAE	 	 	 tris	base,	acetic	acid	and	EDTA	buffer	
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general	more	 fundamental	 rule	of	nature,	 it	gave	 rise	 to	a	complex	multitude	of	diverse	 life	 forms	
during	the	time	course	of	evolution,	with	the	cell	constituting	the	smallest	and	most	basic	unit.	With	
growing	 organisms	 and	 organization,	 division	 of	 labor	 and	 function	 presented	 an	 opportunity	 for	
efficiency.	This	division	consequently	resulted	in	complex	biological	systems	on	their	own,	working	in	
close	 communion.	 Because	 it	 was	 necessary	 to	 provide	 coordinated	 responses	 to	 environmental	
conditions	and	work	in	synchrony,	one	of	these	organizational	subdivisions	acquired	the	function	of	a	
central	 communication	 center,	 collecting	 information	 through	 sensory	 afferents,	 processing	 their	
relevance	 and	 giving	 appropriate	 directives	 to	 other	 organizational	 subdivisions.	 Thus	 it	 is	




adapted	 responses	 and	 thus	 require	 complex	 and	well-reasoned	 behavior,	 which	 gave	 rise	 to	 the	
development	 of	 more	 complex	 nervous	 systems	 in	 some	 organisms.	 This	 demand	 in	 complexity	
consequently	 resulted	 in	 larger	and	more	powerful	processing	abilities.	 Integrated	with	 its	 sensory	
perceptions	of	 the	 surrounding	world	 this	 created	biological	 representations	of	operating	 systems,	
personalities.	Within	specific	parameters	 these	 identities	have	control	over	simple	 functions	of	 the	
organism	 and	 the	 neuronal	 infrastructure,	 while	 this	 behavior	 and	 more	 basic	 functions	 are	




curiosity.	 The	 endeavor	 to	 study	 and	 understand	 the	 origin	 of	 behavior	 and	 perceptual	 reality	 is	
called	 Neuroscience.	 As	 we	 well	 know	 nowadays	 the	 origin	 of	 a	 perceptual	 personality	 is	 the	





of	 years	 to	 evolve	 to	 its	 current	 state.	 And	 while	 humans	 have	 not	 been	 significantly	 changing	
biologically	within	 the	 last	millennia,	 because	 such	 a	 process	would	 take	much	 longer,	 the	 human	
society	is	adapting	through	a	process	of	metaevolution,	where	individuals	learn	and	adapt	according	





neuron],	 PubMed	 lists	956,665	article	entries	 (date	28th	of	March	2016),	with	 currently	more	 than	
30,000	 new	 articles	 every	 year;	 a	 collective	 amount	 of	 information	 that	 is	 beyond	 the	 processing	
capabilities	of	a	single	individual.	And	it	will	take	the	combined	human-network	effort	of	many	more	
generations	to	clarify	all	its	functions.	
In	 order	 to	 understand	 the	 origin	 of	 perception,	 complex	 phenomena	 like	 learning	 and	
memory	and	 consequently	 the	 cause	of	disorders	affecting	 lives,	 researches	were	 trying	 to	 reduce	
complicated	 macroscopic	 biological	 processes	 to	 their	 most	 fundamental	 units,	 the	 neurons.	 The	
human	 central	 nervous	 system	 consists	 of	 an	 estimated	 85	billion	 (85,000,000,000)	 neurons,	 but	
roughly	10	times	more	glia	cells	(Kandel,	2001;	Williams	and	Herrup,	1988).	Just	as	the	heart	is	vital	
for	 the	 brain	 to	 function,	 neurons	 would	 not	 be	 able	 to	 operate	 without	 supporting	 neuronal	
functions	 through	 myelination	 (oligodendrocytes),	 biochemical	 support	 and	 homeostasis	
(astrocytes),	immune	defense	(microglia)	and	formation	of	the	ventricular	system	and	production	of	
cerebrospinal	 fluid	 (ependymal	 cells).	 Recent	 results	 indicate	 that	 some	 of	 these	 cells	 play	 more	
active	roles	in	the	regulation	of	synaptic	transmission.	Though,	neurons	are	still	considered	to	be	the	
most	 substantial	 protagonists	 in	 the	 formation	 of	 human	 perception,	 dysregulations	 in	 any	 of	 the	
above-mentioned	processes	can	affect	the	whole	system	dramatically.	
Only	 1/7th,	 10	-	12	 billion	 neurons,	 actually	 belong	 to	 the	 telenchephalic	 brain	 region	
(Williams	 and	 Herrup,	 1988),	 which	 forms	 the	 Cerebrum,	 including	 the	 cerebral	 cortex,	 and	
subcortical	 areas	 like	 the	 hippocampus	 and	 basal	 ganglia	 -	 structures	 that	 have	 been	 identified	 to	
contribute	most	substantially	to	complex	perceptual	processes.	However,	as	we	know,	this	number	is	
not	 much	 more	 than	 a	 mere	 fun	 fact.	 Size,	 weight	 and	 number	 of	 neurons	 do	 not	 necessarily	
correlate	with	intelligence	or	processing	power	(Cobb,	1965;	Hechst,	1932).	The	secret	lies	within	the	
interconnection	 of	 neurons	 and	 the	 complex	 neuronal	 networks,	 that	 are	 formed	 this	way.	 These	
connections	need	to	be	studied	and	understood.	
The	 first	 basic	 achievements	 in	 understanding	 the	 brain’s	 functions	 depended	 on	 the	
invention	of	appropriate	investigation	methods,	like	the	use	of	lenses	in	optics	to	build	microscopes	
and	 techniques	 to	 enhance	 the	 contrast	 in	 tissue	 and	 view	 small	 structures.	 The	 ongoing	
development	 of	 new	 tools	 and	 technologies	 to	 study	 neuronal	 functions	 is	 essential.	 It	 is	 already	
more	than	a	century	ago,	that	neurons	were	first	described	as	single	units	by	Santiago	Ramon	y	Cajal,	
using	Camillo	Golgi’s	approach	for	staining	single	neurons	in	the	brain.	These	neurons	were	identified	
as	distinct	and	 individual	units	 forming	specialized	connections	 to	other	neurons	and	 thus	building	
large	networks	of	processing	units.	It	is	estimated	that	a	single	neuron	can	form	up	to	1,000	efferent	
synaptic	connections,	while	receiving	input	from	up	to	10,000	afferent	synaptic	connections	(Kandel	






The	most	common	signal	 in	 the	brain	 is	mediated	 through	 the	neurotransmitter	glutamate	
and	 the	 corresponding	 glutamate	 receptors	 such	 as	 ionotropic	 N-methyl-D-aspartate	 receptors	
(NMDA	 receptor)	 and	 non-NMDA	 receptors	 (AMPA	 receptors	 (α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic	 acid	 receptors)	 and	 Kainate	 receptors)),	 which	 respond	 to	 ligand	 binding	 by	 a	
conformational	change,	leading	to	the	formation	of	an	ion	conducting	pore.	These	receptors	are	the	
most	 important	 for	 mammalian	 neural	 systems	 and	 usually	 cluster	 at	 synapses	 by	 binding	 to	
intracellular	 scaffolding	 proteins,	 connecting	 them	 to	 the	 cytoskeleton.	 Furthermore,	 there	 are	
metabotropic	 glutamate	 receptors,	 which	 transmit	 their	 activation	 through	 G-protein	 mediated	
signaling.	 This	might	 also	 directly	 or	 by	 further	 downstream	 second	messengers,	 like	 calcium	 ions	
(Ca2+),	influence	the	activity	of	ion	channels,	through	which	action	potentials	are	propagated.	
In	 the	 resting	 state	 a	 neuron	maintains	 a	 gradient	 of	 ions	 over	 its	membrane.	Overall	 this	
leads	 to	 an	 imbalance	 of	 positive	 and	 negative	 charges	 between	 the	 intracellular	 and	 the	
extracellular	 environment,	 building	 up	 a	 resting	 membrane	 potential,	 which	 is	 normally	
around	 -70	mV.	 The	binding	of	 neurotransmitters	 (e.g.	 glutamate)	 to	 their	 native	 receptors,	 either	
directly	or	 indirectly,	 leads	 to	 the	 formation	of	 ion	 conducting	pores,	 allowing	 for	 the	 flow	of	 ions	
along	their	concentration	gradients,	most	often,	the	influx	of	sodium	ions	(Na+).	This	influx	drives	the	





controlled	 exocytosis	 of	 vesicles	 resting	 in	 the	 pre-synapse,	 releasing	 their	 cargo	 into	 the	 synaptic	
cleft,	 where	 the	 released	 neurotransmitter	 in	 turn	 binds	 to	 appropriate	 receptors	 on	 the	
postsynaptic	 site.	 This	 is	 a	 very	 simple	 description	 of	 the	 basic	 principle	 of	 neuronal	 signal	
propagation.	
Given	 the	 complexity	 of	 signals	 that	 are	 perceived	 and	 processed	 by	 the	 brain,	 this	
mechanism	 can	 of	 course	 not	 be	 that	 simple.	 The	 brain	 has	 the	 remarkable	 ability	 to	 adapt	 in	
response	to	experience	and	variations	in	the	environment,	therefore	synapses	do	not	remain	stable	
and	new	connections	are	continuously	formed	as	well	as	lost.	The	release	of	neurotransmitters	to	a	










well	 accepted	 nowadays,	 not	 many	 scientists	 believed	 in	 the	 idea	 of	 a	 brain	 that	 can	 change	 in	
neurochemistry	 and	 anatomy	 according	 to	 environmental	 stimuli,	 until	 the	 1960s	 (Rosenzweig,	
1996).	Today	we	know	that	such	mechanisms	are	essential	for	brain	function	and	play	an	important	
role	 in	 recovery	 after	 brain	 damage	 (Pascual-Leone	 et	 al.,	 2005).	 Molecular	 mechanisms	 that	
translate	 patterns	 of	 activity	 into	 specific	 synaptic	 changes,	 subsequently	 influencing	 synaptic	
transmission	e.g.	the	number	and	strength	of	synapses	can	be	changed	by	neuronal	activity	(Bliss	and	
Collingridge,	1993;	Kandel,	2001;	Linden,	1994;	Malenka	and	Nicoll,	1999;	McEwen,	1999).	Synaptic	
changes	 that	 lead	 to	an	enhanced	 sensitivity	 contribute	 to	processes	 termed	 short-	 and	 long-term	
potentiation	 (STP/LTP).	 Events	 causing	 decreased	 sensitivity	 of	 synapses	 contribute	 to	 a	 process	
termed	 short-	 or	 long-term	 depression	 (STD/LTD)	 (Kandel	 et	 al.,	 2000).	 Such	 changes	 could	 result	
from	 the	 integration	 of	 more	 or	 less	 receptors	 into	 the	 synaptic	 membrane,	 the	 modification	 of	
already	available	receptors	and	channels	in	order	to	make	them	more	or	less	sensitive	and	active,	or	
the	synthesis	and	release	of	proteins	that	regulate	synaptic	strength.	Even	though	significant	effort	




serve	 as	 a	 mediator	 of	 synaptic	 plasticity,	 the	 group	 of	 neurotrophins.	 Their	 expression	 and	
localization	has	been	found	to	change	in	response	to	neuronal	activity	and	in	turn,	these	molecules	





















et	 al.,	 1995)	 and	 neuronal	 differentiation	 during	 brain	 development	 of	 both	 the	 peripheral	 and	
central	nervous	system	(Huang	and	Reichardt,	2001).	
However,	 recent	 research	 efforts	 have	 focused	 more	 on	 its	 role	 in	 modulating	 synaptic	
plasticity.	 Its	 structure	 and	 function	 is	 highly	 conserved	 throughout	 vertebrates,	 underlining	 its	
importance.	Most	research	has	been	done	in	rats,	mice	or	derived	cultures.	During	development	of	
the	CNS	of	the	rat	embryo,	BDNF	expression	is	low	compared	to	the	other	neurotrophins	(NT-3	and	
NGF)	 and	 first	 significant	 expression	 can	 be	 detected	 around	 day	 11	-	12	 of	 embryological	
development	 with	 expression	 reaching	 higher	 levels	 by	 day	 12	-	13,	 coinciding	 with	 the	 onset	 of	
neurogenesis	 (Maisonpierre	 et	 al.,	 1990).	 Despite	 the	 fact	 that	 early	 purifications	 estimated	 that	
there	is	only	around	5	ng/g	of	BDNF	found	in	the	adult	pig	brain	(Barde,	1988;	Barde	et	al.,	1982),	its	
mRNA	and	protein	can	be	found	in	many	areas	of	the	adult	rat	e.g.	in	large	regions	of	the	cortex,	the	
basal	 ganglia	 and	 hippocampus	 (Conner	 et	 al.,	 1997;	 Ernfors	 et	 al.,	 1990)	 -	 areas	 important	 for	
cognition,	learning	and	emotion,	but	also	voluntary	motor	control.	In	experiments	where	BDNF	was	
removed	 by	 the	 creation	 of	 homozygous	 knockout	 mice,	 animals	 developed	 at	 reduced	 sizes.	 In	
mouse	strains	with	poor	caretaking	of	nursing	females	such	newborns	die	within	the	first	2	postnatal	
weeks,	 otherwise	 they	 normally	 live	 for	 up	 to	 1	 month,	 but	 exhibit	 severe	 deficiencies	 in	
coordination	 and	 balance	 associated	 with	 excessive	 degeneration	 in	 several	 sensory	 ganglia,	
including	 the	 vestibular	 ganglion,	 resulting	 in	 phases	 of	 spinning	 during	 periods	 of	 hyperactivity	




was	 unaffected.	 The	 effect	 can	 be	 rescued	 by	 exogenous	 application	 or	 virus	 mediated	
overexpression	 of	 BDNF,	 and	 induced	 in	 slices	 from	wild-type	 animals	 by	 the	 application	 of	 BDNF	
scavenging	molecules	(Korte	et	al.,	1998;	Patterson	et	al.,	1996).	Conversely	exercise	 is	reported	to	
increase	 physiological	 levels	 of	 BDNF	 and	 has	 been	 implicated	 in	 exercise-mediated	 cognitive	
improvements	(Szuhany	et	al.,	2015).	However,	because	of	the	very	complex	role	of	neurotrophins,	
which	 is	 highly	 tissue	 specific,	 we	will	mainly	 focus	 on	 the	 function	 of	 BDNF	 in	 the	 CNS,	 or	more	
precisely	the	hippocampus,	because	of	its	importance	for	learning	and	memory.	
As	all	neurotrophins,	BDNF	 is	produced	as	a	high	molecular	weight	precursor	 (ProBDNF)	of	
32	kDa,	a	polypeptide	of	229	amino	acids	 (aa),	which	 is	proteolytically	cleaved	during	sorting	to	 its	
mature	 form	 (mBDNF)	of	 14	kDa	or	 119	aa	 (Mowla	et	 al.,	 2001).	 But,	 one	 is	 easily	 deceived	by	 its	
apparent	 simplicity,	 because	 the	 process	 of	 transcription,	 sorting,	 release	 and	 receptor	 binding	 is	
complex;	 for	 instance,	 BDNF	 gene	 expression	 in	 rats	 is	 controlled	 by	 four	 activity-dependent	 and	




upstream	stimulatory	 factors	1/2	 (USF	1/2)	 (Chen	et	al.,	2003b;	Tabuchi	et	al.,	2002),	and	calcium-
responsive	 transcription	 factor	 (CaRF)	 (Tao	et	al.,	2002)	 in	 response	 to	activity-related	 increases	of	
the	 calcium	 concentration.	 Expression	 was	 also	 demonstrated	 to	 be	 influenced	 by	 mechanisms	
affecting	 chromatin	 structure,	 like	 DNA	 methylation	 or	 histone	 deacetylation	 through	 the	
recruitment	of	global	repressors	such	as	the	zinc	finger	transcription	factor	REST/NRSF	(Palm	et	al.,	
1998)	and	MeCP2	 (Chen	et	al.,	2003a).	Methylation	of	cytosine	 residues	and	histone	deacetylation	








initiation	 of	 translation	 extending	 the	 precursor	 N-terminally	 by	 eight	 aa,	 without	 yet	 known	
consequences	 (Aid	 et	 al.,	 2007).	 Similar	 processes	 extending	 the	 available	 pool	 of	 human	 BDNF	
transcripts	 and	 protein	 have	 also	 been	 reported	 (Liu	 et	 al.,	 2005).	 Transcription	 is	 regulated	 and	
depends	 strongly	 on	 tissue	 type,	 physiological	 conditions	 and	 developmental	 stage.	 All	 transcripts	
can	however	be	found	to	be	expressed	in	the	adult	rat	hippocampus	with	varying	transcription	levels,	
based	 on	 age	 and	 neuronal	 activity.	Most	 transcripts	 have	 peak	 expression	 levels	 3	-	6	hours	 after	
seizures	 are	 induced	 in	 rats	 by	 the	 injection	 of	 kainic	 acid	 (Aid	 et	 al.,	 2007).	 The	 evolutionary	
necessity	of	so	many	different	transcripts	strongly	suggests	differential	sorting	and	transport	of	the	
different	BDNF	mRNAs,	 in	combination	with	regulated	and	 local	 translation.	However,	 the	 function	
and	localization	of	the	individual	transcripts	has	not	yet	been	clarified.	Even	before	it	was	known	that	
there	 are	 so	 many	 different	 BDNF	 mRNA	 transcripts,	 BDNF	 mRNA	 and	 protein	 recruitment	 to	
dendritic	sites	was	reported	in	response	to	KCl-mediated	membrane	depolarization	(Tongiorgi	et	al.,	
1997)	and	during	recent	years	there	has	been	more	and	more	evidence	for	transcript	specific	sorting	
(Baj	 et	 al.,	 2011),	 e.g.	 from	 the	 available	 transcripts	 a	 group	 of	 long	 3’	UTR	mRNA	 transcripts	 has	
been	descripted	 to	 be	 present	 in	 the	 soma	 and	 sorted	 to	 dendrites,	while	 another	 group	of	 short	




in	 rat	 hippocampal	 neurons,	 where	 it	 is	 enriched	 and	 released	 in	 response	 to	 KCl-mediated	
membrane	 depolarization	 (Edelmann	 et	 al.,	 2015;	 Goodman	 et	 al.,	 1996;	 Kuczewski	 et	 al.,	 2008;	
Tongiorgi	et	al.,	1997).	But	BDNF	is	also	anterogradly	transported	and	released	from	axonal	terminals	




were	 focused	 on	 BDNF	 containing	 only	 the	 coding	 exon	 transcript	 together	 with	 a	 3’	 attached	
sequence	coding	for	the	fluorescent	tag.	BDNF-GFP	was	found	to	behave	similarly	to	the	endogenous	
variant	 and	was	 sorted	 to	 postsynaptic	 sites	 and	 released	 in	 response	 to	 neuronal	 activity,	 which	
depended	 on	 postsynaptic	 ionotropic	 glutamate	 receptor	 activation	 and	 calcium	 concentration	
increase	 (Hartmann	et	al.,	2001;	Kojima	et	al.,	2001).	BDNF-GFP	was	also	 found	to	move	to	axonal	
terminals	at	which	it	is	also	apparently	released	(Kohara	et	al.,	2001).	Other	studies	reported	distinct	
BDNF	 populations	 perambulating	 neuronal	 processes,	 but	 either	 exclusively	 axonal	 or	 dendritic	
(Dean	et	al.,	2012),	however	without	differentiating	between	expressed	and	potential	endocytosed	
BDNF-GFP.	 Injected	 radio-labeled	 BDNF	 was	 found	 to	 be	 retrogradly	 transported	 in	 the	 rat	
hippocampus	 (DiStefano	 et	 al.,	 1992)	 and	 suggests	 that	 BDNF	 acts	 on	 presynaptic	 terminals,	 from	
where	it	is	taken	up	and	retrogradly	transported.	Despite	the	large	amount	of	data	that	is	available,	
the	question	of	axonal	versus	dendritic	targeting	remains	unclear.	
Besides	 the	 differential	 sorting	 and	 release	 of	 BDNF,	 another	 source	 of	 debate	 is	 the	
processing	and	 form	of	 release.	Under	physiological	 conditions	BDNF	exists	as	a	 tightly	associated,	
but	 non-covalent	 homodimer	 (Radziejewski	 et	 al.,	 1992)	 and	 it	 has	 been	 reported	 that	 it	 can	 also	
form	heterodimers	with	NT-3,	thus	affecting	the	sorting	of	NT-3	(Farhadi	et	al.,	2000;	Heymach	and	
Shooter,	1995;	Robinson	et	al.,	1995);	though	the	functional	purpose	of	such	heterodimers	remains	
elusive.	 The	 secretion	 of	 neurotrophins	 follows	 two	 pathways,	 the	 constitutive	 pathway,	 where	
neurotrophins	 are	 continuously	 secreted	 from	 the	 cell,	 independent	 of	 neuronal	 activity	 or	 other	
stimuli,	and	 the	 regulated	secretory	pathway,	were	proteins	are	sorted	 into	secretory	vesicles	 that	
are	 released	 upon	 stimulation.	 In	 both	 cases	 proteins	 go	 through	 the	 trans-Golgi	 network	 (TGN)	
where	 they	 are	 packed	 in	 vesicles	 and	 secreted	 through	 exocytosis.	 There	 is	 data	 suggesting,	 that	
BDNF	 is	released	 in	 its	precursor	form	(Chao	and	Bothwell,	2002;	Yang	et	al.,	2009)	and	processing	
occurs	extracellularly	through	cleavage	by	the	serine	protease	plasmin	or	selective	metalloproteases.	
Though	some	of	 these	results	were	obtained	 from	experiments	using	virus-mediated	expression	of	
ProBDNF	 in	 non-neuronal	 cultures	 (Heymach	 and	 Shooter,	 1995;	 Lee	 et	 al.,	 2001),	 release	 of	
ProBDNF	was	also	detected	 in	experiments	with	mouse	hippocampal	 cultures	 (Mowla	et	al.,	2001;	
Pang	et	al.,	2004)	or	knock-in	mice,	expressing	ProBDNF	from	the	endogenous	promoter	(Yang	et	al.,	
2014;	Yang	et	al.,	2009).	A	functional	relevance	of	ProBDNF	was	shown,	but	by	applying	recombinant	
BDNF	 resistant	 to	 protease	 cleavage	 (Woo	 et	 al.,	 2005).	 However,	 the	 release	 of	 endogenous	
ProBDNF	is	still	heavily	disputed	(Dieni	et	al.,	2012;	Matsumoto	et	al.,	2008).	Substantial	data	exists	
suggesting	 that	 the	precursor	 is	 only	 released	 in	 small	 amounts	 through	 the	 constitutive	pathway.	
The	 strongest	 indication	 of	 ProBDNF	 release	 was	 published	 by	 Yang	 et	 al.	 2009,	 however	 their	
modification	of	 the	 gene	 locus	by	producing	BDNF-HA	knock-in	mice	 influences	 the	 transcriptional	











mature	BDNF	 (mBDNF)	 can	be	 released	by	 secretory	granules	 (dense	 core	vesicles)	 at	perisynaptic	
sites	in	response	to	neuronal	activity	(Farhadi	et	al.,	2000;	Goodman	et	al.,	1996).	Overexpression	of	
fluorescently	 labeled	BDNF	 is	also	reported	to	be	sorted	 into	the	secretory	pathway	 (Haubensak	et	
al.,	1998).	Interestingly	the	Val66Met	polymorphism,	a	single	nucleotide	polymorphism	in	the	BDNF	
gene	that	affects	brain	anatomy,	memory	and	anxiety	(Chen	et	al.,	2006;	Egan	et	al.,	2003),	appears	
to	affect	 cell	 sorting	and	presumably	also	processing,	decreasing	 the	amount	of	 releasable	mBDNF	
and	increasing	constitutive	release	of	ProBDNF	(Chen	et	al.,	2004).	
There	 is	not	only	uncertainty	about	the	release	site,	 form	and	regulation	of	BDNF,	but	also	
about	 the	effect	 through	which	BDNF	modulates	 synaptic	 transmission.	Because	of	 its	highly	basic	
properties	BDNF	is	considered	to	act	locally	following	release	and	synapse	specifically	or	affect	only	
synapses	 in	 the	 vicinity	 of	 the	 release	 site	 (Poo,	 2001).	 BDNF	was	 found	 to	 selectively	 potentiate	






transmission	 at	 inhibitory	 synapses	 (Frerking	 et	 al.,	 1998;	 Tanaka	 et	 al.,	 1997),	 while	 selectively	





the	 strengthening	 of	 synaptic	 transmission,	 ProBDNF	mediates	 LTD	 and	 apoptosis	 and	 its	 function	
primarily	 on	 activated	 synapses	 suggests	 some	 sort	 of	 underlying	 coincidence	detection	 (Lu,	 2003;	
Poo,	2001).	
The	biological	function	of	BDNF	is	mediated	by	binding	to	two	different	receptors.	ProBDNF	
binds	 to	 the	 pan-neurotrophin	 receptor	 p75NTR	 (also	 LNGFR	 for	 low-affinity	 nerve	 growth	 factor	




(for	 NT-3)	 (Chao	 and	 Bothwell,	 2002;	 Kaplan	 et	 al.,	 1991).	 Activation	 of	 p75NTR	 by	 neurotrophic	
precursors	 mediates	 cell	 apoptosis	 (Lee	 et	 al.,	 2001)	 and	 selective	 binding	 of	 ProBDNF	 has	 been	
implicated	in	NMDA	receptor	mediated	LTD	(Woo	et	al.,	2005).	 In	accordance	with	this,	deletion	of	
the	p75NTR	gene	results	 in	 increased	spine	density	and	complexity	 (Zagrebelsky	et	al.,	2005).	Even	
though	the	existence	of	the	p75NTR	and	its	functions	are	already	known	for	a	long	time,	its	signaling	
is	not	as	well	understood	as	 that	of	TrkB,	but	 it	has	been	 reported	 to	 involve	 JNK,	p53,	and	NF-κB	
signaling	(Bibel	and	Barde,	2000;	Chao	and	Bothwell,	2002;	Kaplan	and	Miller,	2000).	
When	 processed	 and	 released,	 mBDNF	 binds	 with	 high	 affinity	 to	 and	 activates	 the	 TrkB	
receptor	(Soppet	et	al.,	1991;	Squinto	et	al.,	1991).	mBDNF	binding	to	TrkB	mediates	conformational	
changes	 in	 the	 receptor	 (Li	 et	 al.,	 2002)	 resulting	 in	 dimerization	 and	 autophosphorylation	 of	 the	
intracellular	 tyrosine	 residues,	 consequently	 activating	 the	 tyrosine	 kinases.	 Activated	 tyrosine	
kinases	are	involved	in	triggering	many	different	downstream	signaling	pathways	including	the	MAPK	
(mitogen-activated	protein	 kinase)	 pathway,	 the	phosphatidylinositol	 3-kinase	 (PI3K)	 pathway,	 and	
the	 phospholipase	 C-γ	 (PLC-γ)	 pathway	 (Kaplan	 and	 Miller,	 2000).	 These	 signals	 commonly	
participate	in	the	regulation	of	gene	expression.	It	is	also	speculated	that	TrkB	signaling	induces	local	
synthesis	 of	 proteins	 associated	 with	 spine	 growth	 and	 plasticity	 at	 stimulated	 spines.	 Locally	
synthesized	proteins	promote	actin	dynamics	and	AMPA	receptor	trafficking	in	spines,	which	leads	to	
growth	 of	 the	 spine	 head	 and	 formation	 of	 stable	 LTP	 (An	 et	 al.,	 2008).	 Besides	 the	 full-length	
version,	the	TrkB	receptor	gene	locus	produces	2	known	truncated	variants	of	this	receptor	(TrkB.T1	
and	TrkB.T2)	missing	 the	 intracellular	 tyrosine	kinase	domains	 (Klein	et	al.,	1990).	While	 full-length	
TrkB	and	T1	are	expressed	 in	neurons,	differentiated	astrocytes	 in	 the	hippocampus	are	known	 to	
only	 express	 the	 truncated	 T1	 form	 (Climent	 et	 al.,	 2000;	 Colombo	et	 al.,	 2012;	 Rose	 et	 al.,	 2003;	
Rudge	et	al.,	1994).	Initially	the	truncated	versions	were	thought	to	function	primarily	as	scavengers	
through	 rapid	 internalization	 upon	 binding,	 limiting	 BDNF	 diffusion	 (Biffo	 et	 al.,	 1995;	 Fryer	 et	 al.,	
1996).	However	 they	have	been	 reported	 to	 transmit	BDNF	binding	by	non-canonical	 downstream	
signal	 pathways,	 that	 are	 not	 yet	 well	 defined	 (Aroeira	 et	 al.,	 2015;	 Baxter	 et	 al.,	 1997),	 e.g.	






variants	 (full-length	 and	 2	 known	 truncated	 isoforms)	 the	 p75NTR	 is	 reported	 to	 be	 strongly	
expressed	in	the	developing	rat	cortex,	but	only	weakly	in	the	adult	hippocampus	(Yan	and	Johnson,	
1988,	1989;	Yan	et	al.,	1997).	While	rat	astrocytes	exhibit	strong	expression	levels	of	p75NTR	in	the	
glia	 limitans,	 lining	the	hypothalamus	and	amygdala,	p75NTR	expression	 is	only	weakly	detected	 in	
hippocampal	 cultures	 of	 neurons	 and	 astrocytes	 (Rudge	 et	 al.,	 1994).	 This	 is	 interesting	 because	




though	 from	 these	 studies	 it	 is	 also	 apparent	 that	 p75NTR	 expression	 levels	 are	 high	 during	
development	and	early	adulthood,	but	subsequently	decline	to	much	weaker	levels.	Therefore,	it	can	
be	 generally	 assumed	 that	 p75NTR	 is	 present	 in	 the	 hippocampus	 of	 the	 rat	 and	 mouse	 during	
adulthood,	 though	 at	 comparably	 weaker	 levels	 than	 TrkB.	 Similar	 to	 BDNF	 knockout	 mice,	
homozygous	TrkB	knockout	 animals	do	not	display	 feeding	activity,	 and	mostly	die	within	 the	 first	
postnatal	week.	Neuroanatomical	examination	of	TrkB	knockout	mice	revealed	neuronal	deficiencies	





Given	all	of	these	 interesting	 implications	 it	 is	very	 likely	that	BDNF	can	 indeed	act	through	
both	 constitutive	 and	 regulated	 release	 from	 pre-	 and	 postsynaptic	 sites	 affecting	 molecular	
mechanisms	 on	 both	 sites	 of	 the	 synaptic	 cleft	 (Edelmann	 et	 al.,	 2014).	 Though	 some	 important	
questions	 remain,	 for	 instance	 regarding	 the	 function	 of	 BDNF	 release	 in	 response	 to	 activity.	 For	
example:	 Are	 DCVs	 recruited	 to	 synapses	 upon	 stimulation?	What	 happens	 to	 the	 released	 BDNF	
when	it	is	bound	to	TrkB	and	its	truncated	receptors?	Is	it	endocytosed	and	degraded	or	eventually	






regulation	 of	 BDNF	 have	 been	 implicated	 in	 a	 number	 of	 disorders:	 In	 humans,	 a	 prominent	
polymorphism	 (Val66Met)	 exists	 in	 an	 estimated	 30	-	50	%	 of	 people	 worldwide	 that	 are	 either	
homozygous	or	heterozygous	for	this	single	nucleotide	polymorphism	(SNP)	leading	to	the	exchange	
of	valine	at	the	66th	position	of	BDNF	for	methionine	(Hartmann	et	al.,	2012).	The	mutation	occurs	in	
the	 precursor	 region	 and	 BDNF	 with	 the	 Met	 polymorphism	 fails	 to	 be	 sorted	 to	 the	 regulated	
secretory	pathway,	with	the	functional	consequence	of	decreased	episodic	memory	in	patients	(Chen	
et	 al.,	 2004;	 Egan	 et	 al.,	 2003).	 In	 Huntington’s	 disease	 release	 of	 BDNF	 through	 the	 regulated	
secretory	pathway	also	 is	decreased	 (Hartmann	et	al.,	2012).	Reduced	 levels	of	hippocampal	BDNF	
mRNA	 and	 protein	 have	 been	 reported	 in	 Alzheimer’s	 disease	 and	 are	 suspected	 to	 contribute	 to	
progression	 of	 the	 disease	 (Connor	 et	 al.,	 1997;	 Phillips	 et	 al.,	 1991)	 and	 decreased	 BDNF	 protein	
levels	 have	 also	 been	 demonstrated	 in	 the	 substantia	 nigra	 in	 Parkinson’s	 disease	 (Binder	 and	
Scharfman,	 2004).	 On	 the	 other	 hand,	 elevated	 BDNF	 levels	 are	 associated	 with	 increased	 pain	
sensation	for	inflammatory	injury	conditions	in	peripheral	nerves	and	can	lead	to	neuropathic	pain	in	
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the	 CNS,	 in	 which	 normal	 touch	 and	 pressure	 somatosensation	 becomes	 painful	 (Binder	 and	
Scharfman,	 2004).	 BDNF	 has	 further	 been	 implicated	 in	 a	 number	 of	 psychological	 disorders	 like	










Approaches	 to	 determine	 the	 biological	 mechanisms	 underlying	 synaptic	 plasticity	 focus	 on	 the	
artificial	 stimulation	 of	 cells.	 Changes	 in	 cellular	 chemistry,	 protein	 localization	 and	 signal	
propagation	 properties	 can	 subsequently	 be	 investigated.	 To	 achieve	 this	 a	 large	 set	 of	 diverse	
techniques	 has	 been	 developed,	 dedicated	 to	 stimulating	 neurons	 and	 probing	 their	 responses.	
Commonly	 used	 approaches	 include	 whole-cell	 depolarization,	 usually	 aimed	 at	 the	 activation	 of	
voltage-gated	 channels,	 consequentially	 leading	 to	 action	 potentials	 or	 an	 increase	 of	 the	
intracellular	 Ca2+-concentration.	 The	 easiest	 way	 to	 depolarize	 neurons	 is	 chemically,	 either	 by	
causing	 membrane	 depolarization	 with	 increased	 extracellular	 KCl,	 electric	 field	 stimulation	 or	 by	
application	of	neurotransmitters,	e.g.	glycine	and	glutamate.	KCl-mediated	membrane	depolarization	
experiments	are	performed	at	10	to	50	mM	extracellular	KCl	over	the	time	course	of	a	few	hours	and	
up	 to	 a	 few	 days	 and	 have	 yielded	 significant	 physiological	 data	 without	 obvious	 reports	 of	
cytotoxicity	 (Tongiorgi	et	al.,	1997;	Zafra	et	al.,	1990).	However	higher	KCl	concentrations	will	keep	
cells	at	high	membrane	potentials,	 and	may	not	allow	voltage-gated	 ion	channels	 to	de-inactivate,	
which	 might	 mitigate	 prolonged	 neuronal	 stimulation.	 Pharmacological	 agents	 are	 also	 used	 to	
increase	 neuronal	 network	 activity,	 e.g.	 forskolin	 (stimulating	 adenylyl	 cyclase	 and	 raising	
intracellular	cAMP	levels)	or	bicuculline	(an	antagonist	for	the	GABAA	receptor,	which	decreases	the	
effect	 of	 inhibitory	 synaptic	 conections	 in	 the	 neuronal	 network).	 Glutamate	 and	 KCl	 can	 also	 be	
applied	 locally,	 using	 micropipettes.	 This	 already	 allows	 for	 the	 investigation	 of	 many	 important	
signaling	 parameters,	 but	 generally	 does	 not	 allow	 the	 study	 of	molecular	mechanisms	underlying	




intracellular	 Ca2+	 can	 be	 used	 to	 further	 increase	 the	 precision	 of	 stimulation	 by	 ‘releasing’	








covalent	 bond	 is	 broken	 and	 the	 molecule	 is	 released,	 regaining	 its	 biological	 function.	 This	 has	
several	 advantages	 over	 local	 application	 of	 neurotransmitters	 or	 KCl.	 The	 resolution	 that	 can	 be	
achieved	using	UV-light	exposure	is	only	limited	by	the	diffraction-limit	of	light	and	can	be	restricted	
to	 subcellular	 structures	 on	 a	 cell	within	 the	 field	 of	 view,	 significantly	 decreasing	 the	depolarized	
area	(O'Neill	et	al.,	1990;	Wang	and	Augustine,	1995).	However,	out-of-focus	light	above	and	below	
the	focal	plane	limits	the	resolution	of	the	stimulation,	even	when	focused	to	diffraction-limited	spot	








cell	 is	 presumably	 close	 to	 physiological.	 But	 its	 advantage	 is	 also	 a	 disadvantage	 because	 it	 only	




diffusion	 of	 released	 molecules,	 even	 though	 for	 small	 volumes,	 cannot	 be	 controlled	 and	 the	
double-caged	approach	limits	release	events,	since	every	light	pulse	partially	releases	molecules,	the	
concentration	 of	 these	 molecules	 will	 increase	 over	 time	 and	 at	 some	 point,	 will	 become	 fully	
activated	by	a	second	light	pulse,	even	outside	of	the	plane	of	focus.	
Other	 techniques	 such	 as	 using	 two	 electrodes	 for	 direct	 current	 field	 stimulation	 allow	
stimulating	all	cell	structures,	but	cannot	easily	be	focused	to	a	specific	small	area.	A	way	to	combine	










proteins.	These	approaches	 include:	1.	genetically	engineered	photosensitive	G-proteins	 (with	 light	
mediating	activation	of	cation-channels	via	phospholipase	C),	2.	artificially	designed	chemical	gates	
controlling	 K+-channel	 gating	 (a	 molecule	 which	 binds	 to	 a	 genetically	 engineered	 K+-channel,	 a	
corresponding	 pore	 blocker	 and	 a	 photo-isomerizable	 azobenzene,	 promoting	 conformational	
changes	due	to	light	mediated	cis-	and	trans-state	transitions;	When	exposed	to	light	the	blocker	is	





There	 are	many	 different	 kinds	 of	 photosensitive	 proteins	 that	 have	 evolved	 in	 algae,	 like	
photoreceptive	 enzymes	 and	 ion-pumps,	 but	 also	 light-gated	 cation-channels.	 The	 expression	 of	
these	 so-called	 channelrhodopsins	 (ChRs),	 natively	 obtained	 from	 the	 algal	 Clamydomonas	
reinardhtii	allowed	 for	 the	 first	 time	 light-gated	millisecond-timescale	optical	 control	of	membrane	
depolarization	(Boyden	et	al.,	2005;	Li	et	al.,	2005;	Nagel	et	al.,	2003).	Channelrhodopsins	are	sensory	
photoreceptors	 that	 promote	 phototaxis	 in	 algae	 in	 order	 to	 optimize	 the	 light	 conditions	 for	
photosynthetic	 growth.	 Initially	 two	 native	 sub-types	 were	 described:	 ChR1,	 a	 proton-conducting	
channel	and	ChR2,	a	nonselective	cation-channel.	The	photocurrents	elicited	by	illumination	of	ChR1	
were	not	strong	enough	to	cause	sufficient	depolarization	(Nagel	et	al.,	2005b).	When	expressed	in	
neurons	and	exposed	to	blue-light,	ChR2	opens	and	allows	 for	 the	conductance	of	 ions	along	 their	
concentration	gradient	for	the	duration	of	light	exposure.	The	ion	flux	leads	to	electrophysiologically	
measurable	 photocurrents	 of	 several	 hundred	 pA,	 depolarizing	 the	 cell	 and	 thus	 driving	 it	 to	 fire	
action	 potentials.	 Since	 its	 discovery,	 ChR2	was	 successfully	 established	 as	 one	 of	 the	most	 often	
used	tools	in	the	field	of	neuroscience	and	is	commonly	applied	to	a	huge	number	of	diverse	model	
systems,	both	 in	vitro	and	 in	vivo	 (Deisseroth,	2011).	ChR2	channels	were	mutated	for	mammalian	
expression	and	are	continuously	undergoing	optimization	to	generate	a	number	of	different	variants	





al.,	 2008;	 Nikolic	 et	 al.,	 2009;	 Stehfest	 et	 al.,	 2010).	When	 the	 channel	 is	 illuminated	 in	 its	 dark-
adapted	closed	state	(D480),	it	undergoes	a	conformational	change	to	the	open	channel	state	(P520),	
subsequently	 it	passes	 through	several	 intermediate	 states,	until	 it	 finally	 reaches	 its	dark-adapted	
closed	 state	 again	 and	 the	 cycle	 can	 be	 repeated.	 Interestingly	 it	 has	 been	 found	 that	 some	




as	 depicted	by	 the	 arrows	 in	 Figure	 1b.	Due	 to	
its	 fast	 gating	 kinetics,	 this	 is	 usually	 not	 of	
practical	 use.	 The	 ChR2	C128S,	 C128T	 and	
C128A	 mutants,	 termed	 step-function-opsins	
and	 related	 channels,	 possess	 long	 open-
channel	 states	 where	 photocurrents	 can	 be	
efficiently	 stopped	 with	 the	 exposure	 of	 a	
second	 closing	 wavelength.	 Especially	 these	
variants	 exhibit	 another	 distinctive	 feature;	 at	
the	 late	 stage	 of	 their	 photocycle,	 they	 can	
branch-off	 into	 a	 long-lasting,	 non-conducting	
state	 (P380).	Channels	trapped	 in	this	state	will	
take	a	 few	minutes	to	enter	their	dark-adapted	
(D480)	 ground	 state	again	and	during	 this	 time	
cannot	 contribute	 to	 the	 photocurrent.	 This	
state	 is	 supposedly	 entered	 due	 to	 prolonged	
stimulation,	 but	 can	 be	 significantly	 reduced,	 if	
channels	are	closed	prematurely	by	illumination	
with	 the	 respective	 closing	 wavelength	
(Schoenenberger	 et	 al.,	 2009).	 Further	 ChR2-
related	 ion-channels	 and	 ion-pumps	 have	 been	
found	 in	 different	 organisms,	 extending	 the	
spectrum	 of	 available	 channels	 with	 different	
properties	 even	 further.	 Detailed	 information	
about	 channel	 structure	 and	 function	 is	
expected	to	lead	to	more	sophisticated	modifications	and	channel	variants	in	the	future.	




two-photon	 illumination,	 decreasing	 out-of-focus	 activation	 (Mohanty	 et	 al.,	 2008;	 Packer	 et	 al.,	
2012;	 Schoenenberger	 et	 al.,	 2008).	 A	 very	 elegant	 approach	 for	 the	 physiological	 and	 controlled	
stimulation	 of	 postsynaptic	 sites	 can	 be	 achieved	 by	 optogenetic	 stimulation	 of	 the	 presynaptic	
neuron	 (Zhang	 and	 Oertner,	 2007).	 Synapses	 can	 then	 be	 identified	 by	 colocalization,	 e.g.	 of	 a	
fluorescently	labeled	PSD,	expressed	in	the	postsynaptic	neuron	with	the	fluorescent	signal	from	the	
ChR	 in	 the	 presynaptic	 neuron.	 These	 approaches	 have	 been	 combined	 with	 electrophysiological	
stimulation	of	the	postsynaptic	neuron,	demonstrating	the	usefulness	of	this	technique	for	the	study	
of	 synaptic	 plasticity	 (Zhang	 and	 Oertner,	 2007).	 Recent	 combinatorial	 expression	 of	 spectrally	
Figure	1:	Proposed	basic	ChR2	photocycle	(a)	proposed	
by	 and	 graphic	 borrowed	 from	 Bamann	 et.	 al	 2008	
(respective	 figure	 5)	 and	 a	 further	 extended	 variant	
based	on	the	C128	variants	(b)	proposed	by	and	graphic	
borrowed	 from	 Stehfest	 et	 al.	 2010	 (respective	
figure	8).	
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separable	 light-gated	 channels	 with	 pH-sensitive	 fluorophores	 and	 genetically	 encoded	 calcium	
indicators	provides	an	all-optical	approach	for	multiplex	control	and	tracking	of	neuronal	activity	(Li	
and	Tsien,	2012).	
Several	groups	already	 focused	on	 the	use	of	hChR2	 in	order	 to	control	neural	activity	and	
achieve	focal	stimulation	and	using	focused	laser	beams	with	reduced	laser	power	spatial	selectivity	
of	<30	μm	was	achieved	(Schoenenberger	et	al.,	2008).	Two-photon	stimulation	was	already	tested	
by	using	920	nm	 light,	 achieving	a	diffraction	 limited	 stimulation	 spot	of	 ~1.1	μm	 (Mohanty	et	 al.,	
2008;	Papagiakoumou	et	al.,	2010).	However,	most	of	these	techniques	aim	to	elicit	action	potentials	
and	so	far,	no	technique	exists	that	allows	for	the	specific	and	highly	focal	control	of	activity	in	both	
pre-	and	postsynaptic	 structures.	Such	methods	could	significantly	contribute	 to	 the	broadening	of	
our	 understanding	 of	 detailed	 signaling	 processes	 in	 neuronal	 networks	 and	 the	 involvement	 of	
molecules	in	the	regulation	of	synaptic	plasticity	at	individual	synapses	or	even	sub-synaptic	sites.	
We	 developed	 a	 possible	 approach	 to	 stimulate	 single	 synapses	 or	 smaller	 areas	 by	 using	
step-function	 opsins,	 making	 use	 of	 their	 switching	 properties	 and	 illumination	 inspired	 by	 STED/	
RESOLFT	 microscopy.	 A	 center	 focused	 light	 beam	 would	 be	 used	 to	 activate	 channels,	 while	 a	
surrounding	but	partially	overlapping	illumination	with	the	respective	closing	wavelength	of	channels	
would	 eliminate	 the	photocurrent	 in	 this	 area,	 thus	 allowing	unprecedented	nano-regions	 of	 focal	
activation	down	to	single	channels.	
	
The	 goal	 of	 this	 dissertation	 was	 to	 test	 the	 feasibility	 of	 currently	 available	 channels	 for	 the	
stimulation	 of	 single	 synapses	 using	 this	 technique	 in	 order	 to	 study	 cellular	 processes	 underlying	
synaptic	 plasticity,	 in	 particular	 the	 recruitment	 of	 BDNF	 to	 synaptic	 sites.	 This	 idea	 arose	 from	
preliminary	 results	 in	 which	 neurotrophins	 were	 recruited	 to	 synaptic	 sites	 in	 neuronal	 networks	
stimulated	with	LTP-induction	protocols,	where	LTP	of	synapses	 is	thought	to	underlie	 learning	and	
memory.	 Such	 results	 prompted	 the	 novel	 hypothesis	 that	 neurotrophins	 (and	 perhaps	 other	
signaling	molecules)	may	be	 targeted	specifically	 to	activated	synapses	 to	modulate	 their	 strength,	
for	 example	 during	 the	 acquisition	 of	 new	 information	 during	 learning.	 In	 order	 to	 test	 this	 idea	









Unless	 specifically	 indicated,	 lab	 consumables	 were	 bought	 from	 STARLAB	 GmbH	
(‘STARLAB/CytoOne’;	 Hamburg,	 Germany;	 www.starlab.de),	 Sarstedt	 AG	 &	 Co.	 (Nümbrecht,	
Germany;	 www.sarstedt.com),	 Greiner	 Bio-One	 GmbH	 (Frickenhausen,	 Germany;	
www.gbo.com/bioscience),	 Eppendorf	 Vertrieb	 Deutschland	 GmbH	 (Wesseling-Berzdorf,	 Germany;	
www.eppendorf.com)	or	Carl	Roth	GmbH	&	Co.	KG	(‘Roth’;	Karlsruhe,	Germany;	www.carlroth.com).	






Biotech	 AG	 (Konstanz,	 Germany;	 gatc-biotech.com).	 Extensive	 subcloning	 and	 mutagenesis	 tasks	
were	 directed	 to	 GenScript	 (Piscataway,	 U.S.A.;	 www.genscript.com).	 In	 addition,	 kits	 for	 DNA	
purification	and	gel	extraction	were	bought	from	MACHEREY-NAGEL	GmbH	&	Co.	KG	(‘MN’;	Düren,	
Germany;	www.mn-net.com)	and	QIAGEN	(Hilden,	Germany;	www.qiagen.com)	and	for	transfection	
of	 mammalian	 cells	 using	 electroporation	 from	 Lonza	 Cologne	 GmbH	(Cologne,	 Germany;	
www.lonza.com).	
All	 microscopes	 used	 for	 this	 dissertation	 were	 produced	 by	 Carl	 Zeiss	 Microscopy	
GmbH	(‘Zeiss’;	Göttingen,	Germany),	electrophysiological	recordings	were	done	using	amplifiers	and	
software	 from	 HEKA	 Elektronik	 GmbH	 (Lambrecht/Pfalz,	 Germany;	 www.heka.com)	 and	





Most	 common	 vectors	 for	 CaMKIIα-controlled	 expression	 of	 channelrhodopsins	 used	 in	 this	
dissertation	 (pAAV-CaMKIIα-‘hChR2’-mCherry/EYFP-WPRE),	 were	 provided	 by	 the	 lab	 of	 Karl	
Deisseroth,	MD,	Ph.D.	(Stanford	University/Howard	Hughes	Medical	Institute,	U.S.A.).	These	include	
the	H134R,	T159C,	E123T/T159C	and	C128S/D156A	ChR2	variants	(Berndt	et	al.,	2011;	Yizhar	et	al.,	
2011)	 and	 ChR1	 VChR1	 chimera	 C1V1	 E122T/E162T	 (Erbguth	 et	 al.,	 2012),	 as	 well	 as	 a	 P2A-motif	






With	 the	 assistance	 of	 GenScript	 pAAV-CaMKIIα-hChR2(H134R)-mCherry-WPRE,	 pAAV-
CaMKIIα-hChR2(T159C)-mCherry-WPRE	 and	 pAAV-CaMKIIα-C1V1(E122T/E162T)-TS-mCherry	 were	
mutated	 to	 combine	 common	 ChR	 characteristics	 and	 yield	 the	 slow-photocycle	 high-conducting	
variants	 hChR2(C128A/H134R/T159C),	 hChR2(C128A/L132C/T159C)	 and	 C1V1(E122T/C167S)	 in	 the	
same	backbone.	
Additional	ChRs	used	 for	 this	work,	 selected	 for	 their	 strong	photocurrents,	Chronos	 (pN3-





EGFP-WPRE)	 promoter	 control,	 as	 well	 as	 for	 the	 expression	 of	 LSSmOrange	 (pMito-LSSmOrange,	
Addgene	#37135)	and	the	genetically	encoded	calcium	indicator	RCaMP1c	(Akerboom	et	al.,	2013),	
originally	 made	 by	 the	 group	 of	 Loren	 L.	 Looger,	 Ph.D.	 (Janelia	 Farm	 Reseach	 Campus/Howard	
Hughes	 Medical	 Institute,	 Ashburn,	 U.S.A.),	 were	 provided	 by	 Dr.	 Sebastian	 Kügler	 (University	
Medicine	 Göttingen,	 Department	 of	 Neurology,	 Germany).	 By	 molecular	 cloning	 the	 LSSmOrange	
fluorophore	 was	 exchanged	 for	 the	 two	 cell	 type	 specific	 promotors	 to	 yield	 pAAV-hsyn-
LSSmOrange-WPRE	 and	 pAAV-GFAP2.2-LSSmOrange-WPRE	 (refer	 to	 the	 section	 about	 molecular	
cloning	for	further	detail).		
A	 vector	 for	 the	 expression	 of	 rat	 proBDNF,	 fused	 to	mRFP1	 (pBa-BDNF-mRFP1),	 originally	
made	by	the	group	of	Gary	Banker,	Ph.D.	(Oregon	Health	&	Science	University,	U.S.A.)	was	provided	
by	 Michael	 Silverman,	 Ph.D.	 (Simon	 Fraser	 University,	 Canada).	 And	 the	 vector	 with	 the	
corresponding	 receptor,	 TrkB	 (pEGFP-N1-TrkB,	 Addgene	 #32500),	 originally	 produced	 in	 the	 lab	 of	
Rosalind	Segal,	MD,	Ph.D.	(Dana-Farber	Center/Harvard	Cancer	Center,	U.S.A.)	was	provided	by	Katja	
Burk,	Ph.D.	(European	Neuroscience	Institute	Göttingen,	Germany).	By	molecular	cloning,	TrkB-EGFP	
was	 put	 in	 the	 pAAV-hsyn-LSSmOrange	 backbone,	 to	 make	 pAAV-hsyn-TrkB-EGFP/LSSmOrange-
WPRE	(refer	to	the	molecular	cloning	section	for	further	detail).	With	the	assistance	of	GenScript,	the	
backbone	 of	 the	 proBDNF-mRFP1	 was	 swapped	 with	 the	 one	 from	 pAAV-CaMKIIα-hChR2(T159C)-
P2A-EYFP-WPRE,	 provided	by	 the	 lab	of	 Karl	Deisseroth,	MD,	Ph.D.;	 at	 first,	 to	 get	pAAV-CaMKIIα-




ECFP).	 ECFP	 was	 later	 mutated	 to	 EGFP,	 to	 yield	 pAAV-CaMKIIα-BDNF-mRFP1-P2A-EGFP-WPRE.	
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Based	 on	 this,	 BDNF	 was	 removed	 from	 the	 construct	 to	 yield	 pAAV-CaMKIIα-mRFP1-P2A-EGFP-
WPRE	and	the	two	fluorophores	were	swapped	to	produce	pAAV-CaMKIIα-BDNF-EGFP-P2A-mRFP1-
WPRE.	
CMV	 promoter-driven	 expression	 vectors	 for	 GFP	 labeled	 EEA1	(GFP-EEA1)	 and	
RAB5A	(Rab5a-eGFP),	were	provided	by	 the	 lab	of	Pietro	De	Camilli,	MD	 (Yale	 School	of	Medicine,	








containing	 serotype	2	 replication	and	 capsid	 sequences	 (Klugmann	et	 al.,	 2005),	were	provided	by	
the	 lab	 of	 Moritz	 Rossner,	 Ph.D.	 (Psychiatric	 Clinic	 of	 the	 Ludwig-Maximilians-University)	 and	 the	
adenovirus	 helper	 plasmid	 pF∆6	 was	 provided	 by	 Susanne	 Schoch	 McGovern,	 Ph.D.	 (University	
Hospital	of	Bonn,	Germany).	
Adeno-associated	virus	(AAV)	
Purified	 and	 concentrated	 AAV	 serotype	 6	 virions	 for	 the	 delivery	 of	 hsyn-EGFP	 (2	x	108	vp/µl),	
hysn-ProBDNF	 (1.9	x	108	vp/µl),	 CaMKIIα-BDNFmRFP1-P2A-EGFP	(0.7	x	108	vp/µl)	 and	 CaMKIIα-








were	 amplified	 using	 SURE	 (Stop	 Unwanted	 Rearrangement	 Events)	 cells	 (Stratagene;	
cat.	no.	200238).	 Cells	 were	 grown	 in	 LB-media	 after	 the	 formulation	 of	 Luria/Miller	 (Roth;	
cat.	no.	X968.1),	 containing	 the	 appropriate	 antibiotic	 for	 positive	 selection	 (either	 100	µg/ml	
Ampicillin	 or	 50	µg/ml	 Kanamycin)	 and	were	 incubated	 at	 37	°C	 and	 250	-	290	rpm.	 LB-Agar	 plates	
additionally	contained	15	g/l	Agar	(Roth;	cat.	no.	5210.2).	
Cells	were	made	electrocompetent	by	following	a	protocol	provided	by	Sandra	Ott-Gebauer	







To	 transform	 cells,	 0.5	-	1	µg	plasmid	 DNA	 and	 50	µl	 of	 electrocompetent	 cells	 were	
transferred	 to	 a	 1	mm	 electrode	 gap	 electroporation	 cuvette	 from	 Biozym	 Scientific	 GmbH	
(cat.	no.	748010;	 Hessisch	 Oldendorf,	 Germany).	 An	 electric	 pulse	 was	 then	 delivered	 with	 the	
Electroporator	2510	(Eppendorf)	at	1800	Volts.	Subsequently,	cells	were	collected	in	1	ml	LB	medium	
of	which	100	µl	was	distributed	on	a	10	cm	LB-Agar	dish	for	overnight	incubation.	The	following	day	
single	colonies	were	transferred	to	5	ml	LB	 liquid	cultures	 for	6	-	8	hours	of	 incubation,	after	which	
the	 total	 volume	 was	 increased	 to	 300	ml	 for	 overnight	 incubation	 and	 until	 the	 OD600	 ranged	
between	3	-	4.	Cells	were	pelleted	by	centrifugation	at	3320	rcf	and	at	4	°C	for	40	min	and	plasmids	
extracted	with	the	NucleoBond	Xtra	Maxi	kit	(MN),	according	to	the	user	manual	instructions	(MN	-
	March	2014/Rev.	12).	 In	brief	the	extraction	 is	based	on	NaOH/SDS	 lysis	of	the	cells	 (Birnboim	and	
Doly,	 1979),	 removal	 of	 cell	 debris,	 denatured	 proteins	 and	 chromosomal	 DNA	 by	 filtration	 and	
binding	 of	 plasmid	 DNA	 to,	 under	 acidic	 conditions,	 positively	 charged	 methyl-amino-ethanol	
residues	 on	 silica	 beads	 in	 the	 provided	 columns,	 while	 other	 contaminants	 are	 washed	 through.	
Plasmid	DNA	is	eluted	by	neutralization	of	the	positive	charges	in	the	columns	under	slightly	alkaline	
conditions,	 precipitated	 with	 2-propanol,	 washed	 with	 ethanol	 and	 resuspended	 in	 dH2O	 upon	
centrifugation.	 DNA	 yield	 and	 purity	 was	 determined	 with	 a	 Nanophotometer	 (Implen	 GmbH,	
Munich,	Germany;	www.implen.de).	
Vector	quality	control	&	molecular	cloning	
Received	 vectors	were	 commonly	 tested	by	 restriction	digests	 for	 their	 expected	 restriction	digest	
patterns	 and	 also	 sent	 for	 sequencing	 to	 verify	 the	 correct	 insert.	 For	 the	production	of	AAVs	 the	
integrity	 of	 the	 insert-flanking	 ITRs	 is	 essential	 and	 was	 therefore	 assessed	 by	 performing	 SmaI	
digests;	 SmaI	 has	 two	 target	 sequences	 in	 each	 ITR.	 When	 vectors	 failed	 the	 initial	 verification	
process,	 new	 sources	 for	 the	 vectors	were	 found	 and	 contact	with	 collaborators	 providing	 flawed	
vectors	was	discontinued.	
Standard	mix	for	a	restriction	digest	
Plasmid	DNA-solution	 	 	 2	-	5	µg	
10x	restriction	enzyme	specific	buffer	 2	µl	
restriction	enzyme	(10	U/µl)	 	 1	µl/enzyme	






Tris	(C4H11NO3)	 	 	 	 	242	g	 	 									(Roth;	cat.	no.	A411.1,	M	121.14	g/mol)	
Acetic	acid	(C6H4O2)	 	 	 57.1	ml		 									(Roth;	cat.	no.	6755.2,		M	60.05			g/mol)	
0.5	M	EDTA	(pH	8.0,	C10H16N2O8)	 	100	ml		 									(Roth;	cat.	no.	CN06.4,	M	292.25	g/mol)	
dH2O	 	 	 	 	 up	to	1	l	





light.	 Samples	 were	 directly	 loaded	 with	 6	µl	 6x	Loading	 Dye	(Thermo	 Scientific;	 cat.	no.	R0611),	
containing	bromphenol	blue	and	xylene	cyanol	FF	as	visual	references.	100	and	1,000	bp	GeneRuler	





Integrated	DNA	 Technologies,	 Inc.	 (https://eu.idtdna.com/Primerquest/Home/Index)	 and	 produced	
by	Sigma.	
Sequences	for	primers	binding	in	the	promotor	region	
CMV	 	 CGCAAATGGGCGGTAGGCGTG	 (forward)	
CaMKIIα	 GTTCTCCGTTTGCACTCAGG	 (forward)	
GFAP	 	 CAGGTTGGAGAGGAGAC	 (forward)	
U6	 	 ACGATACAAGGCTGTTAG	 (forward)	
Sequences	for	primers	binding	in	the	coding	DNA	sequence	(CDS)	
BDNF	 	 GCTGGCGATTCATAAGGATAGA	 (forward)	
BDNF	 	 ATTCACGCTCTCCAGAGTCC	 (reverse)	
hChR2	 	 AAACTGAACATCGGCGGAAC	 (forward)	




DNA	 fragments	 produced	 through	 restriction	 digest,	were	 separated	 from	 the	 agarose	 gel	 using	 a	
scalpel	 and	 DNA	 was	 extracted	 using	 a	 QIAquick	 Gel	 Extraction	 Kit	(QIAGEN;	 cat.	no.	28704)	
according	 to	 the	 provided	 protocol.	 In	 brief,	 the	 DNA	 fragment	 containing	 gel	 is	 dissolved	 by	





Ligations	were	performed	using	 a	 T4	DNA	 Ligase	 (Thermo	Scientific;	cat.	no.	EL0011),	 following	 the	
recommendations	of	the	User	Guide	provided	by	the	Ligase	manufacturer.	
Ligation	reaction:	
Linear	vector	 	 	 	 100	ng	
Insert	DNA	 	 	 	 300	-	500	ng	
10x	T4	DNA	Ligase	Buffer	 	 2	µl	
T4	DNA	Ligase	 	 	 	 1	µl	
dH2O	 	 	 	 	 to	a	total	of	20	µl	
	
To	 be	 able	 to	 express	 LSSmOrange	 under	 a	 cell-type	 specific	 promotor	 and	 prepare	 it	 for	 AAV-
mediated	transduction,	it	was	subcloned	into	pAAV-6P-noTB-SEWB	and	pAAV-GFAP2.2-EGFP-WPRE.	
EGFP	 was	 removed	 from	 those	 vectors	 and	 LSSmOrange	 was	 cut	 out	 from	 its	 original	 vector	 by	
digesting	all	three	plasmids	with	BsHTI	(AgeI)	and	NotI	(Thermo	Scientific;	cat.	no.	ER1462	&	ER0591).	
Fragments	 were	 separated	 through	 agarose	 gel	 electrophoresis	 and	 respective	 bands	 extracted,	
combined	 and	 ligated	 to	 yield	 pAAV-hsyn-LSSmOrange-WPRE	 and	 pAAV-GFAP2.2-LSSmOrange-
WPRE.	
To	overexpress	TrkB	under	synapsin	promotor-control	and	get	a	LSSmOrange-tagged	variant,	
Trkb-EGFP	 was	 subcloned	 into	 pAAV-hsyn-LSSmOrange-WPRE,	 by	 digesting	 with	 EcoRI	 and	 NotI	
(Thermo	Scientific;	cat.	no.	ER0271	&	ER0591)	to	get	the	EGFP	variant,	and	EcoRI	and	BamHI	(Thermo	
Scientific;	 cat.	no.	ER0271	&	ER0051)	 to	 cut	 away	 the	 EGFP	 and	 produce	 the	 fragments	 for	 the	
LSSmOrange	variant.	Fragments	were	separated	through	agarose	gel	electrophoresis	and	respective	
bands	extracted,	combined	and	ligated	to	produce	the	pAAV-hsyn-TrkB-EGFP/LSSmOrange	vectors.	




For	 this	 dissertation	 the	 most	 frequently	 used	 model	 system	 to	 investigate	 optogenetic	
photocurrents	and	BDNF	transfer	was	dissociated	primary	hippocampal	cultures	from	E19	rats;	these	
cultures	 consist	 mainly	 of	 excitatory	 pyramidal	 cells,	 are	 well	 characterized	 and	 provide	 a	 simple	
approach	 to	 study	 basic	 physiological	 functions	 (Banker	 and	 Cowan,	 1977;	 Benson	 et	 al.,	 1994).	
However,	 organotypic	 hippocampal	 slice	 cultures	 from	 P4	 rats	 were	 also	 prepared	 to	 study	 the	
transfer	of	fluorescently	labeled	BDNF	in	an	intact	circuit,	where	connectivity	is	well	known	(Schaffer,	




where	 they	 were	 housed	 and	 paired	 for	 breeding.	 All	 animal	 handling	 and	 experiments	 were	
conducted	 in	accordance	 to	 relevant	 institutional	guidelines	and	 regulations	of	 the	German	animal	
protection	act.	
Human	 embryonic	 kidney	 cells	 (HEK	293)	 bought	 from	 Stratagene	 (cat.	no.	240073)	 and	






HBSS	(Hank’s	Balanced	Salt	Solution)	 	 	 	 	 			(Gibco;	cat.	no.	14170-088)	
Hepes	(1	M)	 	 	 	 	 10	mM	 	 	 			(Gibco;	cat.	no.	15630-056)	
Plating	medium	
DMEM	(Dulbecco’s	modified	Eagle	media)	 	 	 	 			(Gibco;	cat.	no.	41966-029)	
Fetal	Bovine	Serum	(FBS)	 	 	 10	%	 	 	 			(Gibco;	cat.	no.	10500-064)	
GlutaMax	(200	mM	L-alanyl-L-glutamine)	 2	mM	 	 	 			(Gibco;	cat.	no.	35050-038)
	 	
Penicillin	10,000	units/ml	 	 	 100	units/ml	 	 			(Gibco;	cat.	no.	15140-122)	
Streptomycin	10,000	µg/ml	 	 	 100	µg/ml	
Culture	medium	
Neurobasal	medium	 	 	 	 	 	 	 			(Gibco;	cat.	no.	21103-049)	
B-27	Supplements	(Brewer	et	al.,	1993)	 	 1	ml/50	ml	 	 			(Gibco;	cat.	no.	17504-001)	
GlutaMax	(200	mM	L-alanyl-L-glutamine)	 2	mM	 	 	 			(Gibco;	cat.	no.	35050-038)	
Penicillin	10,000	units/ml	 	 	 100	units/ml	 	 			(Gibco;	cat.	no.	15140-122)	
Streptomycin	10,000	µg/ml	 	 	 100	µg/ml	
PEI	coating	
Dissociated	 hippocampal	 cultures	 were	 cultured	 on	 Ø-25	mm	 borosilicate	 cover	 glasses	 with	 a	
thickness	of	1.5H	(0.17	mm)	Paul	Marienfeld	GmbH	(cat.	no.	0117650;	Lauda-Königshofen,	Germany;	




stocks	were	made	with	dH2O,	 stored	 at	 -20	°C,	 diluted	 further	 to	 0.04	%	and	 for	 coating,	 2	ml	PEI-






1991;	 Kaech	 and	 Banker,	 2006).	 Pregnant	Wistar	 rats	were	 sacrificed	 between	 E18	 and	 E19	 using	
combined	 CO2	 and	 cervical	 dislocation.	 Embryos	 were	 extracted	 and	 brains	 transferred	 to	 10	cm	
dishes	 containing	 dissection	 medium.	 Using	 forceps,	 hemispheres	 were	 separated,	 meninges	
removed,	 hippocampi	 extracted	 and	 collected	 in	 a	 separate	 15	ml	 falcon-tube	 on	 ice.	 Tissue	 was	
digested	 in	2	ml	0.25	%	Trypsin-EDTA	 (Gibco;	 cat.	no.	25200-056)	 for	20	min	at	37	 °C,	 subsequently	
washed	 3	 times	 with	 5	ml	dissection	medium	 and	 triturated	 in	 1	ml	 plating	medium.	 Still	 existent	
tissue	 lumps	 were	 removed	 by	 filtration	 through	 a	 100	µm	 cell	 strainer	 (Corning,	 Inc.;	
cat.	no.	352360)	and	yield	was	determined	using	a	hemocytometer,	 excluding	dead	cells	by	 trypan	
blue	 staining	 (Sigma;	cat.	no.	T8154).	 Final	 concentration	 was	 adjusted	 and	 cells	 were	 plated	 at	
densities	of	30,500	to	37,000	cells/cm2	in	600	µl	plating	medium	per	cover	glass	and	cultured	at	37	°C	
and	5	%	CO2.	 The	 following	day	plating	media	was	 exchanged	 for	 2	ml	 culture	medium.	Cells	were	


















precipitate	 became	 a	 standard,	 highly-efficient	 technique	 to	 deliver	 expression	 vectors	 to	 cells	 in	






NaCl	(sodium	chloride)	 	 	 														274	mM									(Roth;	cat.	no.	P029.4,		M			58.44	g/mol)	
KCl	(potassium	chloride)	 	 	 		10	mM								(Roth;	cat.	no.	6781.1,		M			74.56	g/mol)	
Na2HPO4	(di-sodium	hydrogenphosphate)	 	1.4	mM								(Roth;	cat.	no.	T876.2,		M	141.96	g/mol)	
D(+)-Glucose	(C6H12O6)	 	 	 	 		15	mM								(Roth;	cat.	no.	HN06.3,	M	180.16	g/mol)	








Plasmid	DNA	 	 	 3.5	-	4	µg	
dH2O	 	 	 added	up	to	a	total	of	60	µl	
Transfection	buffer	 	 			60	µl	
To	 make	 the	 transfection	 mix,	 CaCl2	 solution,	 dH2O	 and	 plasmid	 DNA	 are	 thoroughly	 mixed	 and	
transfection	buffer	 is	 subsequently	added	drop-wise,	while	 the	 tube	 is	 continuously	gently	 shaken.	
Before	 application	 the	 finished	 transfection	mix	 is	 incubated	 for	 20	min	 at	 room	 temperature,	 to	
allow	the	calcium	phosphate	precipitate	formation	to	take	place.	
Conditioned	 culture	 medium	 was	 collected	 and	 exchanged	 for	 pre-equilibrated	
Opti-MEM	(Gibco;	cat.	no.	11058-021),	1/3rd	fresh	culture	medium	was	added,	the	mix	sterile	filtered	
using	 0.22	µm	 syringe-driven	 filters	 (Millipore;	 cat.	no.	SLGV033RS)	 and	 stored	 under	 cell	 culture	
conditions	until	needed.	Per	well,	120	µl	transfection	mix	was	gently	distributed	over	the	culture	and	
the	culture	was	put	back	 into	the	 incubator	 for	90	min.	Afterwards	 the	transfection	mix	containing	
Opti-MEM	was	exchanged	for	37	°C	and	10	%	CO2	pre-equilibrated	Neurobasal	medium,	followed	by	
another	 10	min	 of	 incubation	 under	 culturing	 conditions	 and	 subsequent	 exchange	 for	 the	
conditioned	medium	to	remove	the	precipitate.	
If	 cell	 health	 is	 affected	 or	 less	 efficient	 transfection	 is	 wanted,	 incubation	 times	 or	




serotype	1	&	2	chimeric	virions	 (Hauck	et	al.,	2003)	 (see	HEK	293	cell	 section	 for	 further	detail).	Of	
	30	
the	 harvested	 supernatant	 1	-	2	µl	 were	 applied	 per	 well	 and	 directly	 to	 the	 culture	 media	 of	
dissociated	 hippocampal	 cultures	 at	 DIV3.	 These	 chimeric	 virions	 successfully	 transduce	 both	
neurons	 and	 astrocytes	 and	 the	 observed	 transduction	 efficiency	 of	 >80	%,	 detected	 by	 the	
neuronal	(synapsin)	 and	 astrocyte	(GFAP2.2)	 promoter-specific	 expression	 of	 fluorophores	 was	
consistent	 with	 that	 reported	 in	 the	 literature	 (Royo	 et	 al.,	 2008).	 Purified	 AAV	 serotype	 6	 was	
applied	 at	 106	virions	 per	Ø-25	mm	 culture.	 This	was	 sufficient	 to	 drive	 strong	 and	 ICC	 detectable	





be	 used	 to	 deliver	 the	 target	 vector.	 This	 was	 done	 for	 TrkB-LSSmOrange,	 LSSmOrange	 control	
construct,	 and	 subcellular	marker	 proteins	 (EEA1,	 Rab5a,	 Rab7a,	 Lamp1	 and	 LC3).	 Electroporation	
was	 done	 using	 a	 Rat	 Neuron	 Nucleofector	 Kit	 (Lonza;	 cat.	no.	VPG-1003)	 and	 the	 corresponding	




of	 3	µg	 plasmid	 DNA	 and	 transfer	 to	 the	 certified	 cuvettes,	 also	 provided	 with	 the	 kit.	 For	
transfection	of	both	cell	types,	neurons	and	astrocytes,	the	Nucleofector	program	O-003	(for	primary	
rat	hippocampal	or	 cortical	neurons	and	high	 cell	 viability)	was	used.	 Subsequently,	 the	 cells	were	














MEM	(Minimal	Essential	Medium)	 	 50	%	 	 	 			(Gibco;	cat.	no.	11090-081)	
HBSS	(Hank’s	Balanced	Salt	Solution)	 	 25	%	 	 	 			(Gibco;	cat.	no.	14170-088)	
Horse	serum	 	 	 	 	 25	%	 	 	 			(Sigma;	cat.	no.	H1138)	
GlutaMax	(200	mM	L-alanyl-L-glutamine)	 2	mM	 	 	 			(Gibco;	cat.	no.	35050-038)	
D(+)-Glucose	(C6H12O6)	 	 	 														6.5	mg/ml					(Roth;	cat.	no.	HN06.3,	M	180.16	g/mol)	
	 	
Pencillin	10,000	units/ml	 	 	 100	units/ml	 	 			(Gibco;	cat.	no.	15140-122)	
Streptomycin	10,000	µg/ml	 	 	 100	µg/ml	
Based	 on	 the	 original	 recipe	 for	 Filter	 Culture	Medium	published	 at	 Cold	 Spring	Harbor	 Protocols:	
(http://cshprotocols.cshlp.org/content/2007/10/pdb.rec11167)	
Preparation	
P4-Wistar	 rats	 were	 decapitated	 and	 brains	 transferred	 to	 10	cm	 dishes	 containing	 dissection	
medium	enriched	with	6.5	mg/ml	D(+)-Glucose.	Using	forceps	and	periodontal	probes,	hemispheres	
were	 separated,	meninges	 removed,	 hippocampi	 extracted	 and	 collected	 in	 a	 separate	 10	cm	dish	
containing	glucose	enriched	dissection	medium.	400	µm	thick	coronal	 slices	were	prepared	using	a	
manual	 tissue	 slicer	 (Stoelting	 Co.	 Europe,	 Dublin,	 Ireland;	 cat.	no.	51425	 equipped	 with	 Astra	
Superior	 Platinum	 razor	 blades).	 Slices	 were	 selected	 based	 on	 their	 appearance	 under	 the	
stereotactic	 microscope	 and	 2	-	3	slices	 were	 transferred	 on	 Ø-30	mm	 hydrophilic	
polyterafluorethylene	 membranes	 with	 0.4	µm	 pores	 (Millipore;	 cat.	no.	PICM0RG50)	 in	 6-well	




AAV	 injection	was	 done	 at	DIV1	 after	medium	 change.	 Injection	 pipettes	were	made	 from	
borosilicate	 capillaries	 (Drummond	Scientific	Company,	Broomall,	U.S.A.;	 cat.	no.	3-000-203-G/X,	




crude	 AAV1/2	 extract	 or	 purified	 AAV6,	 using	 20	µl	 Microloader	 pipette	 tips	(Eppendorf;	
cat.	no.	5242	956.003)	and	slices	were	injected	in	CA3	or	CA1	areas,	identified	by	morphology,	using	
a	FemtoJet	express	5248	(Eppendorf;	cat.	no.	92001	0521)	at	550	pi	(injection	pressure)	for	3	-	7	s	to	
deliver	 volumina	 in	 the	 range	 of	 estimated	 50	-	100	 nl.	 Successful	 expression	 was	 checked	 the	






DMEM	(Dulbecco’s	modified	Eagle	media)	 	 	 	 			(Gibco;	cat.	no.	41966-029)	
Fetal	Bovine	Serum	(FBS)	 	 	 10	%	 	 	 			(Gibco;	cat.	no.	10500-064)	
Pencillin	10,000	units/ml	 	 	 100	units/ml	 	 			(Gibco;	cat.	no.	15140-122)	
Streptomycin	10,000	µg/ml	 	 	 100	µg/ml	
HEK	293	cell	culturing	
HEK	293	cells	were	cultured	in	10	cm	cell	culture	dishes	(Greiner	Bio-One;	cat.	no.	664160)	with	10	ml	







per	 dish,	 cells	 were	 resuspended	 in	 1	ml	FBS	 containing	 10	%	DMSO	 (Sigma;	 cat.	no.	276855)	 and	
glycerol	 (Roth;	 ca.	no.	3783.1).	 1	ml	 aliquots	 in	 cryotubes	 were	 then	 transferred	 to	 a	 2-Propanol	
freezing	 container	 for	 slow	 freezing	 (Thermo	 Scientific/Nalgene;	 cat.	no.	5100-0001),	 frozen	 and	
subsequently	stored	at	-80	°C.	For	starting	a	culture,	one	of	these	cryostocks	was	thawed	and	diluted	




transfecting	 HEK	293	 cells	 with	 vectors	 encoding	 AAV	 sequences	 for	 the	 generation	 of	 the	 viral	
particles	and	the	vector	containing	the	sequence	that	the	AAVs	are	supposed	to	deliver,	flanked	by	
two	 internal	 tandem	 repeats	 (ITR),	 that	 are	 important	 for	 the	 packaging	 process	 (McClure	 et	 al.,	
2011).	 Different	 serotypes	 have	 different	 target	 tissue	 or	 can	 handle	 larger	 genes	 for	 packaging	
better	 than	others.	These	can	be	mixed	by	delivering	vectors	with	 the	different	specific	 replication	
and	 capsid	 sequences,	 the	 chimeric	 variants	 hold	 mixed	 characteristics	 from	 the	 contributing	
serotypes;	especially	the	serotype	1	&	2	hybrids	were	shown	to	be	efficient	 in	transducing	neurons	
and	astrocytes	(Allocca	et	al.,	2008;	Hauck	et	al.,	2003;	Royo	et	al.,	2008).	
HEK	293	 cells	 were	 grown	 until	 a	 density	 of	 60	%	 was	 reached	 and	 transfected	 with	 the	
vector	plasmid,	a	50:50	 ratio	of	plasmids	 for	AAV1	 (pH21)	and	AAV2	 (pRV1)	 replication	and	capsid	
sequences	 and	 the	 adenovirus	 helper-plasmid	 (pF∆6),	 using	 an	 adapted	 calcium	 phosphate	
transfection	protocol	for	10	cm	dishes	(80	µg	total	plasmid	DNA,	50	%	pF∆6,	25	%	expressionvector,	
12.5	%	pH21	 and	 pRV1).	 Important	 differences	 are,	 that	 prior	 to	 transfection	 HEK	293	 cells	 were	




culture	 for	 at	 least	48	-	72	hours.	 Successful	 transfection	 could	often	be	observed	by	 fluorescence;	
most	 constructs,	even	 though	equipped	with	a	CaMKIIα,	 synapsin	or	GFAP	promotor,	were	weakly	
expressed	 in	 HEK	293	 cells.	 Cell	 culture	 health	 was	 continuously	 checked	 during	 this	 time	 and	 if	
medium	pH	dropped,	 indicated	by	 the	phenol	 red	pH	 indicator	 contained	 in	 the	medium,	medium	
was	 gently	 exchanged.	 Cells	 were	 kept	 as	 long	 as	 possible	 in	 culture	 to	 maximize	 the	 time	 cells	
produce	 viral	 particles	 and	 therefore	 increase	 yield.	 In	 case	 cells	 grew	 too	 dense	 and	 started	
detaching,	or	after	48	-	72	hours	post	transfection,	cells	were	harvested	in	500	µl	DPBS	and	lysed	by	4	
repeated	 freezing	 (-80	°C)	and	 thawing	 (37	°C)	cycles.	Cell	debris	was	 removed	by	centrifugation	at	
10,000	rcf	 for	 5	min.	 Supernatant	 containing	 a	 crude	AAV	 extract	was	 transferred	 to	 1.5	ml	 tubes,	




Immunocytochemistry	 generally	 describes	 the	 detection	 of	 specific	 antigens	 via	 binding	 of	 an	
antigen-specific	antibody,	which	either	directly	or	 indirectly	can	be	detected	with	dyes	or	enzymes	
connected	 to	 the	 antibodies.	 Since	 the	 first	 use	 of	 dye-coupled	 antibodies	 for	 the	 detection	 of	 a	
specific	 antigen	 (Coons	et	 al.,	 1941),	 this	 technique	became	a	 common	 laboratory	method	 for	 the	




NaCl	(sodium	chloride)	 	 	 	 80	g	 						(Roth;	cat.	no.	P029.4,					M			58.44	g/mol)	
KCl	(potassium	chloride)	 	 	 2	g	 						(Roth;	cat.	no.	6781.1,					M			74.56	g/mol)	
Na2HPO4	(di-sodium	hydrogen	phosphate)	 14.4	g	 						(Roth;	cat.	no.	T876.2,					M	141.96	g/mol)	
KH2PO4	(potassium	dihydrogen	phosphate)	 2.4	g	 					(Merck;	cat.	no.	104873,	M	136.08	g/mol)	













Donkey	serum	 	 	 	 			2	%	 	 (Sigma;	D9663)	
Triton-X	 	 	 	 0.1	%	 	 (Roth;	cat.	no.	3051.2)	
NaN3	(sodium	azide)	 	 												0.05	%	 	 (Roth;	cat.	no.	K305.1)	
in	2x	PBS	
Primary	antibodies	 	 	 	 	 Secondary	antibodies	
antigen	|	host	spec.	|	dilution	|	provider	(cat.	no.)	 Fluorph.	|	antigen	|	host	|	provider	(cat.	no.)	
ALDH1L1				mouse									1:500	 NeuroMab	(75-164)	 AF488	 					mouse			donkey		 A-21202	
BDNF		 						mouse									1:100	 DSHB	#9	 	 AF488	 						rabbit						goat		 A-11008	
EEA1	 							rabbit									1:300	 R.	Jahn,	Dr.	(MPI:bpc)	 AF488	 								rat	 						donkey		 A-21208	
GFAP								guinea	pig					1:750	 Synaptic	Sys.	(173	004)	 AF546	 								rat							donkey		 A-11081	
GFP	 						mouse							1:1000	 Abcam	(ab1218)	 AF647	 					mouse			donkey		 A-31571	
GFP	 							rabbit							1:1000	 Abcam	(ab290)	 	 AF647	 					mouse						goat	 A-21235	
Iba1	 							rabbit									1:100	 Wako	(019-19741)	 AF647	 						rabbit						goat				 A-21244	
Lamp1	 						mouse									1:100	 Enzo	Life	Sciences	(ADI-VAM-EN001-D)	
Map2	 						mouse							1:2000	 Millipore	(MAB3418)	 AF647	 		guinea	pig		goat				 A-21450	







samples	were	blocked	and	permeabilized	by	 incubation	 in	1	ml	blocking	buffer	 for	30	min.	Primary	
antibody	was	applied	in	1	ml	blocking	buffer	in	the	above	stated	dilutions	and	kept	overnight	at	4	°C.	







GFP	detection,	was	mixed	with	 the	 respective	 fluorescently	 labeled	 secondary	antibody,	 incubated	






NaCl	(sodium	chloride)	 	 	 	 90	mM	 								(Roth;	cat.	no.	P029.4,		M			58.44	g/mol)	
KCl	(potassium	chloride)	 	 	 		5	mM	 								(Roth;	cat.	no.	6781.1,		M			74.56	g/mol)	
CaCl2	(calcium	chloride)		 	 	 		2	mM	 								(Roth;	cat.	no.	HN04.3,	M	147.02	g/mol)	
MgCl2	(magnesium	chloride)	 	 			 		2	mM	 								(Roth;	cat.	no.		KK36.3,	M			95.22	g/mol)	
NH4Cl	(ammonium	chloride)	 	 	 50	mM	 									(Roth;	cat.	no.	P726.1,		M			53.49	g/mol)	
Hepes	(C8H18N2O4S)	 	 	 	 20	mM	 								(Roth;	cat.	no.	HN77.4,	M	238.31	g/mol)	




low	 profile	 RC-41LP	 imaging	 chamber	 from	Warner	 Instruments,	 LLC	 (Hamden,	 U.S.A.;	 cat.	no.	64-
0368)	with	a	bottom	part	suitable	to	hold	Ø-25	mm	cover	glasses	and	chambers	were	filled	with	1	ml	
of	 an	 imaging	 buffer,	 which	 was	 principally	 the	 same	 as	 the	 extracellular	 solution	 for	 doing	
electrophysiology	 (refer	 to	 the	 electrophysiology	 section	 below	 for	 contents),	 but	 the	 KCl	
concentration	 was	 increased	 to	 5	mM	 and	 NaCl	 concentration	 was	 adjusted	 accordingly	 to	







and	 a	 cover	 glass.	 OHBS	 were	 imaged	 using	 Plan-APOCHROMAT	 10x	 or	 20x	 objectives	 (Zeiss;	
cat.	no.	420640-9900	&	420650-9901).	Image	acquisition	was	controlled	with	the	provided	Zen	Black	
software;	 software	 intrinsic	 algorithms	 determined	 optimal	 imaging	 parameters,	 laser	 line,	 filters,	
detector	 ranges,	 scanning	 speed	 and	 resolution,	 based	 on	 the	 used	 fluorophores	 and	 objectives.	
Laser	 intensity	 and	 gain	 was	 adjusted	 with	 the	 help	 of	 the	 range	 indicator.	 8-bit	 images	 were	
considered	sufficient	 for	most	 images	meant	 for	quantitative	analysis.	Unless	specifically	 indicated,	
images	were	acquired	and	saved	as	8-bit	 images	 in	the	Zeiss	microscope	file	format	CZI,	preserving	
the	 provided	 metainformation.	 Within	 the	 separate	 experiments	 imaging	 conditions	 were	 kept	
consistent.	
Fixed	 and	 mounted	 samples	 were	 imaged	 using	 the	 same	 microscope,	 equipment	 and	





Image	 files	were	 handled	 and	 analyzed	with	 the	Open	 Source	 and	public	 domain	 software	 ImageJ	
(Wayne	 Rasband,	 National	 Institutes	 of	 Health,	 U.S.A.;	 version	 1.50e)	 and	 the	 derived	 image-
processing	 package	 Fiji	 (‘Fiji	 is	 just	 ImageJ’,	 version	 2.0.0-rc-43/1.50e).	 Colocalization	 was	 tested	
using	 the	 provided	 Coloc	2	 plugin.	 For	 this,	 backprojected	 pinhole	 radii	 and	 PSF	 for	 20x	 W	Plan	
(1332.42	nm	&	2D	4.88	µm)	and	40x	(710.63	nm	&	2D	3.75	µm)	Plan	objectives	were	calculated	using	
the	 PSF	 calculator	 (Scientific	 Volume	 Imaging	 B.V.,	 Hilversum,	 Netherlands;	
https://svi.nl/forms/pinhole.php;	 https://svi.nl/NyquistCalculator).	 Data	 handling,	 calculations	 and	
graphs	 were	 done	 using	 Microsoft	 Excel	 for	 Mac	 2011	 (Microsoft;	 version	 14.6.0)	 and	 statistical	
analysis	was	done	and	representative	graphs	were	created	using	Prism	(GraphPad	Sofware,	 Inc.,	La	




NaCl	(sodium	chloride)	 	 	 	 148	mM								(Roth;	cat.	no.	P029.4,		M			58.44	g/mol)	
KCl	(potassium	chloride)	 	 	 		2.4	mM							(Roth;	cat.	no.	6781.1,		M			74.56	g/mol)	
CaCl2	(calcium	chloride)		 	 	 					2	mM							(Roth;	cat.	no.	HN04.3,	M	147.02	g/mol)	
MgCl2	(magnesium	chloride)	 	 	 					1	mM							(Roth;	cat.	no.		KK36.3,	M			95.22	g/mol)	
Hepes	(C8H18N2O4S)	 	 	 	 			10	mM							(Roth;	cat.	no.	HN77.4,	M	238.31	g/mol)	





potassium	gluconate	 	 	 															130	mM							(Sigma;	cat.	no.	P1847,	M	234.25	g/mol)	
KCl	(potassium	chloride)	 	 	 					8	mM							(Roth;	cat.	no.	6781.1,		M			74.56	g/mol)	
CaCl2	(calcium	chloride)		 	 	 					2	mM							(Roth;	cat.	no.	HN77.4,	M	283.31	g/mol)	
MgCl2	(magnesium	chloride)	 	 	 					1	mM							(Roth;	cat.	no.		KK36.3,	M			95.22	g/mol)	
EGTA	 	 	 	 	 	 			10	m	 								(Sigma;	cat.	no.	P1847,	M	234.25	g/mol)	
Hepes	(C8H18N2O4S)	 	 	 	 			10	mM							(Roth;	cat.	no.	HN77.4,	M	238.31	g/mol)	
Mg-ATP	 	 	 	 	 					2	mM							(Sigma;	cat.	no.	A9187,	M	507.18	g/mol)	
GTP-Na		 	 	 	 				 		0.3	mM						(Sigma;	cat.	no.	G8877,	M	523.18	g/mol)	
Osmolality	should	be	between	290	-	295	mOsm.	pH	was	adjusted	to	7.3	with	1	M	KOH.	
Optogenetic	&	electrophysiological	experiments	





9910),	 40x	 and	 63x	EC	 Plan-NEOFLUAR	 (cat.	no.	420460-9900	 &	 420480-9900)	 and	 100x	α	 Plan-
APOCHROMAT	 (cat.	no.	420792-9800);	 a	 TIRF	 slider	 module	 (cat.	no.	423683-9021),	 a	 laser	
manipulation	 module	 (‘Direct	 FRAP’;	 cat.	no.	423635-9000)	 and	 an	 Evolve	 512	 EMCCD	 camera	
(Photometrics,	 Tucson,	 U.S.A.).	 The	 AxioObserver.Z1	 was	 custom-modified	 with	 the	 help	 of	 Rapp	
OptoElectronic	 GmbH	 (‘ROE’;	 Hamburg,	 Germany).	 An	 additional	 594	nm	 laser	 (DL594	 594	nm	
100	mW	(DPSS	laser))	was	added	and	brought	into	the	epi-fluoresence	light	path	with	a	940	µm	light	
guide	Figure	2a,	together	with	custom	photomasks,	complementing	the	already	existing	DirectFRAP	
photomasks	 by	 adding	 a	 594	nm	 border	 (2	µm	 for	 100x	 objective)	 around	 the	 DirectFRAP	
photomasks	(Figure	2b,c).	ROE	photomask	#1,	providing	illumination	of	a	150	µm	wide	area	with	the	
100x	 objective	(Figure	 2c)	 or	 no	 photomask	was	 used	 for	 initial	 wavelength	 response	 tests.	More	
positions	 for	DirectFRAP	and	ROE	photomasks	exist,	but	were	not	used	 in	 this	dissertation.	System	
lasers	and	DL594	were	operated	by	TTL	pulses	delivered	by	the	HEKA	amplifier	to	the	generic	digital	
in	port	at	the	SVB1	component	or	directly	to	the	acousto-optic	modulator	of	the	DL594	(Figure	2d).	
The	 purpose	 of	 generic	 digital	 in	 ports	was	 defined	 using	 the	 software	 controlling	 the	microscope	
components	 to	 design	 custom	 imaging	 procedures,	 delivering	 light	 aligned	 to	 the	 recording	
procedure.	 The	 measured	 channel	 properties	 and	 observed	 effects	 of	 simultaneous	 illumination	
were	well	within	reasonable	limits	and	conserved	throughout	related	channel	variants.	We	therefore	
reason,	 that	 the	 results	 are	 still	 meaningful	 to	 draw	 conclusions	 about	 the	 individual	 channel	
properties.	In	addition,	because	we	did	not	use	a	specialized	setup	for	electrophysiological	recordings	
and	combined	optical	stimulation,	where	all	the	components	would	work	perfectly	syntonic	and	are	
adjusted	 to	 the	 experimental	 conditions,	we	were	 depending	 on	 a	 ready-made	 conventional	 TIRF-
laser	microscope	 hardware	 and	 software	 controlling	 the	 laser	module	with	 the	 405,	 488,	 561	 and	
639	nm	 lasers.	 The	 amplifier	was	 operated	 using	 a	 second	 computer	 running	 the	 software	 for	 the	
electrophysiological	 recordings,	 simultaneously	 orchestrating	 the	 laser	 stimulations	 by	 TTL	 trigger	
pulses	 delivered	 by	 the	 amplifier	 to	 control	 the	 DL594	 auto	 occustic	 mirror	 and	 trigger	 the	 SVB1	
microscope	 signal	distribution	box	of	 the	TIRF	microscope.	This	 complex	 stimulation	and	 recording	
apparatus	was	the	origin	for	inaccuracies	and	delays	in	the	signaling	and	hence,	control	and	timing	of	
the	 laser	 pulses.	 Consequently,	 some	 recordings	 exhibit	 tiny,	 but	 nevertheless	 noticeable	 shifts	 in	
illumination	onset,	duration	and	stop	of	the	single	wavelength	or	simultaneous	 illumination.	This	 is	
only	 a	 cosmetic	 problem	 and	 should	 have	 no	 influence	 on	 the	 significance	 of	 the	 here	 reported	
findings.	
Laser	 powers	were	 determined	with	 a	 laser	 power	meter	 (Fieldmate)	 and	 a	 silicon	 optical	




use	 and	with	 the	 TIRF/FRAP	 beamsplitter	 set	 at	 50	%	TIRF/50	%	FRAP.	 The	measured	 laser	 powers	
	38	
were	 subsequently	 corrected	 for	 the	 respective	 transmission	 of	 the	 objective	 (~90	%	 and	 ~70	%).	
Laser	output	generally	fluctuated	±30	µW	and	the	measurement	error	was	previously	determined	to	
be	around	10	%.	DL594	was	measured	using	 the	200	µm	 light	guide	and	 respective	powers	 for	 the	










being	 tested	 were	 applied	 (Figure	 2d).	 To	 increase	 the	 available	 594	nm	 power,	 the	 940	µm	 light	
guide	was	 exchanged,	 first	 for	 a	 200	µm	 and	 then	 finally	 a	 100	µm	 light	 guide,	 consequently	 also	
decreasing	 the	 maximal	 diameter	 of	 the	 ROE	 photomask	 #1	 to	 100	µm	 and	 the	 system-provided	
beamsplitter	 in	 the	 DirectFrap	 module	 was	 exchanged	 for	 an	 AHF	 beam-splitter	 providing	 80	%	
transmission	 from	 the	 epi-fluorescence	 and	 ROE	 mask	 illumination	 and	 20	%	 reflection	 for	 the	
DirectFRAP	laser	(AHF	analysetechnik	AG,	Tübingen,	Germany;	cat.	no.	F21-008).	




with	200	ms	 long	488	nm	 light	pulses	using	 the	DirectFRAP	#7	at	 2	%	 laser	power.	 Finally,	 #9	&	10	
DirectFRAP	 photomasks	 were	 overlaid	 with	 #15	&	16	 ROE	 photomasks	 to	 produce	 a	 rough	
macroscopic	representation	of	an	illumination	inspired	by	STED/	RESOLFT	microscopy	(Figure	2e,f).		
To	 investigate	 the	 effect	 of	 local	 ChR	 stimulation	 on	 the	 mobility	 of	 BDNF-mRFP	 puncta,	
BDNF-mRPF-P2A-hChR2(T159C	or	L132C)-ECFP	expressing	cells	were	imaged	using	the	63x	objective	
and	sequential	0.5	Hz,	250	ms	long	405	or	488	nm	light	pulses	at	20	%	laser	power	(~300	W/cm2	or	
1,300	W/cm2)	 were	 delivered	 for	 1	-	3	min	 using	 the	 DirectFRAP	 photomask	 #10	 focused	 onto	
traversing	processes.	Before	and	after	the	 light	stimulation	puncta	were	 imaged	at	0.1	Hz	for	10	or	
up	 to	 90	min.	 In	 order	 to	 verify	 local	 ChR	 activation	 visually	 red	 fluorescent	 genetically	 encode	




photocurrents	 and	decrease	 spontaneous	and	network	activity,	 1	µM	Tetrodotoxin	 (‘TTX’,	 selective	





2,3-dione,	 competitive	AMPA/Kainate	 receptor	 agonist	 (Honoré	 et	 al.,	 1987);	 Sigma;	 cat.	no.	C239)	
and	10	µM	gabazine	(GABAA	receptor	antagonist	 (Heaulme	et	al.,	1987);	Abcam;	cat.	no.	ab120042)	
was	 added	 to	 the	 extracellular	 solution.	 Patch	 pipettes	 were	 made	 of	 fire	 polished	 borosilicate	
capillaries	 (Harvard	 Apparatus,	 Holliston,	 U.S.A.;	 cat.	no.	300060,	 OD	1.5	mm	x	ID	0.86	mm)	 with	 a	
horizontal	P-97	Micropipette	Puller	equipped	with	a	3	x	3	mm	box	filament	(Sutter	Instruments	Co.;	
cat.	no.	P-97	&	FB330B).	 The	 defined	 pulling	 protocol	 was	 closest	 to	 the	 ones	 recommended	 for	
patch	pipettes	provided	 in	 the	user	manuals;	 and	was	 adapted	 to	produce	pipettes	with	 electrical	




Instruments,	 Inc.).	The	whole	setup	was	carefully	grounded	and	shielded	 to	 reduce	electrical	noise	
from	 nearby	 components.	 Whole-cell	 patch-clamp	 recordings	 were	 obtained	 with	 an	 EPC10	 USB	
double	 patch-clamp	 amplifier	 from	 HEKA	 and	 the	 corresponding	 Patchmaster	 software	 at	
40	µs	(25	kHz)	 sampling	 intervals.	Microscope	 and	 components	 including	 lasers	were	 controlled	 at	
first	via	the	Zeiss	AxioVision	software	and	 later	using	Zen	Blue.	Transfected	cells	were	 identified	by	
fluorescence	 and	 selected	 for	 experiments	 based	 on	 health	 and	 membrane	 integrity.	 Recordings	
were	 acquired	 while	 voltage-clamping	 cells	 at	 -70	mV	 holding	 potential.	 Liquid	 junction	 potential,	
pipette	 and	 cell	 capacitance	 influences	 were	 compensated	 using	 amplifier-provided	 internal	
compensation	 procedures.	 Recording	 files	 were	 managed	 with	 IGOR	 Pro	 (Wavemetrics;	 version	
6.22A),	 with	 the	 addition	 of	 the	 Patcher’s	 Power	 Tools	 extension	 for	 working	 with	 HEKA	 files,	





electrophysiological	 experiments.	 (a)	Modified	 schematic	 from	 ROE	 showing	 light	 paths	 and	 entry	 for	 the	
DL594	on	the	Axio	Observer.Z1.	(b)	Modified	summary	of	the	photoactivation	masks	of	the	DirectFRAP	system	
by	 Zeiss,	 taken	 from	 the	 instrument	 description	 (M60-2-0042	e	05/2012),	 showing	 photomask	 patterns	 and	
sizes	 according	 to	 the	 respective	 objective	magnifications.	 (c)	Specifications	 for	 the	 ROE	mask	 design.	 Given	




the	 Pulse	 Generator	 of	 the	 amplifier	 software,	 orchestrating	 laser	 pulses.	 (f)	Schematic	 showing	 the	










The	aim	of	 this	project	was	 to	 investigate	 the	 feasibility	of	optogenetically	 stimulating	highly	 focal	
areas	 on	 neurons	 from	 single	 synapses	 down	 to	 structures	 of	 a	 few	 nanometer,	 by	 using	 an	
illumination	strategy	borrowed	from	the	field	of	super	resolution	microscopy.	This	strategy	consists	
of	 illuminating	 a	 specific	 area	 with	 a	 wavelength	 that	 activates	 channelrhodopsins,	 while	
simultaneously	 illuminating	 an	 overlapping	 donut	 with	 a	 wavelength	 that	 de-activates	 these	
channels,	as	graphically	displayed	 in	Figure	2f	and	g,	 thereby	activating	a	small	central	 region	only.	
Prospective	 favorable	 channelrhodopsin	 characteristics	 and	 candidates	 were	 identified	 and	
illumination	conditions	optimized.	Finally,	we	provide	data	to	prove	the	proposed	concept.	
Channelrhodopsin	characterization	
Due	 to	 a	 lack	 of	 sufficient	 information	 about	 the	 structure-function	 relationship	 in	
channelrhodopsins,	 it	 was	 not	 possible	 to	 predict	 if	 any	 given	 channel	 protein	 can	 be	 efficiently	




promising.	 Their	 photocurrents	 could	 be	 substantially	 reduced	when	 gated	with	 405	nm	 light	 and	





As	 a	 first	 step,	 channels	 were	 tested	 for	 functional	 expression	 in	 dissociated	 hippocampal	
neurons	 with	 photocurrents	 elicited	 by	 405,	 488,	 561,	 594	 and	 639	nm	 single	 wavelength	 laser	
illumination	 (Figure	3,	Figure	4;	yellow	boxes)	and	subsequently	 for	 their	behavior	under	combined	
coillumination	 (Figure	 3,	 Figure	 4;	 blue	boxes	 below	 respective	 channels).	 All	 available	 laser	
combinations	 for	 two	 wavelengths	 were	 tested.	 The	 hereafter-displayed	 combinations	 are	 those	
where	 effects	 could	 be	 observed.	 The	 first	 group	 of	 tested	 channels	 included	 the	 common	 ChR2	
variants	with	fast-photocycles	(H134R,	T159C,	E123T/T159C	and	L132C),	channels	published	to	have	
red-shifted	 activation	 spectra	 (namely	 C1V1	(E122T/E162T)	 and	 ReaChr)	 and	 channels	 that	 were	
reported	to	have	strong	photocurrents	(Chronos	and	CoChr)	(Figure	3).	Single	wavelength	responses	
of	the	H134R	and	T159	variants	were	almost	identical.	Both	demonstrated	pronounced	peak	currents	
of	 0.6	-	1	nA	 and	 stationary	 currents	 of	 around	 500	pA	 for	 405	 and	 488	nm	 illumination.	 These	




and	 594	nm.	 The	 most	 intriguing	 characteristic	 of	 this	 channel	 is	 its	 fast	 kinetics	 for	 which	 it	 is	
popular	(Berndt	et	al.,	2011).	This	characteristic	was	not	specifically	assessed,	but	can	be	inferred	by	





red-shifted	 wavelengths,	 but	 respond	 almost	 equally	 well	 to	 405	 and	 488	nm.	 However,	
photocurrents	 for	 both	 channels	 ranged	 around	 300	-	400	pA.	 Chronos	 and	 CoChR	 could	 both	 be	
efficiently	opened	by	 illumination	at	405,	488	and	561	nm.	Of	 these,	488	nm	evoked	 the	strongest	
photocurrents.	With	2	nA	to	800	pA,	Chronos	exhibited	a	very	distinct	peak-stationary	current	ratio	
for	488	nm	stimulation,	which	was	markedly	 reduced	 for	 the	other	wavelengths	 tested.	CoChR	did	




efficiently	 close	 channels.	 None	 of	 the	 channels	 from	 the	 first	 group	 displayed	 efficient	 channel	
closing	 under	 simultaneous	 illumination.	 Some	 photocurrent	 reduction	 was	 observed	 for	 488	nm	
mediated	 activation	 and	 simultaneous	 594	nm	 inactivation,	 however	 these	 reductions	 were	 very	
limited.	 The	 H134R	 variant	 was	 tested	 first	 and	 displayed	 some	 reduction.	 Decreased	 activation	
intensities	 did	 not	 increase	 the	 effect	 further,	 even	 though	 maximum	 depolarizing	 photocurrents	
were	 reduced.	 Experiments	 testing	 increasing	 594	nm	 intensities	 at	 a	 constant	 488	nm	 intensity	
suggested	 that	 photocurrent	 reduction	 efficiencies	 were	 not	 yet	 fully	 saturated	 at	 100	%	 594	nm,	
which	was	the	reason	for	later	modifications	to	the	light	path	of	the	setup	to	further	increase	594	nm	
intensities.	 T159C	 demonstrated	 even	 weaker	 photocurrent	 reduction	 by	 594	nm.	 Interestingly,	
reduction	 in	 photocurrent	 was	 stronger	 when	 T159C	 channels	 were	 coilluminated	 with	 405	nm	
compared	to	594	nm.	E123T/T159C	and	L132C	both	exhibited	a	weak	photocurrent	reduction	for	the	
488	nm	activated	state,	with	simultaneous	594	nm	coillumination,	but	due	to	its	increased	activation	
properties	 in	 the	 red	 spectrum,	 photocurrents	 of	 E123T/T159C	 elicited	 by	 405	nm	 light	 even	
increased	 for	 simultaneous	 illumination	 with	 561	 or	 594	nm.	 The	 red-shifted	 channels	 C1V1	
E122/E162T	and	ReaChR	were	mainly	tested	for	405	nm	mediated	photocurrent	reduction,	because	
simultaneous	 illumination	 with	 488,	 561	 or	 594	nm	 light	 in	 addition	 to	 405	 or	 488	nm	 activated	
currents	 caused	 a	 further	 photocurrent	 increase.	 C1V1	 and	 ReaChR	 channels	 exhibited	 only	 mild	
405	nm	mediated	photocurrent	reduction	when	activated	with	561	or	488	nm.	Interestingly,	CoChR	
photocurrents	 could	 be	 reduced	 when	 488	 and	 561	nm	 activation	 was	 combined	 with	 405	nm	




than	 those	 evoked	 by	 561	nm.	 Thus	 we	 expected	 a	 further	 photocurrent	 increase	 with	
coillumination.	 594	nm	 had	 no	 noticeable	 effect	 on	 the	 different	 conducting	 states,	 but	 561	nm	
coillumination	 decreased	 currents	 evoked	 by	 405	nm.	 Chronos	 did	 not	 show	 any	 significant	
photocurrent	 reduction	 under	 the	 tested	 conditions,	 only	 very	 weakly	 for	 simultaneous	 405	nm	
illumination,	 when	 activated	 with	 488	nm.	 On	 the	 contrary	 and	 as	 expected	 from	 the	 single	
wavelength	 results;	 405,	 488	 or	 561	nm	 coillumination	 did	 increase	 photocurrents	 of	 the	 405	 or	
561	nm	activated	states.	
Based	on	published	information	about	their	closing	behavior,	the	above	mentioned	group	of	
channels	was	extended	to	 include	step-function	opsin	variants,	 including	 the	 ‘classical’	 stable	step-
function	ChR2	C128S/D156A	also	termed	SSFO,	the	custom-combined	variants	C128A/H134R/T159C	
and	 C128A/L132C/T159C,	 a	 C1V1-derived	 E122T/C167S	 and	 the	 CoChR-based	 C108S	 and	
C108S/D136A	variants.	Chronos	slow	photocycle	variants	were	also	tested,	but	did	not	express	well	
in	 dissociated	 hippocampal	 neurons.	 All	 of	 these	 channels	 are	 best	 characterized	 by	 their	 much	
slower	photocycles	or	more	precisely,	stable	open	channel	state.	In	addition	we	also	included	eNPAC,	
a	co-expression	construct,	combining	co-expression	of	halorhodopsin	3.0	and	ChR2	H134R	(Figure	4).	
Channels	with	 a	 stable	 open	 state	 have	 in	 common	 that	 they	 are	 very	 light	 sensitive.	 Even	 under	
unspecific	 broad-spectrum	 daylight	 conditions	 channels	 open	 and	 start	 accumulating	 in	 the	
conducting	open	channel	state.	Therefore	channels	were	closed	before	and	after	each	experiment	by	
a	brief	 illumination	with	the	respective	closing	wavelength.	The	classical	stable	step-function	opsin,	
C128S/D156A,	was	 tested	 first.	Generally,	 it	 can	be	noted,	 that	 the	mutations	giving	 rise	 to	a	 slow	
photocycle	phenotype	significantly	reduce	photocurrents;	these	two	variables	appear	to	be	directly	
coupled.	 If	C128	and	D156	or	 their	corresponding	sites	 in	other	channels	are	mutated	to	the	slow-
photocycle	 variants,	 a	 drop	 in	 the	 photocurrent	 of	 around	 90	%	 can	 be	 expected.	 For	 ChR2	




(Berndt	 et	 al.,	 2009;	 Prakash	et	 al.,	 2012)	with	 the	 stable	 and	 strong	photocurrents	of	 the	H134R,	
T159C	or	L132C	variants.	Both	channels	did	exhibit	photocurrent	responses	of	350	-	400	pA	for	405	
or	488	nm	illumination	and	some	weak	photocurrents	for	561	nm.	For	both	stimulation	wavelengths,	
currents	 directly	 rose	 to	 stationary	 levels	 and	 without	 any	 detectable	 peak	 photocurrents.	 When	
488	nm	 exposure	 was	 stopped,	 currents	 exhibited	 a	 small	 increase,	 because	 even	 488	nm	 light	
partially	 closes	 channels,	 an	 effect	 that	 was	 not	 detected	 for	 405	nm	 stimulation.	 The	 major	
difference	between	these	channels	was	the	marked	slower	channel	kinetics	of	the	L132C	containing	
variant.	 Even	when	 illuminated	with	 only	 594	nm	 at	 full	 intensity,	 photocurrents	 decreased	much	
slower	 than	 for	 other	 channels	 and	 exhibited	 a	 declining	 curve,	 suggesting	 a	 minimum	 of	 two	





from	 the	 original	 channels	 without	 the	 step-function	mutation.	 Photocurrents	 were	 reduced	 to	 a	
mere	50	-	300	pA	for	405	and	488	nm	illumination.	No	marked	responses	to	red-shifted	wavelengths	






unlike	 the	original	C1V1	channel	 this	 version	was	derived	 from,	C1V1	E122T/C167S	did	not	exhibit	
405	nm	 evoked	 photocurrents,	 but	 continued	 to	 respond	 to	 488,	 561,	 594	 and	 weakly	 also	 to	
639	nm.	 Instead,	 the	 channel	 containing	 the	 step	 function	 mutations	 could	 now	 be	 closed	 by	
exposure	 to	 405	nm.	 488	nm	 illumination	 evoked	 typical	 slightly	 increased	 initial	 photocurrents,	
subsequently	 reducing	to	a	stable	plateau;	while	561	and	594	nm	excitation	evoked	more	step-like	
photocurrents.	
As	 opposed	 to	 other	 approaches,	 the	 use	 of	 the	 eNPAC	 construct	 does	 not	 depend	 on	 a	
specific	illumination	to	close	channels,	but	rather	on	a	balance	between	blue	light	activation	of	ChR2	
H134R	 to	 depolarize	 cells	 and	 red	 light	 activation	 of	NpHR3.0	 to	 hyperpolarize	 cells.	 Photocurrent	
responses	were	detected	for	all	tested	wavelengths.	405	and	488	nm	evoked	responses	were	almost	
identical	 to	 standard	 ChR2	 H134R	 responses.	 However,	 photocurrents	 for	 both	 wavelengths	 and	
especially	 for	 488	nm	were	 slightly	weaker	 and	displayed	a	 small	 and	brief	 transient	 just	 after	 the	
illumination	was	 stopped.	NpHR3.0	 is	not	exclusively	 active	at	 red	wavelengths,	but	 is	 also	weakly	
activated	by	488	nm	and	less	by	405	nm	illumination.	For	that	reason,	the	488	nm	currents	are	more	
affected	 by	 hyperpolarizing	 currents	 than	 currents	 evoked	 by	 405	nm.	 The	 small	 current	 increase	
after	 the	 stimulation	 originates	 in	 part	 from	 the	 same	 phenomenon.	 Because	 the	 pumping	 of	
chloride-ions	by	NpHR3.0	 is	an	active	process	driven	by	 light,	 it	stops	almost	 instantaneously	when	
the	 illumination	 is	 discontinued.	 ChR2	 H134R	 channels	 passively	 conduct	 ions	 along	 their	
concentration	gradients	as	long	as	their	conducting	pore	is	open.	The	channels	open	when	they	are	
activated	 with	 light	 and	 change	 their	 conformation,	 passing	 through	 several	 intermediate	 states,	
until	they	finally	reach	their	closed	ground	state	again.	This	process	takes	time,	represented	by	the	
curve	 of	 the	 photocurrent	 when	 illumination	 is	 stopped.	 For	 a	 brief	 moment,	 the	 hyperpolarizing	
current	drops	faster	than	the	depolarizing	currents	and	therefore	causes	further	depolarization.	This	
effect	 is	 not	 present	 for	 405	nm	 excitation,	 implying	 that	 halorhodopsins	 are	 not	 significantly	
activated	 at	 this	 wavelength	 and	 the	 drop	 in	 the	 hyperpolarizing	 current	 does	 not	 surpass	 the	





We	 then	 tested	 various	 channels	 for	 their	 inactivation	 properties	 during	 simultaneous	
illumination	 with	 405	 or	 488	 nm	 light,	 and	 with	 561	 or	 594	 nm	 light.	 The	 C128S/D156A	 channel	




markedly	 stronger	photocurrent	 reduction	 for	405	and	594	nm	coillumination.	The	 channel	 closing	
speed	 depended	 on	 the	 594	nm	 light	 intensity	 and	 was	 not	 fully	 saturated,	 even	 with	 maximal	
intensity	in	our	experiments.	The	very	slow	closing	kinetics	of	the	L132C	containing	variant	rendered	
this	variant	suboptimal.	For	CoChR	properties	changed	more	profoundly.	While	the	original	version	
did	 not	 possess	 any	 594	nm	 mediated	 photocurrent	 inactivation,	 the	 two	 mutated	 step-function	
variants	exhibited	some	inactivation	with	594	nm	light	when	activated	with	488	nm	and	more	when	
activated	with	405	nm.	This	effect	appeared	more	promising	for	the	double	mutant,	because	405	nm	
stimulated	 currents	 were	 greater.	 The	 photocurrent	 reduction	 observed	 with	 activation	 488	 and	
405	nm	 coillumination	 of	 the	 original	 channel	was	 not	 noticeable	 in	 the	 two	mutant	 channels.	 As	
expected,	 the	 C1V1	 E122T/C167S	 showed	 superb	 photocurrent	 reduction	 when	 stimulated	 with	
561	nm	 and	 coilluminated	 with	 405	nm	 (Prigge	 et	 al.,	 2012).	 High	 405	nm	 intensities	 were	 more	
important	than	low	561	nm	intensities	for	efficient	photocurrent	reduction.	 In	 initial	experiments	a	
photocurrent	 reduction	 of	 about	 84	%	 could	 be	 achieved.	 However,	 405	nm	 illumination	 alone	
already	 evoked	 currents	 of	 5.1	%	 of	 the	 maximal	 photocurrents	 evoked	 by	 561	nm.	 This	 current	
however	 cannot	 be	 eliminated	 by	 illumination	with	 another	wavelength,	 but	 dissipated	 over	 time	
with	the	channels	closing.	 It	 is	 interesting	to	note	that	488	nm	coillumination	also	reduced	561	nm	
evoked	 photocurrents,	 even	 though	 currents	 evoked	 by	 488	nm	 illumination	 alone	 are	 usually	
stronger	 than	 561	nm	 currents.	 And	 in	 contrast	 to	 the	 inactivating	 influence	 of	 405	 nm	 light	 on	










405,	 488,	 561,	 594	 and	 639	nm	 single	 wavelength	 laser	 illumination	 (yellow	 boxes)	 and	 responses	 to	
simultaneous	 illumination	 (blue	 boxes	 below	 respective	 channels).	 Photocurrent	 recordings	 at	 specific	
illumination	wavelengths	 are	 indicated	 by	 the	 respective	 color	 of	 the	 recording.	 Scale	 bars	 above	 individual	
experiments	 indicate	 recorded	 currents	 (vertical)	 and	 time	 (horizontal).	 For	 coillumination	 experiments	 bars	
below	recordings	indicate	time	of	illumination	for	the	indicated	wavelength.	Black	bars	refer	to	coillumination	







bars	below	the	recordings	 indicate	wavelengths	and	timing.	Black	bars	 refer	 to	 the	 illumination	time	of	each	




ion-channels	 with	 slow	 photocycles	 (step-function	
opsins)	and	the	eNPAC	construct.	Responses	to	405,	
488,	 561,	 594	 and	 639	nm	 single	 wavelength	 laser	
illumination	 (yellow	 boxes)	 and	 coillumination	 (blue	




During	 testing	 it	 became	 apparent	 that	 even	 when	 the	 594	nm	 laser	 was	 used	 at	 100	%	





the	 CoChR	mutant	 variants	 C108S	 and	 C108S/D136	 (Figure	 6).	 Channels	were	 activated	with	 10	%	
laser	power	of	488	(41.92	W/cm2)	or	20	%	405	nm	(9.92	W/cm2)	illumination	through	the	DirecFRAP	
laser	 path	 (Figure	 2a)	 and	 inactivation	 was	 probed	 by	 simultaneously	 illuminating	 cells	 three	
consecutive	 times	 with	 594	nm	 light	 for	 500	ms	 each.	 The	 photocurrent	 values	 from	 these	 three	
exposures	were	pooled	and	compared	to	the	average	maximum	photocurrent	determined	from	the	
500	ms	between	coillumination	and	a	final	594	nm	exposure.	Additionally,	activation	intensities	from	
1	 to	 20	%	 were	 tested	 against	 100	%	 DL594	 power	 (129.75	W/cm2)	 (Figure	 5	 -	 graphics	on	right).	
Using	 the	 modified	 setup,	 we	 were	 able	 to	 reduce	 depolarizing	 currents	 of	 ChR2	
C128A/H134R/T159C	elicited	with	488	nm	by	54	%.	 If,	however,	 channels	were	exposed	 to	405	nm	
activation	light,	photocurrent	inactivation	of	up	to	90	%	was	possible	with	marginal	differences	in	the	
depolarizing	current	strength,	compared	to	488	nm.	Nevertheless,	both	experiments	 indicated	that	
with	 the	 current	 equipment	 a	 complete	 reduction	 of	 100	%	 is	 not	 feasible.	 Different	 activation	
intensities	 increased	photocurrents	 only	minimally	 for	 488	nm	activation,	 but	 significantly	 affected	





laser	 power	 as	 indicated	 in	 the	 figure	 legend,	 was	 tested	 in	 10	%	 steps	 from	 0	 to	 100	%.	Middle	 diagrams	
represent	 the	 respective	 relationship	between	594	nm	 laser	 intensity	and	photocurrent	 reduction.	Right	 two	




Tests	 for	 488	 and	 405	nm	 activation	 of	 the	
CoChR	 mutant	 variants	 yielded	 comparable	
results	 (Figure	 6).	 Photocurrent	 reduction	 was	
most	 efficient	 for	 405	 and	 594	nm	
coillumination.	 There	 was	 no	 significant	
advantage	in	using	488	nm	or	higher	intensities.	
A	 photocurrent	 increase	 when	 488	nm	
illumination	 is	 discontinued	was	 also	 visible	 for	
the	 CoChR	 channel,	 especially	 for	 the	 C108S	
mutant.	 In	 general,	 currents	 of	 the	CoChR	 step	
function	 variants	 were	 weaker	 than	 the	 ChR2	
step	function	variants	and	did	not	increase	when	
higher	405	nm	 intensities	were	used.	However,	
405	nm	 evoked	 currents	 could	 be	 efficiently	
reduced	 by	 exposure	 to	 594	nm.	 These	
experiments	 suggest	 405	nm	 as	 the	 ideal	
activation	 wavelength	 for	 experiments	 where	
strong	 photocurrents	 and	 efficient	 photo-
current	 reduction,	using	594	nm	coillumination,	
is	needed.	
Effects	 of	 strong	 594	 laser	 power	 on	 fast-
photocycle	variants	
We	 also	 tested	 whether	 higher	 594	nm	
intensities	 reduce	 488	 and	 405	nm	 evoked	
photocurrents	 of	 the	 fast-photocycle	 variants	
ChR2	T159C	and	CoChR	more	efficiently	 (Figure	
7).	 However,	 illumination	 at	 594	nm	 at	 high	
intensity	 alone,	without	 coillumination,	 evoked	
photocurrents	 of	 100	-	200	 pA	 in	 cells	
expressing	 either	 one	 of	 these	 channels.	 No	
significant	 photocurrent	 reduction	 during	
coillumination	 with	 405	 or	 488	 nm	 light	 for	
either	of	these	channels	was	seen.	 Instead	small	photocurrent	transients	could	be	observed,	which	
were	most	pronounced	 for	 405	 and	594	nm	coillumination	of	 CoChR	expressing	 cells.	 This	 is	 quite	
critical,	because	 it	 implies	 that	 slow-photocycle	variants	have	a	 significant	 conductance	at	594	nm,	
which	due	to	the	prolonged	open	channel	states	is	not	detected,	but	which	may	cause	a	portion	of	
channels	to	remain	open	when	illuminated	at	594	nm.	
Figure	 6:	 Photocurrent	 reduction	 of	 488	 and	 405	nm	
evoked	 currents	 in	 CoChR	 C108S	 and	 C108S/D136A	
mustants.	 Trace	 and	 stimulation	 bar	 colors	 represent	
individual	 laser	wavelengths	and	 intensities	 (5,	10,	15,	
20	%).	
Figure	7:	Effect	of	higher	594	nm	laser	intensity	on	fast	
photocycle	 variants.	 Photocurrents	 evoked	 by	 10	%	
488	nm	or	20	%	405	nm	16.7	µm	spotlight	 stimulation,	
using	the	DirectFRAP	system	with	coillumination	of	594	
nm	 light	 for	 T159C	 (a)	 and	 CoChR	 (b)	 channels.	




Based	 on	 the	 experience,	 gained	 from	 the	
previous	experiments,	we	tested	focal	activation	
of	 proximal	 neuronal	 processes	 of	 cells	
expressing	 the	 fast	 photocycle	 ChR2	 T159C	
channel	 with	 488	nm	 light	 from	 the	 DirectFrap	
unit.	 Photocurrents	 elicited	 by	 stimulations	 of	
membrane	 areas	 with	 diameters	 down	 to	
1.2	µm	 could	 reliably	 be	 detected	 using	
electrophysiological	 patch-clamp	 recordings	 in	
the	 whole-cell	 configuration	 (Figure	 8a).	
However,	 detectable	 photocurrents	 were	
already	weak,	implying	that	photocurrents	from	
smaller	 areas	 will	 be	 beyond	 detection	 limits.	
Photocurrents	 from	 focal	 activation	 would	 be	
expected	 to	 be	 even	 smaller	 for	 the	 slow-
photocycle	 channel	 variants,	 which	 have	
significantly	reduced	photocurrents.	
To	 visually	 confirm	 the	 site	 of	
stimulation,	 we	 tested	 genetically	 encoded	
calcium	indicators.	Due	to	spectral	overlap	with	
channel	 activation,	 most	 commonly	 used	
indicators,	 i.e.	 GCaMPs	 are	 activated	 by	 blue	
light,	 could	 only	 be	 imaged	 at	 wavelengths	
which	 depolarized	 cells,	 making	 it	 impossible	 to	 use	 them	 for	 the	 visualization	 of	 local	 Ca2+	
concentration	 increases.	 RCaMP1c	 however,	 can	 be	 imaged	 at	 a	 low	 561	nm	 intensities	 and	
therefore	 be	 combined	 with	 most	 blue-light	 activated	 channels.	 RCaMP1c	 and	 the	 ChR2	 L132C	
variant	were	 expressed	 in	 neurons	 and	 cells	 briefly	 stimulated	with	 2.5	µm	 spotlight	 488	nm	 light,	
using	 the	 DirecFRAP	 system,	 while	 imaging	 RcaMP1c	 calcium	 indicator	 fluorescence	 at	 561	nm	
(Figure	 8b).	 Interestingly,	 small	 increases	 in	 RCaMP1c	 fluorescent	 signal	 were	 detected	 reliably	
during	photostimulation.	These	signal	increases	were	however	very	small	and	difficult	to	distinguish	
from	 background	 noise	 of	 the	 two	 control	 areas	 (R1	 and	 R2)	 in	 single	 trials.	 Most	 other	 channel	





Figure	 8:	 Electrophysiological	 recordings	 and	 visual	
detection	 of	 focally	 stimulated	 areas.	 (a)	 T159C	
channelrhodopsin	 photocurrents	 elicited	 by	 20	%	
488	nm	 TIRF	 or	 DirectFRAP	 (photoactivation	 masks	
#6	-	10)	 laser	 stimulation	 of	 the	 cell	 body.	 (b,	 c)	 Focal	
488	nm	activation	of	ChR2	L132C	using	the	DirectFRAP	
mask	 #7	 (2.5	µm)	 on	 a	 neuronal	 process	 visualized	 by	
RCaMP1c	 fluorescence.	 (b)	 Images	 show	 L132C-EYFP	
(left)	 and	 RCaMP1c	 (right)	 fluorescence	 signal	 within	
the	area	of	stimulation	(FRAP)	and	two	nearby	 control	
areas	(R1	and	R2).	Scale	bar	is	5	µm.	(c)	RCaMP1c	signal	






diffraction	 limit	of	 light,	we	performed	validation	experiments	at	a	 larger	scale.	To	accomplish	this,	
we	 used	 photoactivation	masks	 for	 405	 or	 488	nm	 illumination	 of	 6.2	 and	 16.7	µm	wide	 areas	 in	
combination	with	a	donut-shaped	photoactivation	mask	(Figure	9a)	to	stimulate	neurons	expressing	
the	 eNPAC	 (Figure	 9b)	 or	 C128A/H134R/T159C	 channels	 (Figure	 9c).	When	eNPAC	expressing	 cells	
were	stimulated	with	6.2	or	16.7	µm	spots	with	488	nm	laser	light,	they	responded	with	20	or	50	pA	
photocurrents,	respectively.	When	16.7	µm	488	nm	stimulation	of	ChR2	was	combined	with	594	nm	
costimulation	 of	 halorhodopsins,	 using	 an	 overlapping	 donut-shaped	 photoactivation	 mask	 at	
different	 594	nm	 light	 intensities	 (resulting	 in	 an	 activated	 area	 of	 approximately	 6.2	 µm),	 net	








concept	 at	 the	 macro	
scale.	 (a)	 Images	 of	 ye-
llow	 text-marker,	 used	as	
a	 dye	 for	 a	 uniform	 fluo-
rescent	field	(for	488	nm)	
and	 Rhodamine	 B	 (594	
nm),	 excited	 using	 488	
nm	 DirectFRAP	 #7	 and	 9	
and	 594	nm	 ROE	 #16	
photomask	 illumination	
with	 a	 40x	 objective.	
Lower-right	 image	 shows	
a	 two-color	 merge	 of	
DirectFRAP	#6	and	ROE	#16	photomask	images.	A	substantial	part	of	the	488	nm	illuminated	is	overlapped	by	
594	nm	illumination,	leaving	a	center	spot	of	roughly	6.2	µm	that	is	not	coilluminated.	Scale	bar	is	10	µm.	(b)	




trace)	 to	 current	 elicited	by	6.2	µm	 stimulation	of	ChR2.	 (c)	 Photocurrents	of	 the	ChR2	C128S/H134R/T159C	
variant	evoked	by	6.2	or	16.7	µm	20	%	405	nm	laser	stimulation	and	subsequent	594	nm	illumination	mediated	




C128A/H134R/T159C	 (Figure	 9c).	 The	 respective	 evoked	 photocurrents	 for	 6.2	 and	 16.7	µm	 wide	
	52	
areas,	 illuminated	 with	 405	 nm	 light,	 were	 50	 and	 150	pA,	 respectively.	 If	 16.7	µm	 405	nm	
photostimulation	was	 combined	with	 an	 overlapping	 donut	 of	 594	nm	 illumination,	 photocurrents	
could	be	 reduced	 to	values	close	 to	 those	evoked	by	 stimulation	of	a	6.2	µm	area	alone.	This	was	
independent	of	the	order	in	which	the	different	wavelengths	were	applied.	
Different	illumination	approaches	for	reaching	focal	photostimulation	in	the	nanoscale	
Based	 on	 our	 experiments,	 there	 are	 four	 illumination	 approaches	 using	 light-gated	 ion-
channel/pumps,	 that	 could	 be	 used	 to	 achieve	 highly	 focal	 photostimulation	 (Figure	 10).	 The	 first	
approach	 is	 simultaneous	 activating	 and	 inactivating	wavelength	 illumination	 (Figure	9c).	 For	 step-






and	 the	 possibility	 to	 control	 depolarizing	 and	 hyperpolarizing	 currents	 with	 different	 wavelength	
illuminations.	 Unlike	 for	 the	 two	 other	 approaches,	 here	 the	 area	 with	 activated	 channels	 would	
remain	 constant,	 but	 a	 second	 channel	 type,	 i.e.	 halorhodopsins	 or	 other	 hyperpolarizing	 ion-
channels/pumps	 can	 be	 used	 to	 counterbalance	 the	 depolarizing	 currents	 in	 the	 area	 where	 no	






area	 of	 depolarization.	 2)	 Step-function	 opsins	 could	 be	 sequentially	 illuminated:	 channel	 opening	 can	 be	
followed	 instantaneously	 by	 closure	 of	 channels	 leaving	 a	 focal	 area	 of	 open	 channels.	 Remaining	 open	
channels	can	be	closed	by	whole	field	illumination.	3)	Hyperpolarizing	currents	can	be	used	to	counterbalance	








function	 of	 these	 synapses.	 Fluorescently-tagged	 BDNF	 is	 commonly	 used	 as	 a	 marker	 of	 BDNF	
trafficking.	 When	 overexpressed	 in	 neurons	 and	 imaged	 using	 epifluorescence	 microscopy,	
BDNF-GFP	puncta	appear	highly	mobile	and	can	be	 found	actively	perambulating	processes	 (Figure	
11a,b),	as	already	demonstrated	elsewhere	(Dean	et	al.,	2012;	Hartmann	et	al.,	2001).	Co-expression	
of	 ChR2	 under	 CaMKII	 promoter	 control	 with	 BDNF-mRFP1,	 in	 BDNF-mRFP1-P2A-ChR2-ECFP	
transfected	cells,	results	in	depolarizing	photocurrents	in	response	to	405	and	488	nm	light	exposure	
(Figure	 11c).	 Currents	 were	 not	 detected	 in	 cells	 expressing	 only	 BDNF-mRFP1-P2A-ECFP.	
Interestingly,	 when	 these	 cells	 were	 photostimulated	 with	 405	nm	 light	 for	 3	min	 using	 the	
DirectFRAP	system,	we	observed	accumulations	of	fluorescent	BDNF-mRFP1	puncta	over	the	course	
of	 90	min;	 subsequently	 the	 accumulations	 gradually	 disappeared	 (Figure	 11d).	 During	 this	 time	
fluorescent	puncta	were	also	observed	 traversing	 through	 this	area	of	accumulation.	These	 results	
however	 have	 to	 be	 interpreted	 carefully.	 Although	 occurring	 less	 frequently	 and	with	 longer	 and	




Figure	 11:	 Fluorescent	 BDNF	 puncta	 trafficking	 and	 effects	 of	 focal	 optogenetic	 stimulation.	 Representative	
images	of	GFP	tagged	BDNF	puncta	in	the	cell	soma	(a)	and	trafficking	through	a	neuronal	process	(b)	acquired	
by	epifluorescence	microscopy.	Modified	 representation	of	data	published	earlier	 (Dean	et	al.,	2012).	 (c)	405	
and	 488	nm	 elicited	 photocurrents	 from	 a	 BDNF-mRFP1-P2A-ChR-ECFP	 expressing	 cell.	 (d)	 Focal	 10.6	µm	





When	 we	 expressed	 BDNF-mRFP1	 under	 the	 control	 of	 the	 beta	 actin	 promotor	 in	 dissociated	
hippocampal	cultures,	we	observed	a	gradient	of	fluorescent	signal,	highest	 in	very	bright	cells	and	
weaker	 by	 distance	 to	 this	 cell,	 in	 other	 cell	 somata.	We	 performed	 ICC	 experiments	 by	 labeling	





produced	 in	 astrocytes,	 we	 transfected	 cells	 with	 a	 CaMKIIα-BDNF-mRFP1-P2A-EGFP	 construct;	
expressing	 BDNF-mRFP1	 under	 a	 promotor	 specific	 for	 glutamatergic	 neurons	 and	 labeling	 the	
transfected	 and	 producing	 cells	 with	 a	 cytosolic	 EGFP	 fluorophore.	 We	 then	 examined	 if	 BDNF-
mRFP1	transfer	to	neighboring	cells	occurs	and	if	this	could	be	detected	in	live	and	immunostained	
samples	 (Figure	 13).	 Interestingly,	 we	 observed	 that	 there	 is	 indeed	 transfer	 of	 BDNF-mRFP1	 to	
neighboring	 cells	 (negative	 for	 EGFP	 fluorescence).	We	also	 found,	 that	BDNF-mRFP1	 fluorescence	
signal	 in	 neighboring	 cells	was	 significantly	 reduced	 by	 treatment	with	 AraC	 (an	 antimitotic	 agent	
used	 to	 limit	 glial	 cell	 growth)	 from	DIV7	 onwards,	 fixing	 the	 culture	with	 4	%	PFA,	 permeabilizing	
(with	the	anionic	detergent	Triton	X-100),	and	blocking	(with	donkey	serum)	for	subsequent	antibody	
staining.	 The	 combination	 of	 these	 effects	 led	 to	 an	 almost	 complete	 loss	 of	 BDNF-mRFP1	




cytochemical	 labeling	 of	 a	 P0	
derived	 dissociated	 hippocampal	
culture	 expressing	 BDNF-mRFP1.	
BDNF-mRFP1	 produced	 by	 the	
neuron	 in	 the	 center	 can	 be	 found	
in	 nearby	 cells	 positive	 for	 GFAP.	






thus	 the	observed	red	 fluorescent	signal	 in	neighboring	cells	 is	not	auto-fluorescence	or	 remaining	
fluorescent	substances	in	the	culture	media	like	phenol	red.	
	
are	shown	below	the	respective	 fluorescence	 images.	 (b)	Graphs	 represent	averages	and	SEM	of	signal	 from	
3	-	4	 images	 of	 at	 least	 2	-	5	 individual	 cultures	 (In	 total	 Live	 n	=	18,	 AraC	 n	=	13,	 4%	PFA	 n	=	18,	 4%	PFA	 +	
permeabilization	n	=	18,	 3x	PBS	wash	n	=	10	 and	 EGFP	only	 n	=	6).	 Statistical	 significance	was	 determined	by	
one-way	ANOVA	(p	=	0.0054)	and	 individual	differences	were	determined	by	Dunnett’s	multiple	comparisons	
test	(*P	<	0.05,	**P	<	0.01,	***P	<	0.001	and	****P	<	0.0001).	Scale	bars	represent	50	µm.	
To	 exclude	 for	 specific	 fluorophore-mediated	 effects	 (i.e.	 mRFP1	 versus	 EGFP),	 we	 compared	 the	
expression	and	distribution	patterns	in	culture	of	BDNF-mRFP1-P2A-EGFP	to	BDNF-EGFP-P2A-mRFP1	
and	 mRFP1-P2A-EGFP	(Figure	 14a	 -	 from	 left	 to	 right,	 two	 images	 per	 condition).	 All	 constructs	
expressed	 equally	well	 and	 there	was	 no	 significant	mRFP1	 fluorescence	 outside	 of	 the	 producing	
cell,	when	it	was	not	fused	to	BDNF	(Figure	14a,	b).	On	the	other	hand,	BDNF-EGFP	signal	spread	was	
very	weak	 and	 only	 a	 few	 cells	 could	 be	 detected	 at	 high	 detector	 gain	 levels.	 To	 test	whether	 a	
potential	acidic	environment	inside	intracellular	compartments	might	quench	the	EGFP	fluorophore,	
we	 applied	 25	mM	 NH4Cl	 to	 the	 culture	 to	 de-acidify	 internal	 compartments.	 This	 treatment	
significantly	 increased	 the	 EGFP	 fluorescence	 in	 neighboring	 cells	 (Figure	 14c,	 d),	 indicating	 that	
BDNF-EGFP	 is	 also	 transferred	 to	 neighboring	 cells	 and	 is	 present	 predominantly	 in	 acidified	
compartments.		
Figure	 13:	 Loss	 of	 BDNF-
mRFP1	 fluorescence	 in	 cul-
ture	 through	 standard	 fix-
ation	 and	 permeabilization	
procedures	 for	 ICC.	 (a)	
Representative	 images	 of	
BDNF-mRFP1-P2A-EGFP	 or	
EGFP	 expressing	 neurons	 at	
DIV14	 in	 different	 culturing	
conditions	 or	 stages	 of	 ICC	
(4	%	PFA	 fixation	 and	 per-
meabilization).	 Inverted	 im-




Figure	 14:	 Assessment	 of	 fluorophore	 contribution	 to	 transfer.	 (a)	 Images	 show	 two	 examples	 each	 of	








The	 above	 experiments	 imply,	 that	 the	 observed	 transfer	 is	 not	 an	 artifact	mediated	 by	 a	 specific	
fluorophore,	 but	 any	 tag	 on	 BDNF	 could	 affect	 its	 properties.	 To	 exclude	 this	 possibility,	 we	
transduced	cultures	with	untagged	BDNF	delivered	by	AAV6	and	expressed	under	synapsin	promotor	
control	for	expression	exclusively	in	neurons.	BDNF	was	then	detected	using	immunocytochemistry.	
BDNF	 virus	 application	 dramatically	 increased	 BDNF	 signal	 in	 cultures	 detected	 by	 antibody	
immunoreactivity	 (Figure	 15a),	 confirming	 BDNF	 overexpression.	 To	 detect	 specific	 cell	 types,	
cultures	were	 cotransduced	with	 EGFP,	 also	 expressed	 under	 synapsin	 promotor	 control,	 to	mark	
neurons	 (Figure	 15b),	 or	 immunostained	 for	GFAP	 to	mark	 astrocytes	 (Figure	 15c)	 or	 both	 (Figure	
15d).	BDNF	immunoreactivity	was	not	only	confined	to	EFGP	positive	neurons,	but	was	also	detected	
in	GFAP	immunopositive	cells,	which	are	not	reported	to	express	BDNF	themselves.	Since	there	was	




















neighboring	 cells	 is	 internalized	 by	 these	 cells,	
we	 immunostained	 for	 surface	 versus	 internal	
BDNF-mRFP1.	As	a	control	for	a	surface	localized	
protein,	 we	 transfected	 cells	 with	 mRFP-Nrx,	
where	 the	 mRFP	 is	 extracellular.	 Immuno-
staining	 against	 RFP	 with	 a	 primary-secondary	
antibody	 preconjugate,	 coupled	 to	 AF647,	
without	 permeabilization	 confirmed	 the	
extracellular	 presence	 of	 mRFP	 in	 mRFP-Nrx	
transfected	 cells	 (Figure	 16b).	 Secondary	
antibody	application	without	primary	antibody	did	not	 result	 in	positive	 staining	of	 the	membrane	
(Figure	16a).	
The	 same	 approach	 was	 used	 on	 BDNF-mRFP1-P2A-EGFP	 expressing	 cultures,	 where	
antibodies	 applied	 without	 permeabilizing	 cells,	 detected	 neither	 the	 cytosolic	 EGFP,	 nor	
overexpressed	or	 transferred	BDNF-mRFP1	 (Figure	17b,	 c),	 confirming	 that	 the	BDNF-mRFP1	signal	
transferred	to	neighboring	cells	is	internal.	The	weak	signal	that	can	be	detected	is	most	certainly	an	
amplification	 of	 a	 small	 amount	 of	 BDNF-mRFP1	 that	 sits	 on	 the	 membrane	 or	 cover	 glass,	 or	
background	signal	from	non-specific	binding	of	the	antibody.	This	signal	however	does	not	co-occur	
with	 the	 large	 BDNF-mRFP1	 accumulations	 found	 in	 the	 cell	 somata.	 The	 observations	 that	
BDNF-mRFP1	 is	 not	 easily	 washed	 away	 with	 PBS	 (Figure	 13)	 and	 cannot	 be	 detected	 by	 RFP	
antibodies,	when	cells	are	not	permeabilized,	show	that	BDNF-mRFP1	is	internalized	upon	release.	
Figure	15:	 Fluorophore	 independent	 transfer	of	 BDNF.	
(a)	 Images	 show	 BDNF	 immunoreactivity	 (white)	 in	
DIV14	 dissociated	 hippocampal	 cultures,	 untreated	
(left)	or	transduced	with	AAV6,	leading	to	expression	of	
BDNF	 under	 synapsin	 promotor	 control	 (right).	
Additionally,	 cells	 were	 transduced	 with	 AAV6	 EGFP	
under	 synapsin	 promotor	 control	 (b,	d)	 and/or	 were	
costained	 for	 GFAP	 (c,	d).	 A	 strong	 increase	 in	 BDNF	
immunoreactivity	 was	 observed	 in	 the	 AAV6	 BDNF	
overexpressing	 neurons,	 which	 is	 transferred	 to	 and	
colocalizes	 with	 GFAP	 immunopositive	 cells.	 The	
expression	pattern	and	spread	of	signal	appear	similar	
for	 untagged	 BDNF	 and	 mRFP1-BDNF,	 indicating	 that	





Figure	 17:	 Transferred	 BDNF-mRFP1	 is	 internalized.	 Confocal	 images	 of	 dissociated	 hippocampal	 cultures	
expressing	 BDNF-mRFP1-P2A-EGFP	 at	 DIV16	 incubated	 with	 AF647	 secondary	 antibody	 alone	 (a)	 or	
preconjugated	 to	 a	 primary	 antibody	 against	GFP	 (b)	 or	 RFP	 (c).	 Inverted	 single	 channel	 images	 show	 ECFP,	
BDNF-mRFP1	 and	 AF647	 signal.	 Cytosolic	 localized	 EGFP	 and	 transferred	 BDNF-mRFP1	 is	 inaccessible	 by	
primary-secondary	 antibody	 complexes	 added	 to	 the	 medium,	 indicating	 that	 BDNF-mRFP1	 is	 internalized.	
Scale	bar	represents	50	µm.	
Figure	 16:	 Validation	 of	
preconjugated	primary	and	
secondary	 antibody	 detec-
tion	 of	 extracellular	 anti-
gens.	 Confocal	 images	 of	
dissociated	 hippocampal	
cultures	 expressing	 mRFP-




(b)	 for	 30	 min.	 Inverted	
single	 channel	 images	
show	 Nrx-mRFP	 (middle)	






To	 address	 the	 question	 of	 BDNF	 release	 from	 pre-	 or	 postsynaptic	 sites,	 we	 used	 organotypical	
hippocampal	 slices,	 providing	 an	 intact	 neuronal	 network,	 that	 is	 well	 studied,	 and	 where	
connectivity	 is	 known	 and	 preserved	 during	 preparation.	 We	 first	 injected	 AAV1/2	 EGFP	 under	
synapsin	promotor	control	 in	the	hippocampal	CA3	or	CA1	region	and	found	positive	expression	of	
EGFP	that	was	mostly	confined	to	neurons	of	the	pyramidal	cell	layer	in	the	area	of	injection	(Figure	
19a,	b).	 We	 then	 injected	 AAV1/2	 CaMKIIα	 promotor	 controlled	 BDNF-mRP1-P2A-ECFP.	 To	 our	
surprise,	no	clear	ECFP	fluorescence	could	be	found.	But	the	sites	of	 injection	were	clearly	positive	
for	BDNF-mRFP1,	 showing	strong	and	 locally	 confined	 fluorescence	 (Figure	19c,	d).	However,	given	
the	lack	of	ECFP	fluorescence	in	the	cells	of	origin,	transfer	of	the	BDNF-mRFP1	to	another	area	in	the	




CaMKIIα	 promotor	 (Figure	 18).	 This	 implies	 that	 there	 is	 release	 of	 BDNF-mRFP1	 and	 uptake	 by	
nearby	cells	in	a	dense	and	physiological	environment.	
Under	 the	assumption,	 that	 the	 lack	of	ECFP	 fluorescence	 is	 caused	by	 low	expression	and	
weak	 fluorescence,	 we	 exchanged	 the	 cytosolic	 fluorophore	 for	 EGFP	 and	 used	 purified	 AAV6	 as	
carrier	to	increase	local	transduction	efficiency.	We	also	included	a	control	for	the	transfer	of	BDNF-
mRFP1	 by	 co-expression	 of	 cytosolic	mRFP1	 and	 EGFP.	 Expression	 and	 potential	 spread	 of	 BDNF-
mRFP1	 could	 be	observed	 (Figure	 20a	-	d),	 but	 only	 a	 few	EGFP	positive	 cells	 could	 be	 found,	 and	
these	 were	 only	 faintly	 positive	 for	 BDNF-mRFP1	 (Figure	 20c,	d).	 The	 injection	 of	 AAV6	 carrying	
CaMKIIα-mRFP1-P2A-EGFP	 let	 to	 locally	 confined	 expression	 with	 less	 spread	 of	 the	 mRFP1	






organotypic	hippocampal	brain	slice	 (OHBS)	 cultures.	Confocal	 images	show	slices	expressing	EGFP	 (a,	b)	and	
BDNF-mRFP1-P2A-ECFP	 (c,	d)	 in	 neuronal	 pyramidal	 cells	 of	 CA3	 (a,	c)	 or	 CA1	 (b,	d).	 Scale	 bars	 represent	
400	µm.		








or	 mRFP1-P2A-EGFP	 AAV6	 to	 CA3	 and	 CA1	 in	 OHBS.	
Confocal	 images	of	 slices	 injected	 in	CA3	 (a)	 and	 CA1	
(c)	 regions.	 (b,	d)	 Respective	 zoomed	 images	of	areas	
marked	 by	 squares.	 (e)	 OHBS	 expressing	mRFP1-P2A-
EGFP.	 Scale	 bars	 represent	 400	µm	 for	 the	 images	





identify	 specific	 cell	 types	 containing	 large	 BDNF-mRFP1	 accumulations.	 We	 performed	
immunocytochemistry	 experiments	 on	 BDNF-mRFP1-P2A-ECFP	 expressing	 cultures	 to	 identify	
specific	 cell	 types	 based	 on	 GFAP	 immunoreactivity	 (astrocytes),	 Map2	 (neurons),	 NG2	
(oligodendrocyte	progenitor	 cells)	 and	 Iba1	 (microglia).	We	 found	only	 little	 or	 no	BDNF-mRFP1	 in	





Figure	 21:	 Assessment	 of	 BDNF-mRFP1	 uptake	 by	 different	 cell	 types	 regularly	 found	 in	 dissociated	
hippocampal	cultures	at	DIV14.	Cultures	expressing	BDNF-mRFP1-P2A-ECFP	were	stained	for	Map2	and	GFAP	
(a),	 NG2	 and	 GFAP	 (b)	 or	 Iba1	 and	 GFAP	 (c).	 Inverted	 single	 channel	 images	 show	 ECFP,	 Map2/NG2/Iba1,	
BDNF-mRFP1	 and	 GFAP.	 Green	 or	 red	 arrows	 indicate	 soma	 of	 Map2-positive	 neurons	 or	 GFAP-positive	
astrocytes,	 respectively.	 Only	 traces	 of	 BDNF-mRFP1	 signal	 were	 present	 in	 ECFP-negative	 Map2	
immunopositive	 cells	 (a),	 however	 NG2	 and	 GFAP	 immunopositive	 cells	 appear	 clearly	 positive	 for	
BDNF-mRFP1	signal	(b).	Iba1	immunostaining	did	not	show	any	detectable	cells.	Scale	bar	represents	50	µm.	
Because	 immunocytochemistry	 reduces	 detectable	 BDNF-mRFP1,	 we	 utilized	 AAVs	 to	 express	
different	 fluorophores	under	neuron	 (synapsin)	and	astrocyte	 (GFAP2.2)	specific	promotors	 for	 live	
imaging.	 We	 tested	 AAV	 transduction	 efficiencies	 and	 determined	 that	 our	 AAV1/2	syn-EGFP	
successfully	 transduces	 and	 labels	 87.5	±	8.2	%	 of	 Map2	 positive	 cells	 (Figure	 22a)	 and	
AAV1/2	GFAP2.2-EGFP	labels	81.9	±	11.6	%	of	GFAP	immunopositive	cells	(Figure	22b).	In	addition	we	








but	 emits	 in	 the	 orange/red	 spectrum	 and	 is	 thus	 separable	 from	 ECFP,	 EGFP	 and	 mRFP1	
fluorescence.	 As	 shown	 by	 the	 individual	 channels	 (Figure	 22d),	 LSSmOrange-expressing	 neurons,	
EGFP-expressing	 astrocytes,	 ECFP-labelled	 BDNF-mRFP1	 producing	 cells	 and	 BDNF-mRFP1	 signal	
could	 be	 easily	 distinguished.	 However,	 if	 EGFP	 fluorescence	 was	 very	 strong,	 it	 did	 also	 appear	
weakly	 in	 the	 LSSmOrange	 channel.	 But	 since	 the	 two	 fluorophores	 were	 expressed	 under	 the	
control	 of	 two	 exclusive	 promotors,	 the	 EGFP	 signal	 could	 in	 these	 cases	 be	 subtracted	 from	 the	
LSSmOrange	 channel.	 Using	 this	 approach,	 we	 determined	 that	 10.1	±	7.3	%	 of	 total	 released	
BDNF-mRFP1	was	in	neurons,	48.6	±	16.8	%	was	in	astrocytes	and	36.5	±	10.8	%	did	not	co-occur	with	






and	 GFAP	 immunoreactivity	 on	 DIV14.	 EGFP	 was	 found	 in	 87.5	±	8.2	%	 of	 Map2	 immunopositive	 (a)	 and	
81.9	±	11.6	%	of	GFAP	immunopositive	cells	(b)	(n	=	6	for	each	condition).	Few	cells	were	positive	for	ALDH1L1	
only	 and	 not	 GFAP.	 (C)	 AAV1/2	 synapsin	 LSSmOrange	 and	 GFAP2.2	 EGFP	 in	 a	 culture	 expressing	
BDNF-mRFP1-P2A-ECFP,	 allowing	 identification	 of	 individual	 cell	 type,	 where	 neurons	 are	 identified	 by	
LSSmOrange,	 astrocytes	by	 EGFP	and	BDNF-mRFP1	producing	 cells	 by	 ECFP	 fluorescence,	while	 the	 released	
BDNF-mRFP1	 can	 be	 simultaneously	 observed	 (d).	 10.1	±	7.3	%	 of	 the	 released	 BDNF-mRFP1	 signal	 could	 be	
allocated	 to	neurons,	48.6	±	16.8	%	 to	astrocytes	and	36.5	±	10.8	%	 to	neither	of	 these	groups.	 Therefore,	 in	








localization	 of	 these	 overexpression	 constructs	 by	 testing	 cells	 expressing	 the	 respective	 marker	
proteins	 for	 immunoreactivity	 of	 antibodies	 against	 EEA1,	 Rab5,	 Rab7	 and	 Lamp1	 (Figure	 23);	 a	
suitable	LC3	antibody	was	not	available	and	LC3	could	therefore	not	be	tested.	Marker	proteins	and	
antibodies	 stained	 the	 same	 intracellular	 puncta.	 Antibodies	 also	 labeled	 signal	 in	 nearby	 non-
transfected	 cells	 and	 in	 some	 cases	 displayed	 slightly	 higher	 background	 signal	 than	 expression	
constructs,	but	in	general	the	expression	of	subcellular	localization	marker	proteins	appears	to	be	a	
reliable	method	to	mark	subcellular	compartments.	
Next,	 we	 electroporated	 cells	 with	 the	 different	 subcellular	 marker	 constructs,	 and	
subsequently	transfected	them	with	BDNF-mRFP1-P2A-ECFP	and	applied	AAV1/2	virus	mediating	the	
expression	 of	 LSSmOrange	 under	 synapsin	 or	 GFAP2.2	 promotor	 control.	 Cells	 having	 taken	 up	
BDNF-mRFP1	and	transfected	with	one	of	the	subcellular	markers	were	identified	by	the	presence	of	
LSSmOrange	 and	 absence	 of	 ECFP	 fluorescence	 (Figure	 24a).	 Colocalization	 was	 confirmed	 by	
determining	 individual	 Pearson	 product-moment	 correlation	 coefficients.	 Colocalization	 was	
relatively	high	 for	BDNF-mRFP1	and	Rab7	 (>	0.5)	and	BDNF-mRFP1	and	Lamp1	(>	0.7)	compared	to	




(Yan	 et	 al.,	 1997),	 much	 of	 the	 BDNF-mRFP1	 was	 found	 in	 astrocytes.	 Potentially	 BDNF	 is	 either	
released	as	in	its	precursor	form,	preferably	binding	to	p75	receptor	or	astrocytes	express	more	TrkB	
receptors	 than	 the	 neurons.	 To	 test	 this,	 we	 created	 AAV1/2	 synapsin	 promotor	 controlled	
expression	 constructs	 of	 the	 TrkB	 receptor,	 tagged	 with	 either	 EGFP	 or	 LSSmOrange.	 To	 verify	
exclusive	neuronal	expression,	we	compared	AAV1/2	mediated	expression	of	TrkB-EGFP	with	EGFP	in	
neurons	 (Figure	25a,	b	or	d,	e)	or	astrocytes	 (Figure	25c),	with	 the	 signal	of	Map2	 (Figure	25a,	c,	d)	
and	GFAP	(Figure	25b,	e)	in	immunocytochemical	stainings.	Like	synapsin	promotor	controlled	EGFP	
expression,	Trkb-EGFP	expression	was	confined	to	Map2	immunopositive	cells	(Figure	25a,	d)	and	did	
not	overlap	with	GFAP	 immunoreactive	cells	 (Figure	25b,	e).	Map2	 immunostaining	did	not	overlap	
with	AAV1/2	mediated	expression	of	EGFP	under	GFAP2.2	promotor	control	(Figure	25c).	
We	found	that	 the	accumulation	of	BDNF-mRFP1	 fluorescence	 in	neurons	was	dramatically	
increased	 in	 the	 cell	 soma	 of	 neurons	 expressing	 TrkB-EGFP	 in	 cultures	 transfected	 with	





Figure	 23:	 ICC	 validation	 of	 subcellular	 localization	 marker	 constructs	 for	 EEA1,	 Rab5a,	 Rab7	 and	 Lamp1.	
Confocal	 images	of	dissociated	hippocampal	cultures	at	DIV13	expressing	EGFP-EEA1,	Rab5-EGFP,	Rab7-EGFP	







Synapsin	 promotor	 controlled	 EGFP	 and	 TrkB-EGFP	 were	 only	 detected	 in	Map2	 (a,	d),	 but	 not	 GFAP	 (b,	e)	
immunoreactive	 cells	 and	 GFAP2.2	 promotor	 active	 cells	 were	 not	 immunoreactive	 for	Map2	 (c).	 Scale	 bar	
represents	100	µm.	
Figure	 25:	 Verification	 of	 exclusive	
TrkB	receptor	expression	in	neurons.	
Confocal	images	show	BDNF-mRFP1-
P2A-ECFP	 expressing	 cultures	 at	
DIV13,	 transduced	 with	 AAV1/2,	
delivering	 syn-EGFP	 (a,	b)	 and	 syn-
TrkB-EGFP	(d,	e)	 or	 GFAP2.2-EGFP	
(c)	 expression	 constructs,	 immune-
cytochemically	 stained	 for	 Map2	
(a,	c,	d)	 or	 GFAP	(b,	e)	 using	 AF647-
coupled	 secondary	 antibodies.	
Synapsin promotor	 controlled EGFP
Figure	 24:	 Colocalization	 of	 taken	 up	 BDNF-mRFP1	 with	
subcellular	marker	 proteins.	 (a)	 Confocal	 images	 of	 neuronal	
and	 astrocytic	 somata	 (identified	 by	 synapsin	 or	 GFAP2.2	
driven	 LSSmOrange	 expression)	 with	 BDNF-mRFP1	 and	 EGFP-
EEA1,	 Rab5a-EGFP,	 Rab7-EGFP,	 Lamp1-mGFP	 or	 EGFP-LC3.		
Scale	 bars	 represent	 10	µm.	 (b)	 Graph	 depicts	 average	 and	
SEM	 for	 Pearson	 product-moment	 correlation	 between	
subcellular	markers	and	BDNF-mRFP1.	





Figure	 26:	 TrkB	 overexpression	 in	 neurons	 increases	 BDNF-mRFP1	 uptake.	 Confocal	 images	 show	 DIV16	
dissociated	 hippocampal	 cultures	 transfected	 with	 BDNF-mRFP1-P2A-ECFP	 and	 transduced	 with	 AAV1/2	
delivering	either	 syn-EGFP	 (a)	 or	 syn-TrkB-EGFP	 (b).	 For	 clarity	 EGFP	 fluorescence	 signal	was	partly	 removed	




effect	 on	 astrocytic	 BDNF-mRFP1	 uptake.	 For	 this,	we	 combined	 BDNF-mRFP-P2A-ECFP	 expression	
with	 AAV1/2	 mediated	 expression	 of	 EGFP	 in	 astrocytes	 and	 LSSmOrange	 with	 (Figure	 27b)	 or	
without	TrkB	 (Figure	27a)	 in	neurons.	As	observed	before,	neuronal	 cell	 soma	contained	markedly	





BDNF-mRFP1	 found	 in	 astrocytes.	 Confocal	 images	of	 dissociated	hippocampal	 cultures	 at	DIV16,	 expressing	
BDNF-mRFP1-P2A-ECFP	 and	 transduced	 with	 AAV1/2	 GFAP2.2-EGFP	 and	 either	 syn-LSSmOrange	 (a)	 or	
syn-TrkB-LSSmOrange	(b).	For	clarity	EGFP	and	LSSmOrange	fluorescence	was	partly	removed	from	cell	bodies	
(a’,	b’)	 by	 applying	 a	 standard	 Sobel	 edge	 detector	 filter.	 (a”)	 and	 (b”)	 show	 separated	GFAP2.2	 -	 EGFP	 and	







SEM	 for	 values	 extracted	 from	 confocal	 images	 (Control	 n=23,	 TrkB	 overexpressing	 n=22;	 two	 separate	
cultures).	 There	 was	 no	 difference	 in	 the	 amount	 of	 released	 BDNF-mRFP1,	 between	 Control	 and	 the	 TrkB	
overexpression	within	individual	cultures.	(b)	TrkB	overexpression	in	neurons,	increased	the	relative	amount	of	
BDNF-mRFP1	 in	neurons	from	25.69	%	to	73.55	%	and	decreased	BDNF-mRFP1	 in	astrocytes	 from	57.65	%	to	
10.87	%.	 BDNF-mRFP1	 uptake	 remained	 roughly	 the	 same	 for	 the	 unassigned	 group	 of	 cells	 (15.72	%	 to	
14.34	%).	The	abundance	of	astrocytes,	measured	by	surface	coverage	of	the	respective	fluorophore,	dropped	
significantly	by	52.15	%	 in	cultures,	 in	which	TrkB	was	over-expressed	 (c).	However,	 the	effect	of	differential	
increased	 BDNF-mRFP1	 uptake	 in	 neurons	 and	 decreased	 uptake	 in	 astrocytes	 persisted	 when	 average	
BDNF-mRFP1	 in	 cells	 was	 normalized	 to	 cell	 abundance	 and	 total	 released	 BDNF-mRFP1	 (d).	 Differences	






total	 released	 BDNF-mRFP1	 by	 neurons	 increased	 from	 25.69	%	 in	 control	 cultures	 to	 73.55	%	 in	
TrkB-overexpressing	cultures	and	BDNF-mRFP1	uptake	decreased	from	57.65	%	in	control	cultures	to	
10.87	%,	 when	 TrkB-LSSmOrange	 was	 expressed	 in	 neurons	 (Figure	 28b).	 Interestingly,	 we	 also	
noticed	that	the	abundance	of	astrocytes	decreased	by	52.15	%	in	cultures,	in	which	TrkB	was	over-
expressed	 in	neurons,	as	 indicated	by	 the	coverage	of	GFAP	 -	EGFP	 fluorescence	 (Figure	28c).	 This	
could	 in	part	affect	 the	observed	changes	 in	relative	uptake.	We	therefore	normalized	the	average	
BDNF-RFP1	fluorescence	to	the	individual	cell	type	abundance	and	total	released	BDNF-mRFP1	of	the	
respective	 control	 experiment.	 Though	 less	pronounced,	 the	 change	 in	 relative	uptake	by	neurons	
and	 astrocytes	 was	 still	 preserved.	 BDNF-mRFP1	 fluorescence	 in	 individual	 neurons	 increased	




culture.	 To	 further	 increase	 BDNF-mRFP1	 release,	 we	 tested	 if	 10	mM	KCl	 or	 cLTP	 (by	 adding	
10	µM	bicuculine,	200	µM	glycine,	50	µM	forskolin,	100	nM	rolipram)	stimulation	for	8	-	10	days	had	
an	influence	on	released	BDNF-mRFP1	levels.	We	found	a	small	increase	in	released	BDNF-mRFP1	for	
10	mM	KCl	 stimulation,	 but	 a	 strong	 enhancement	 in	 released	 BDNF-mRFP1	 for	 cLTP	 stimulation	
(Figure	29a).	When	cultures	were	stimulated	using	cLTP,	BDNF-mRFP1	allocated	to	neurons	and	the	
unassigned	population	was	reduced,	but	BDNF-mRFP1	increased	in	astrocytes	(Figure	29b).	While	the	
abundance	 of	 neurons	 identified	 by	 LSSmOrange	 fluorescence	 remained	 stable,	 there	 was	 a	
tendency	 for	 10	mM	KCl	 stimulation	 and	 a	 clear	 effect	 for	 cLTP	 stimulation	 to	 increase	 the	
abundance	 of	 astrocytes	 in	 the	 culture	 identified	 by	 EGFP	 signal	 (Figure	 29c).	We	 found	 that	 the	
relative	amount	of	BDNF-mRFP1	per	cell	did	not	change	for	neurons	in	the	different	conditions,	but	
significantly	 decreased	 for	 the	 astrocytic	 population,	 when	 average	 BDNF-mRFP1	 signal	 found	 in	







separate	 cultures	 (Control	 n	=	25,	 10	mM	KCl	n	=	30,	 cLTP	n	=	30),	 expressing	 BDNF-mRFP1-P2A-ECFP,	
GFAP2.2-EGFP	 and	 syn-LSSmOrange	 at	 DIV14	-	16.	 (a)	 The	 amount	 of	 released	 BDNF-mRFP1	 was	 increased	
when	 cells	 were	 stimulated	 with	 10	mM	KCl	 or	 cLTP	 for	 8	-	10	 days	 (ordinary	 one-way	 ANOVA,	 P	=	0.0034;	
significance	 of	 stimulated	 groups	 to	 control	was	 assessed	 by	Dunnett’s	multiple	 comparisons	 test	 *P	≤	0.05,	
****P	≤	0.0001).	 (b)	 No	 significant	 changes	 in	 relative	 BDNF-mRFP1	 uptake	 was	 found	 for	 10	mM	KCl	
stimulation.	 cLTP	 stimulation	 significantly	 reduced	 BDNF-mRFP1	 in	 the	 unassigned	 population	 and	 neurons	
(ordinary	 one-way	 ANOVA	 was	 used	 to	 test	 for	 statistical	 significance	 within	 the	 individual	 groups	 (all	
P	≤	0.0001);	significance	of	stimulated	groups	to	control	was	assessed	by	Dunnett’s	multiple	comparisons	test	
(****P	≤	0.0001)).	 (c)	 Change	 in	 cell	 type	 abundance	 due	 to	 the	 different	 stimulations.	 Astrocytes	 exhibit	
significantly	 increased	 and	 neurons	 a	 slightly	 decreased	 abundance,	 when	 cultures	 were	 treated	 with	 cLTP	
(ordinary	one-way	ANOVA,	P	≤	0.0001;	significance	of	stimulated	groups	to	control	was	assessed	by	Dunnett’s	
multiple	comparisons	test	**P	≤	0.01,	****P	≤	0.0001).	(d)	When	normalized	to	abundance	and	total	released	






To	 further	 investigate	a	possible	 influence	of	BDNF	on	astrocyte	abundance	 in	 culture,	we	 treated	
dissociated	hippocampal	cultures	with	10	mM	KCl,	cLTP,	TrkB-IgG	(a	BDNF	scavenger),	expression	of	
TrkB	in	neurons	by	calcium	phosphate	transfection,	application	of	recombinant	BDNF,	expression	of	
BDNF-mRFP1	 and	 combined	 expression	 of	 BDNF-mRFP1	 with	 cLTP	 for	 12	 days	 and	 subsequently	
quantified	average	GFAP	immunoreactivity	(Figure	30).	Only	BDNF-mRFP1	expression	and	combined	
expression	with	cLTP	 treatment	appeared	 to	have	a	 significant	effect,	 respectively	 increasing	GFAP	
average	immunoreactivity	1.37	or	2.1-fold.	
Figure	 30:	 Influence	 of	 BDNF	 abundance	 on	 GFAP	
immunoreactivity.	 Graph	 represents	 averages	 and	
SEM	 for	 GFAP	 positive	 AF647	 intensity	 of	 n=15	
images	 per	 condition	 (5	 images	 per	 coverslip,	 3	
coverslips	 per	 culture).	 Cultures	 were	 treated	 with	
10	mM	KCl,	cLTP,	TrkB-IgG,	overexpression	of	TrkB	in	
neurons,	 application	 of	 recombinant	 BDNF,	 or	
BDNF-mRFP1	 overexpression	 without	 and	 with	
additional	 cLTP	 for	 12	 days	 and	 tested	 for	 GFAP	




way	 ANOVA,	 P	<	0.0001.	 Statistical	 differences	 of	
individual	 groups	 to	 control	 was	 assessed	 by	 Dunnett’s	 multiple	 comparisons	 test	 ***P	≤	0.001,	
****P	≤	0.0001).	
In	a	separate	experiment	on	BDNF-mRFP1-P2A-ECFP,	syn-LSSmOrange	and	GFAP2.2-EGFP	expressing	
cells,	we	 could	 reduce	 total	 released	BDNF-mRFP1	 in	 the	 culture	with	 the	application	of	0.4	µg/ml	
TrkB-IgG	every	3	days,	starting	at	DIV3	until	DIV14-15,	by	63.8	±	9.1	%	(Control	n=19,	TrkB-IgG	n=18,	
unpaired	 two-tailed	 t	 test,	 p	<	0.0001).	 This	 affected	 BDNF-mRFP1	 uptake	 by	 all	 groups	 (neurons,	

















In	 order	 to	 gain	 control	 over	 synaptic	 or	 even	 sub-synaptic	 activity,	 optogenetics	 represents	 a	
promising	 approach,	 especially	 when	 studying	 biological	 processes	 in	 dissociated	 hippocampal	
cultures.	 Under	 these	 conditions	 cells	 can	 be	 easily	 transfected	 and	 are	 accessible	 for	
electrophysiology	 and	 light	 stimulation.	 However,	 the	most	 important	 processing	 unit	 of	 neuronal	
networks,	the	synapse,	is	a	very	small	structure.	An	average	excitatory	postsynaptic	site	in	the	rodent	
hippocampus	ranges	 from	approximately	0.04	µm2	(Schikorski	and	Stevens,	1997)	to	approximately	
0.1	µm3	 for	a	dendritic	spine	 (Nimchinsky	et	al.,	2002).	The	development	of	a	 tool	allowing	control	
over	 neuronal	 activity	 through	 the	 stimulation	 of	 single	 synapses	 or	 even	 smaller	 synaptic	




on-cell	 direct	 current	 injection,	 expression	 and	 targeting	 of	 chemically	 and	 genetically	 modified	
receptors	and	of	course	also	using	optogenetic	 tools,	such	as	 light-gated	 ion-channels	 (Banghart	et	
al.,	 2004;	 Lima	 and	 Miesenbock,	 2005;	 Zemelman	 et	 al.,	 2002)	 or	 chromophore-assisted	 light	
inactivation	(Lin	et	al.,	2013).	Channels	have	also	been	used	in	combination	with	genetic	engineering,	
to	enrich	them	at	synaptic	sites	allowing	efficient	targeted	stimulation	(Greenberg	et	al.,	2011).		




the	 physiological	 and	 controlled	 stimulation	 of	 postsynaptic	 sites	 can	 be	 achieved	 by	 optogenetic	
stimulation	 of	 the	 presynaptic	 neuron.	 Synapses	 can	 then	 be	 identified	 by	 colocalization	 of	
fluorescently	 labeled	 PSD-95,	 to	 mark	 post-synaptic	 sites	 in	 the	 postsynaptic	 neuron	 and	
fluorescently-tagged	 ChR2	 in	 the	 presynaptic	 neuron.	 This	 approach	 has	 been	 combined	 with	
electrophysiological	 stimulation	 in	 the	 postsynaptic	 neuron,	 demonstrating	 the	 usefulness	 of	 this	
	74	
technique	 for	 the	 study	 of	 synaptic	 plasticity	 (Zhang	 and	 Oertner,	 2007).	 Recent	 combinatorial	
expression	 of	 spectrally	 separable	 light-gated	 channels	 with	 pH-sensitive	 fluorophores	 and	
genetically	 encoded	 calcium	 indicators	 provides	 an	 all-optical	 approach	 for	 multiplex	 control	 and	
tracking	of	neuronal	activity	(Li	and	Tsien,	2012).	However,	so	far	no	technique	exists	that	allows	for	
the	 specific	 and	 highly	 focal	 control	 of	 activity	 in	 both	 pre-	 and	 postsynaptic	 structures.	 Such	
methods	 could	 significantly	 contribute	 to	 our	 understanding	 of	 detailed	 signaling	 processes	 in	
neuronal	 networks	 and	 the	 plasticity	 of	 individual	 synapses,	 the	 underlying	 signaling	 units	 for	
complex	mechanisms	such	as	the	formation	of	memory.	






of	a	 second	 (usually	 red-shifted)	wavelength	 (Berndt	et	al.,	2009).	We	reasoned,	 that	by	activating	
channels	 with	 a	 center	 beam	 and	 using	 a	 partly	 overlapping	 donut-shaped	 surrounding	 beam	 for	
channel	deactivation,	we	would	principally	be	able	 to	 reduce	 channel	 activation	 in	 the	outer	area,	




The	 approach	 described	 above	 critically	 depends	 on	 the	 property	 of	 light-gated	 channels	 to	 close	
when	simultaneously	illuminated	with	both	activation	and	inactivation	wavelengths	of	light.	In	order	
to	 identify	 suitable	 candidates,	 exhibiting	 the	 required	 photocurrent	 reduction	 for	 simultaneous	
illumination,	we	tested	a	battery	of	diverse	channel	candidates.	We	focused	our	investigation	on	the	
step-function	opsins,	since	they	appeared	most	promising	given	their	switchable	gating	properties.	
Dissociated	 hippocampal	 cultures	 were	 transfected	 using	 a	 standard	 calcium	 phosphate	
transfection	protocol	with	expression	constructs	for	CMV,	synapsin	or	CaMKIIα	promotor	controlled	
expression	of	EYFP	or	mCherry	tagged	 light-gated	 ion-channels/pumps.	Functional	validation	of	the	
expressed	 channels	 was	 performed	 using	 patch-clamp	 recordings	 of	 cells	 identified	 by	 their	
respective	 fluorescence.	 A	 tendency	 towards	 intracellular	 accumulations	 of	 fluorescence	 was	
detected	 for	 mCherry,	 but	 not	 for	 EYFP	 expressing	 cells.	 Such	 accumulations	 can	 result	 from	






Channel	 specific	 light	 evoked	 photocurrents	 were	 then	 tested	 qualitatively	 to	 determine	
channel	 activation	 spectra,	 conductance,	 gating	 kinetics	 and	 the	 ability	 to	 close	 channels	 with	 a	
second	 wavelength.	 Individual	 variations	 in	 transfection	 efficiency	 and	 expression	 levels	 pose	 a	
challenge	for	comparison	of	recordings	from	different	cells.	We	recorded	photocurrents	from	single	
cells	evoked	by	the	illumination	with	multiple	sequential	wavelengths	to	compare	the	responses.	To	
avoid	 signal	 masking	 by	 spontaneous	 neuronal	 activity	 and	 to	 single	 out	 photocurrents	 from	 the	
transfected	light-gated	ion-channels,	spontaneous	activity	was	suppressed	by	the	application	of	TTX,	
APV,	 CNQX	 and	 gabazine,	 blocking	 action	 potentials,	 NMDA	 channels,	 AMPA	 channels,	 and	
GABAergic	transmission,	respectively	(Nikolic	et	al.,	2009).	We	could	successfully	record	light-evoked	
photocurrents	 from	 cells	 up	 to	 DIV30	 and	 photocurrents	 were	 similar	 to	 those	 reported	 in	 the	
literature	 (Boyden	 et	 al.,	 2005;	 Nagel	 et	 al.,	 2003).	 As	 expected,	 photocurrents	 of	 fast	 photocycle	
variants	 (ChR2	H134R,	T159C,	E122T/T259C,	L132C)	were	generally	 strong	and	disappeared	quickly	
when	illumination	was	stopped.	This	group	of	channels	did	not	exhibit	interference	of	the	conducting	
state	 for	 any	 of	 the	 simultaneous	 illumination	wavelengths	 tested.	 Though	 it	 is	 assumed,	 that	 the	
tested	 channels	 share	 the	 fundamentally	 same	photocycle,	 opening	and	 traversing	 through	 similar	
intermediate	 channel	 states	 and	 only	 differ	 in	 ion-specificity,	 conductance,	 activity	 spectrum	 and	
channel	 kinetics.	 This	 cannot	 confidentially	 be	 inferred	 for	 the	 photocycles	 of	 the	 C1V1,	 ReaChR,	
Chronos	 and	 CoChR	 channels,	 because	 their	 photocycles	 have	 not	 been	 as	 extensively	 studied.	
However,	 the	absence	of	 interference	with	 the	conducting	state	by	simultaneous	 illumination	with	
other	wavelengths,	indicates	that	these	channels	have	a	comparable	and	fast	photocycle	with	strong	
single	 channel	 conductance.	 Most	 channels	 of	 this	 group	 displayed	 pronounced	 peak	 to	 plateau	
current	ratios.	
For	 fast	 photocycle	 channels	 (Figure	 3),	 initially	 all	 channels	 are	 closed	 and	 open	 at	 once	
upon	 illumination.	 Subsequently	 channels	 proceed	 through	 their	 photocycles,	 close	 and	 re-open.	
They	 finally	 reach	 an	 equilibrium	 (the	 stationary	 current	 phase)	 of	 constantly	 opening	 and	 closing	
channels,	in	which	approximately	50	%	of	all	illuminated	channels	can	be	found	in	the	open-channel	
state	(Feldbauer	et	al.,	2009),	inferred	by	the	peak	to	stationary	current	ratios.	The	stationary	current	
is	 very	 robust;	 the	 individual	 contribution	 of	 a	 single	 channel	 is	 very	 small	 and	 only	 of	 a	 short	
persistence,	 because	 each	 individual	 channel	 closes	 quickly	 and	 re-opens	 again.	 Therefore	
illumination	with	a	closing	wavelength,	exciting	 the	conducting	P520	or	 respective	state	 (Figure	1),	









spectrum	 daylight	 at	 standard	 room	 intensities	 and	 light	 from	 the	 bright-field	 light	 source	 of	 the	




cells	 expressing	 these	 channels	 should	 be	 kept	 in	 completely	 dark	 conditions,	 to	 avoid	 unwanted	
channel	 stimulation.	Repeated	excitation	of	ChR2	expressing	brain	 slices	 for	up	 to	4	days	does	not	
lead	 to	 cytotoxicity	 (Schoenenberger	et	 al.,	 2009),	but	 less	exposure	may	 still	 cause	excessive	Ca2+	
influx	 through	VGCCs	 and	 thus	 have	 an	 effect	 on	 cell	 physiology.	 In	 addition	 it	 has	 been	 reported	
that,	because	of	their	significantly	slower	photocycles,	the	ChR2	C128	mutant	SFO	variants	(C128A,	
C128T	and	C128S)	tend	to	accumulate	in	a	separate	previously	undetected	branch	of	the	photocycle,	
especially	 after	 prolonged	 and	 repeated	 activation.	 This	 branch	 occurs	 at	 a	 late	 stage	 of	 the	
photocycle,	either	via	the	late-conducting	(P520)	or	closed	channel	state	(P480)	and	leads	to	P390,	a	
new	 non-conducting	 state	 (Figure	 1)	 (Schoenenberger	 et	 al.,	 2009;	 Stehfest	 et	 al.,	 2010).	 Because	





ChR2	C128	mutant	 variants.	 It	 is	 important	 to	note	 that	 closing	of	 C128	 variants	within	 3	 seconds	
after	 opening	was	 reported	 to	 reduce	 the	 photocurrent	 decline	 already	 from	 66.5	%	 to	 16.7	%	 by	




except	 when	 illuminated	 at	 405	nm	 (Figure	 5).	 The	 photocurrent	 decrease	 following	 405	 nm	
activation	 was	 most	 likely	 caused	 by	 either	 insufficient	 channel	 closure	 at	 the	 lower	 594	nm	
intensities	or	405	nm	stimulation	significantly	increases	the	chances	for	driving	channels	into	a	non-
conducting	 state,	 a	 potentially	 interesting	 observation,	 that	 could	 be	 addressed	 in	 future	 studies.	
Whether	 other	 channel	 variants	 containing	 the	 corresponding	 C128	mutation	 also	 possess	 such	 a	
non-conducting	state	is	not	clear.	This	behavior	has	not	been	addressed	during	our	experiments	and	
has	so	far	not	been	reported	in	the	literature.	
An	 additional	 characteristic	 of	 SFO	 channels	 is	 that	 channel	 closing	 is	 considerably	 slower	








closing	 with	 coillumination	 of	 a	 second	 wavelength	 during	 initial	 screening.	 The	 C1V1	 mutant	





405	nm	 light	 short-circuits	 the	 otherwise	 longer	 traverse	 through	 the	 closed	 intermediate	 states,	
thus	 slightly	 increasing	 the	 number	 of	 channels	 in	 the	 open	 state.	 But	 we	 cannot	 exclude	 the	
existence	 of	multiple	 further	 conducting	 states,	 that	 branch	 off	 from	 the	 open-channel	 state.	 The	
ChR2	 L132C	 SFO	 variant	 exhibited	 in	 part	 much	 slower	 closing	 than	 other	 SFO	 variants	 and	 was	
therefore	not	considered	useful	for	our	purpose.	Even	though	561	nm	illumination	of	the	ChR2	SFO	
variant	 channels	 should	be	more	efficient	 in	 switching	 channels	 from	 the	P520	 state	 to	 the	 closed	
state,	 it	partly	 cross-activates	 the	P470	state	and	 therefore	also	opens	channels	at	 the	 same	 time,	
mitigating	 the	 photocurrent	 reduction.	 In	 contrast,	 594	nm	 illumination	 appeared	 to	 stimulate	 the	
P520	state	and	subsequent	channel	closure	strongly,	without	significant	cross-stimulation	of	P470.	
For	 initial	 identification	 of	 suitable	 light-gated	 channel	 candidates,	 we	 used	 wide-field	
illumination	 with	 the	 40x	 objective	 at	 power	 densities	 of	 405	nm	 86.83	mW/cm2,	 488	nm	
295.6	mW/cm2,	561	nm	146.3	mW/cm2	and	594	nm	for	ROE	photomask	#1	of	801.48	mW/cm2	and	
#15	-	19	 of	 1.08	 W/cm2.	 594	nm	 intensity	 was	 directly	 related	 to	 the	 efficiency	 of	 suppressing	
depolarizing	currents.	Given	only	partial	 reduction	of	photocurrents	by	coillumination	with	594	nm	
light,	we	reasoned	that	the	ratio	of	inactivation	to	activation	power	was	not	sufficient	and	therefore	
modified	parts	of	 the	 light	path	to	shift	more	transmittance	to	the	DL594,	which	only	 led	to	minor	
reductions	 in	 the	 wide-field	 illumination	 power	 densities	 using	 the	 40x	 objective	 of	 405	nm	
27.10	-	64.56	mW/cm2,	488	nm	228.1	mW/cm2,	561	nm	133.4	mW/cm2,	but	markedly	 increased	the	
available	 594	nm	 power	 densities	 for	 the	 40x	 objective	 ROE	 photomask	 #1:	 129.75	W/cm2	 and	
#15	-	19:	267.25	W/cm2.	Because	the	594	nm	photomasks	did	not	cover	the	whole	area	illuminated	
with	 wide-field	 illumination,	 the	 FRAP-photomasks	 were	 used	 for	 stimulation	 of	 405	nm	 with	
9.92	W/cm2	 and	 488	nm	 with	 41.92	 W/cm2.	 The	 power-densities	 for	 illumination	 with	 the	 FRAP-
photomask	 were	 slightly	 underestimated.	 Later	 laser	 intensity	 measurements	 showed	 that	 FRAP	
photomask	intensities	are	higher	than	the	corresponding	laser	power	settings	of	the	wide-field	TIRF	




with	 C128A/H134R/T159C	 using	 FRAP-stimulation	 and	ROE	 photomask	 #1	 for	 594	nm	 inactivation,	
we	 were	 only	 able	 to	 reduce	 488	nm	 elicited	 photocurrents	 by	 about	 54	%	 at	 which	 point	












reported	 to	 possess	 good	 photocurrent	 inhibition	 (Venkatachalam	 and	 Cohen,	 2014)	 or	 to	 reduce	
488	nm	laser	intensities	further.	In	our	experiments,	we	tested	the	lowest	available	laser	power	(1%;	
4.48	W/cm2)	 for	 the	 FRAP-photoactivation	 mask,	 but	 further	 power	 density	 reduction	 could	 be	





when	 488	 nm	 illumination	 is	 stopped	 (Figure	 6)	 (Venkatachalam	 and	 Cohen,	 2014).	 These	 small	
stimulation	artifacts	may	mask	photocurrent	 signal	when	operating	at	nanoscale	dimensions.	With	








UV	spectrum,	which	 is	more	easily	 reduced	by	594	nm	 illumination.	 In	any	case,	405	nm	activation	
provides	an	interesting	alternative.	
In	addition	to	ChR2	C128S/H134R/T159C,	we	also	tested	inactivation	of	the	two	CoChR	slow	










for	which	561	nm	mediated	photocurrents	were	 reduced	84	%	with	405	nm	coillumination,	 is	 also	
worth	being	considered	for	future	experiments.	
We	 also	 tested	 the	 effect	 of	 increased	 594	nm	 power	 densities	 on	 channel	 closure	 of	 the	
ChR2	T159C	 and	 CoChR	 fast-photocycle	 variants,	 because	we	were	 curious	 if	we	 could	 detect	 any	
photocurrent	reduction.	In	fact	we	found	that	due	to	substantial	cross-activation	of	the	P470	state	by	
the	 stronger	594	nm	 intensities,	we	could	now	observe	pronounced	594	nm	activation	of	 channels	
(Figure	 7).	 Interestingly	 simultaneous	 594	nm	 illumination	 with	 488	 or	 405	nm	 only	 led	 to	 brief	
current	 transients	 or	 a	 weak	 photocurrent	 increase.	 This	 coillumination	 experiment	 demonstrates	
that	594	nm	illumination	can	also	close	the	channels,	but	594	nm	illumination	might	accelerate	the	
photocycle	 by	 bypassing	 the	 inactivity	 states	 and	 increasing	 the	 number	 of	 channels	 in	 the	 open	
state.	
In	addition	to	the	ChR-only	approach,	we	also	tested	the	feasibility	of	the	eNPAC	construct,	
through	 which	 blue	 light	 illumination	 causes	 ChR2-mediated	 depolarization	 and	 orange	-	red	 light	
illumination	 causes	 NpHR3.0-mediated	 hyperpolarization.	 Unlike	 the	 photocurrent	 reduction	
approach,	 to	 open	 and	 close	 a	 single	 channel	 type	 with	 two	 different	 wavelengths,	 as	 described	
above,	 here	 we	 tested	 whether	 it	 is	 principally	 possible	 to	 use	 a	 second	 light-evoked	
counterbalancing	photocurrent,	 caused	by	 the	activation	of	NpHR3.0,	 to	annihilate	ChR2-mediated	
depolarization	 in	 an	 area	 of	 simultaneous	 illumination.	 ChR2	 was	 easily	 gated	 in	 cells	 expressing	
eNPAC	using	488	nm	illumination	at	86.83	mW/cm2.	Photocurrents	were	markedly	smaller	than	for	
the	 single	 ChR2	H134R,	 most	 likely,	 because	 of	 differential	 expression	 levels	 of	 ChR2	 H134R	 and	
eNPAC.	Besides	the	substantially	larger	size	of	the	eNPAC	construct,	it	was	also	expressed	using	the	
human	 synapsin	 promotor	 while	 ChR2	H134R	 was	 expressed	 using	 the	 CaMKIIα	 promotor.	
Comparable	 magnitudes	 of	 NpHR3.0	 hyperpolarizing	 photocurrents	 were	 recorded	 at	 561	nm	 at	
146.3	mW/cm2	and	594	nm	at	approximately	160.3	mW/cm2.	Such	evoked	hyperpolarizing	currents	
where	already	strong	enough	to	completely	counterbalance	ChR2-mediated	depolarization	and	even	
shift	 cells	 to	 a	 slightly	 hyperpolarized	 state	 (Figure	 4).	 As	 we	 did	 show	 during	 the	 following	
experiments,	 such	an	approach	 is	principally	possible.	Hyperpolarizing	currents	are	easily	 tuned	by	
adjusting	594	nm	laser	power	and	can	be	adjusted	to	be	stronger	or	weaker	than	the	ChR2	mediated	
depolarizing	 currents	 (Figure	 9).	 For	 our	 experiments,	 we	 determined	 a	 range	 of	
80.15	-	160.3	mW/cm2	594	nm	 illumination	sufficient	 to	completely	 counterbalance	ChR2-mediated	
depolarization.	These	values	fluctuated	between	different	experiments,	but	these	fluctuations	should	
be	minimal,	because	of	the	approximate	equimolar	expression	of	ChR2	and	NpHR3.0	by	using	a	P2A	
sequence	 construct.	 As	 mentioned	 earlier,	 ChR2	 activation	 using	 405	nm	 is	 preferred	 to	 488	 nm	
activation,	 to	 reduce	peak	 to	 stationary	 current	 ratios	and	avoid	 currents	 that	arise	 from	NpHR3.0	
blue-light	coactivation.		
With	 their	 fast	 on-	 and	 offset,	 ion-pumps	 have	 ideal	 properties	 for	 temporally	 precise	
activation	and	reduction	of	ChR2-mediated	photocurrents.	This	 feature	 is	an	advantage	over	single	
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step	 function	 light-gated	 channels,	 which	 have	 comparably	 slower	 kinetics.	 However,	 the	
development	of	future	optogenetic	tools	may	yield	single	channels	with	faster	switching	kinetics	that	




and	NpHR3.0	 can	be	 kept	 at	 0	mV,	one	has	 to	 acknowledge,	 that	 there	will	 still	 be	 changes	 in	 ion	
concentration.	This	approach	might	be	useful	to	study	local	voltage-dependent	processes,	but	only	if	
an	 influence	 of	 the	 different	 ion	 concentrations	 on	 the	 observed	 mechanism	 can	 be	 excluded.	
Fortunately	most	ChR2	variants	do	not	exhibit	Ca2+-permeability,	which	reduces	the	risk	of	mediating	
unwanted	 physiological	 effects,	 caused	 by	 the	 cation-influx.	 However,	 data	 exists	 suggesting	 that	
even	Cl-	 ions	may	 function	 as	 second	messengers,	 tuning	GABAA-receptor	 responses	 (Succol	 et	 al.,	
2012).	 This	 possibility	 should	 be	 investigated	 thoroughly	 before	 this	 technique	 can	 be	 applied.	




thus,	 used	 not	 only	 to	 for	 focal	 depolarization,	 but	 also	 to	 create	 highly	 focal	 areas	 of	
hyperpolarization,	potentially	mimicking	inhibitory	synaptic	input.	
Electrophysiological	and	visual	detection	of	focal	stimulation	
Consistent	 focal	 stimulation	 relies	 on	 equal	 distribution	 of	 light-gated	 channels	 in	 cell	membranes	
and	 a	 slow	 rate	 of	 channel	 diffusion,	 so	 that	 activated	 channels	 remain	 confined	 to	 the	 site	 of	
illumination.	 We	 further	 examined	 ChR2,	 SSFO	 and	 NpHR3.0	 distribution	 in	 the	 membrane	 of	
expressing	 neurons	 using	 conventional	 epifluorescence	 microscopy	 and	 STED	 microscopy.	 In	
addition,	 SSFO	 diffusion	 was	 assessed	 by	 fluorescence-recovery-after-photobleaching	 (FRAP)	
experiments	 to	 determine	 channel	 diffusion	 speed.	 Fluorescently	 tagged	 ChR2	 variants	 were	
homogeneously	distributed	over	the	membrane	and	only	the	NpHR3.0	variant	showed	some	grainy	
patterns,	 when	 imaged	 using	 STED	 microscopy,	 suggesting	 that	 it	 may	 form	 small	 clusters.	








Stevens,	 1997),	 will	 likely	 impose	 a	 problem	 for	 the	 detection	 of	 the	 signal	 electrophysiologically,	
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although	 averaging	 of	multiple	 repeated	 stimulations	may	 improve	 detection	 in	 smaller	 areas.	 An	
alternative	approach,	necessary	to	verify	focal	activation,	is	visual	confirmation	of	channel	activation	
using	 voltage	 or	 calcium-sensitive	 dyes.	 Initially	 we	 investigated	 the	 use	 of	 the	 commonly	 used	
acetoxymethyl	 ester	 bound	 Fluo-4	 calcium	 dye	 and	 the	 latest	 generation	 of	 genetically	 encoded	
calcium	 indicators;	GCaMP5G	 and	 6s	 (Akerboom	et	 al.,	 2012;	 Chen	 et	 al.,	 2013;	Gee	 et	 al.,	 2000).	
Although	these	calcium	indicators	have	the	highest	reported	signal	to	noise	ratios,	they	are	not	ideal,	
due	 to	 the	 similar	 illumination	 spectrum	 for	 calcium	 imaging	 and	 channel	 activation.	 If	 cells	 are	
imaged	with	wide-field	epifluorescence	microscopy	or	 related	 techniques,	 488	nm	 illumination	will	
also	 activate	 channels.	 We	 reasoned	 that	 eventually	 channels	 with	 red-shifted	 activation	 spectra	
could	be	used	and	thus	extended	our	analysis	to	ReaChR	and	C1V1	channels.	Unfortunately	until	now	
there	is	no	such	thing	as	a	channel	exclusively	activated	by	the	red	spectrum	and	all	tested	channels	
still	 possessed	 strong	 activation	 in	 the	 blue	 spectrum.	 Because	 of	 the	 superb	 photocurrent	
inactivation	 that	 we	 observed	 for	 the	 C1V1	E122T/C167S	 using	 405	nm,	 it	 may	 be	 possible	 to	
illuminate	the	whole-field	with	the	closing	wavelength,	while	exciting	green	calcium	indicators	with	
488	nm,	 subsequently	 focally	 activating	 a	 small	 area	 with	 488	 nm	 light	 by	 removing	 the	 405	nm	
illumination	there.	This	is	however	a	very	complicated	approach.	The	fact,	that	full-field	optogenetic	
controlled	 stimulation,	while	 imaging	 a	 green	 calcium	 indicator	 is	 principally	 possible,	 has	 recently	
been	 shown	 (Venkatachalam	and	Cohen,	2014),	but	 it	 remains	 to	be	 tested	 in	 combination	with	a	
focal	stimulation	approach.		




and	 an	 area	 of	 4.91	µm2	was	 stimulated	with	 488	nm	 by	 using	 the	 DirectFRAP	 and	 RCaMP1c	was	





coincided	 with	 photostimulation	 were	 evident,	 but	 they	 were	 difficult	 to	 distinguish	 from	
background	 signal	 in	 single	 traces.	 Repeated	 stimulation	 and	 averaging	 of	 signal	 may	 improve	
detection	in	this	case.	Voltage-indicator	dyes	might	present	a	more	suitable	tool	for	the	detection	of	
light-gated	 channel	 mediated	 depolarizations	 of	 small	 areas.	 And	 indeed	 optical	 stimulation	 has	
already	 been	 used	 successfully	 along	with	 voltage	 imaging	 (Hochbaum	 et	 al.,	 2014).	 Although	 the	
signal	to	noise	of	fluorescent	voltage-sensitive	dyes	is	often	not	as	high	as	for	calcium	indicators	and	
still	 possess	 a	 substantial	 spectral	 overlap	with	 the	 ChR2	 activation	 spectrum.	 Even	 though	 recent	
archaerhodopsin-based	 voltage	 indicators	 are	 reported	 to	 allow	 detection	 of	 miniature	 excitatory	








a	 simultaneous	 illumination	 approach	 in	 order	 to	 achieve	 focal	 activation.	 Using	 macroscopic	
photocurrent	 from	 recordings	 of	 Xenopus	 oocytes,	 available	 information	 about	 the	 ChR2	 channel	
kinetics	 and	 assuming	 similar	 expression	 and	 abundance	 as	 for	 bacteriorhodopsin,	 open	 channel	
populations	 of	 ChR2	 are	 assumed	 to	 be	 10	%	 and	 single	 channel	 conductance	 of	wildtype	 ChR2	 is	
estimated	to	be	around	50	fS,	which	yields	single	channel	currents	of	around	5	fA	(Nagel	et	al.,	2003).	
Using	 nonstationary	 noise	 analysis,	 conductances	 of	 wildtype	 ChR2	 and	 ChR2	 H134R	 in	 HEK	 cells	
were	 41.5	 fS	 for	 single	 channel	Na+	 conductance	 at	 200	mM	extracellular	Na+,	with	 single	 channel	
currents	of	3.5	fA	at	-60	mV	(Feldbauer	et	al.,	2009).	It	was	also	shown,	that	in	the	stationary	phase	
around	 51	%	 of	 the	 channels	 are	 in	 the	 open	 channel	 state,	 thus	 approximately	 226	 channels	 are	
active	per	µm2	cell	membrane	in	HEK	cells	(Feldbauer	et	al.,	2009).	However,	H134R	exhibits	stronger	
stationary	photocurrents,	because	of	an	extended	persistence	in	the	open	channel	state,	thus	60	%	
of	 the	 channels	 are	 expected	 to	 be	 open	 during	 stimulation	 (Feldbauer	 et	 al.,	 2009;	 Nagel	 et	 al.,	












these	 channels	 need	 to	 allow	 organisms	 to	 sense	 different	 light	 intensities	 over	 several	 orders	 of	
magnitude	 and	 prevent	 complete	 block	 by	 low	 light	 saturated	 depolarization	 and	 dangerous	
deflections	 from	 physiological	 intracellular	 ion-concentrations,	 that	 might	 result	 from	 higher	
conductance	channels.	Thus	the	channels	have	evolved	to	transport	a	minimal	amount	of	 ions	and	
further	 decrease	 this	 transport	 under	 conditions	 of	 extended	 illumination	 to	 relatively	 small	
stationary	levels	(Hegemann	and	Moglich,	2011).	Increased	laser	intensities	will	not	lead	to	stronger	
photocurrents	after	channels	have	been	activated,	but	rather	 lead	to	a	 loss	of	spatial	selectivity	by	
spatial	 tails	of	 the	 laser	beam	and	scattered	 light	as	well	as	stimulation	of	channels	 in	out-of-focus	
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membrane	 (Dobrucki	 et	 al.,	 2007;	 Schoenenberger	 et	 al.,	 2011).	 This	 is	 suboptimal	 for	 local	
stimulation	of	subcellular	structures.	Ideally	a	center	two-photon	activation	could	be	used	to	restrict	
ChR2	 activation	 to	 very	 small	 volumes	 and	 subcellular	 structures	 with	 high	 spatial	 selectivity,	
decreasing	the	chance	of	out-of-focus	membrane	depolarization	(Packer	et	al.,	2012;	Rickgauer	and	
Tank,	2009).	
To	make	 light-gated	channels	usable	 for	highly	 focal	stimulation,	 further	 improvements	are	
needed	and	we	either	have	to	increase	channel	abundance	in	the	membrane	area	to	be	stimulated,	
e.g.	by	higher	expression	levels	or	targeting	motifs	to	synapses,	or	single	channel	conductance	has	to	
be	 further	 improved	 to	match	 the	one	of	native	neuronal	 ion-channels.	 In	order	 to	mimic	synaptic	
activation	in	physiological	conditions,	ideal	channels	would	possess	properties	that	match	the	mixed	
currents	 elicited	 by	 AMPA	 and	 NMDA	 receptors	 at	 excitatory	 synapses.	 The	 largest	 proportion	 of	
glutamatergic	 synapses,	 approximately	 70	%,	 contain	 both	 AMPA	 and	NMDA	 receptors,	 20	%	 only	
AMPA	 and	 the	 rest	 only	 NMDA	 (Bekkers	 and	 Stevens,	 1989).	 Amounts	 of	 NMDA	 receptors	 are	
reported	to	be	mostly	consistent	and	 independent	of	spine	volume	and	synapse	 location,	however	
AMPA	receptor	densities	have	been	described	to	vary	in	abundance	depending	on	their	location	on	
the	 dendritic	 tree	 (Andrasfalvy	 and	Magee,	 2001).	 Thus	 for	 an	 ideal	 imaginary	 excitatory	 synaptic	
site,	 we	 can	 assume	 that	 synaptic	 transmission	 at	 low	 frequencies	 is	 conveyed	 by	 5.9	-	35	 AMPA	
receptors	 and	 between	 0.5	-	19	 NMDA	 receptors,	 of	 which	 during	 the	 peak	 of	 the	 postsynaptic	
current	 only	 1	-	2	 receptors	 are	 expected	 to	 be	 open	 at	 the	 same	 time	 (Nimchinsky	 et	 al.,	 2004;	
Spruston	 et	 al.,	 1995).	 Single	 channel	 AMPA	 conductances	 have	 been	 determined	 to	 be	 around	
8	-	10	pS	(Jonas	and	Sakmann,	1992;	Spruston	et	al.,	1995).	And	NMDA	receptors	have	a	conductance	
of	 about	 45	pS	 (Gibb	 and	 Colquhoun,	 1992;	 Spruston	 et	 al.,	 1995)	 of	which	 approximately	 10	%	 is	
contributed	to	by	calcium	conductance	at	an	extracellular	calcium	concentration	of	2	mM	Ca2+	(Jahr	
and	 Stevens,	 1993).	 To	match	 currents	 of	 a	 single	 AMPA	 receptor,	 the	 conductance	 of	 a	wildtype	
ChR2	needs	to	be	enhanced	roughly	200-fold	and	to	match	a	single	NMDA	receptor,	roughly	1000-
fold,	 including	 a	 10	%	 Ca2+	 conductance.	 Recently	 developed	 light-gated	 ionotropic	 glutamate	
channels	could	potentially	help	to	overcome	such	problems	(Berlin	et	al.,	2016;	Volgraf	et	al.,	2006).	





these	 fast	 photocycle	 variants	 are	 not	 actually	 useful	 to	 achieve	 depolarization	 at	 the	 nanoscale,	
because	 they	 lack	 the	 inactivation	properties	of	 the	slow	photocycle	variants.	The	slow	photocycle	
variants,	 on	 the	 other	 hand,	 have	 significantly	 reduced	 photocurrents	 compared	 to	 the	 fast	






the	 key	 mediators	 and	 regulators	 of	 neuronal	 differentiation,	 growth	 and	 formation	 of	 neuronal	
processes	and	connections,	and	synaptic	plasticity,	which	shows	that	it	is	fundamentally	involved	in	
almost	 all	 essential	 processes,	 that	 characterize	 the	 brain.	 BDNF	 is	 essential	 for	 long-term	
potentiation	 of	 synaptic	 strength,	 which	 is	 thought	 to	 be	 the	mechanism	 underlying	 learning	 and	
memory.	 The	potentiation	of	 synaptic	 strength	occurs	 in	 a	 synapse-specific	manner	 at	 synapses	 in	
which	there	 is	a	coincident	 increase	 in	pre-	and	post-synaptic	activity.	We	hypothesized	that	BDNF	
may	be	specifically	targeted	to	synapses	with	increased	activity,	to	promote	long-term	potentiation	
of	 their	strength.	We	aimed	to	address	the	question	of	activity-dependent	recruitment	of	BDNF	by	




Previous	work	using	 fluorescently	 tagged	BDNF	 in	 rat	neuronal	cultures	already	demonstrated	that	
BDNF	 is	 localized	 to	 secretory	 granules	 and	 can	 be	 found	 at	 synaptic	 junctions	 (Haubensak	 et	 al.,	
1998).	In	later	studies	it	was	shown	that	BDNF	localized	to	pre-	and	or	postsynaptic	sites	in	response	
to	 glycine-induced	 increase	 of	 neuronal	 network	 activity	 (Dean	 et	 al.,	 2012)	 and	 that	 it	 can	 be	
released	 from	 pre-	 and	 postsynaptic	 sites	 in	 response	 to	 neuronal	 activity	 (Kohara	 et	 al.,	 2001;	
Kuczewski	et	al.,	2008).	Neurotrophin-containing	DCVs	can	 fuse	and	release	 their	cargo	at	synaptic	
and	extra-synaptic	 sites	 in	an	activity-dependent	 fashion	 (Farina	et	al.,	2015;	Matsuda	et	al.,	2009;	
van	de	Bospoort	 et	 al.,	 2012).	 In	 addition,	BDNF	 containing	 vesicles	 are	highly	mobile	 and	actively	
traverse	 axons	 and	 dendrites.	 This	 prompted	 the	 hypothesis	 that	 BDNF-containing	 DCVs	 may	 be	
recruited	 to	 sites	 of	 increased	 activity.	 In	 timelapse-imaging	 experiments	 with	 BDNF-mRFP1	
expressing	neuronal	cultures,	we	observed	highly	mobile	fluorescent	puncta,	actively	moving	in	and	
out	 of	 the	 cell	 body	 and	 perambulating	 neuronal	 processes,	 as	 previously	 described	 (Dean	 et	 al.,	
2012).	 Using	 the	 focal	 optogenetic	 stimulation	 approach	 described	 above	 (with	 a	 single	 activating	
wavelength),	 we	 co-expressed	 BDNF-mRFP1	 with	 a	 ECFP	 labeled	 ChR2,	 either	 T159C	 or	 L132C,	
connected	 via	 a	 P2A	 sequence.	 By	 performing	 patch-clamp	 electrophysiological	 recordings	 from	
expressing	cells	in	the	whole-cell	configuration	we	could	detect	light-evoked	currents	in	response	to	
405	 and	 488	nm	 illumination.	 These	 currents	 were	 not	 present	 in	 ECFP	 negative	 cells.	 As	 a	
stimulation	protocol,	we	used	3	min	long	stimulations	at	0.5	Hz	and	250	ms	pulses,	to	test	the	effect	
of	 focal	 405	 and	 488	nm	 illumination	 at	 power	 densities	 of	 300	 and	 1,300	W/cm2	 using	 the	 #10	
photoactivationmask	 of	 the	 DirectFRAP	 system	 for	 the	 illumination	 of	 a	 112.36	µm2	 large	 spot	 on	
randomly	chosen	processes	that	were	positive	for	BDNF-mRFP1	and	ECFP.	As	described	earlier,	laser	
powers	 of	 the	 DirectFRAP	 were	 initially	 underestimated	 due	 to	 the	 relatively	 low	 powers	 of	 the	
corresponding	TIRF	 laser	at	 the	given	settings.	488	nm	 illumination	bleached	the	mRFP1	signal	and	
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was	 therefore	not	used,	because	 it	did	not	allow	 for	 the	 tracking	of	 fluorescent	puncta	during	 the	
stimulation.	405	nm	laser	stimulation,	on	the	other	hand,	did	not	bleach	the	mRFP1	fluorophore.	We	
mainly	focused	on	the	use	of	the	L132C	variant,	because	of	its	presumptive	Ca2+-permeability;	but	we	
found,	 that	 focal	 stimulation	 of	 both	 ChR2	 T159C	 and	 L132C	 led	 to	 pronounced	 accumulation	 of	
fluorescent	 BDNF-mRFP1	 puncta	 in	 the	 area	 of	 activation.	 Before,	 during,	 and	 after	 stimulation,	
BDNF-mRFP1	puncta	actively	moved	through	the	illuminated	area,	indicating	that	neuronal	processes	





in	part	mediated	by	 the	 light	exposure.	 There	was	no	obvious	evidence	 that	 the	 laser	 illumination	
was	 leading	 to	 damage	 or	 loss	 of	 membrane	 integrity.	 Direct	 laser	 exposure	 has	 been	 reported	
before	to	cause	depolarization	in	neurons	without	obvious	damage	occurring	(Fork,	1971;	Hirase	et	
al.,	2002;	Hirase	et	al.,	2012).	Such	currents	might	also	here	be	responsible	 for	the	stopping	of	the	
BDNF	 puncta,	 especially	 if	 the	 depolarizing	 currents	 also	 entailed	 a	 rise	 of	 the	 Ca2+-concentration.	
Another	 possibility	would	 be	 photodamage	 by	 heat	 or	 by	 direct	 interaction	with	 the	 proteins	 and	
intracellular	 structures	 involved	 in	 DCV	 transport	 (microtubuli,	 motor	 proteins);	 also	 fluorophore	
excitation	created	reactive	oxygen	species	(Jay,	1988;	McLean	et	al.,	2009)	could	affect	BDNF-mRFP1	
transport.	 Such	mechanisms	 are	 indeed	used	purposefully	 to	 inactivate	 the	 function	of	 genetically	
modified	proteins	locally	(Jay,	1988;	Lin	et	al.,	2013;	McLean	et	al.,	2009).	Our	protocol	exposed	the	
neuronal	process	for	a	total	of	22.5	s	with	405	nm	at	3	W/mm2,	which	translates	to	an	energy	dose	of	
67.5	J	 for	the	same	area.	For	fluorophore/chromophore	assisted	 light	 inactivation	 longer	exposures	
and	higher	laser	powers	are	normally	used	(Lin	et	al.,	2013;	McLean	et	al.,	2009).	Nevertheless,	it	is	
possible	that	the	405	nm	exposure	led	to	the	generation	of	reactive	oxygen	species	by	excitation	of	
the	 ECFP	 fluorophore	 attached	 to	 the	 ChR2,	 even	 though	 ECFP	 is	 not	 an	 ideal	 candidate	 for	
fluorophore	 assisted	 light	 inactivation	 (McLean	 et	 al.,	 2009).	 This	 might	 have	 affected	 the	 cell	
membrane	 integrity,	but	 is	unlikely	 to	affect	 the	DCV	 transport	mechanism	 itself,	due	 to	 the	 small	
effective	distance	of	fluorophore	assisted	light	inactivation.	It	is	important	to	note,	that	not	only	the	
BDNF-mRFP1	 harboring	 vesicles	 that	 were	 directly	 exposed	 to	 the	 laser	 light	 accumulated,	 but	
vesicles	 that	 traversed	the	area	after	stimulation	were	also	recruited.	Moreover,	 this	accumulation	
started	to	disappear	again	after	90	min,	which	excludes	permanent	photodamage	to	the	intracellular	
cytoskeletal	elements	and	leaves	strong	local	depolarization	as	a	consequence	of	channel	activation	
and	generation	of	 free	 radicals,	 affecting	membrane	 integrity,	 as	 the	most	 reasonable	explanation	
for	accumulation	of	BDNF	vesicles	at	the	site	of	stimulation.	For	this	reason,	these	experiments	were	
discontinued,	 but	 could	 eventually	 be	 resumed	 at	 weaker	 light	 intensities	 or	 focusing	 on	 larger	
subcellular	 areas	 to	decrease	 the	 chance	of	damage,	mediated	either	by	direct	 light	exposure,	 the	




expressed	 from	 a	 single	 plasmid	 with	 a	 P2A	 sequence	 separating	 them,	 the	 ECFP	 fluorophore	 on	
ChR2	 could	 also	 be	 removed	 completely	 to	 reduce	 possible	 effects	 of	 ECFP	mediated	 fluorophore	
assisted	light	inactivation,	and	transfected	cells	could	still	be	identified	by	their	mRFP1	fluorescence.	
BDNF	cell-to-cell	transfer	




expression	 of	 11	 different	 BDNF	 mRNA	 splice	 variants	 (Aid	 et	 al.,	 2007).	 Interestingly,	 with	 the	
exception	 of	 one	 splice	 variant,	 were	 8	 amino	 acids	 can	 be	 added	 to	 the	 N-terminal	 part	 of	 the	
protein,	all	mRNAs	code	for	the	very	same	protein.	There	are	also	amino	acid	differences	between	
species	that	should	be	respected,	e.g.	V23A	and	G35A	propeptide	residues	from	mouse	to	rat.	The	
exchange	 from	 valine	 and	 glycine	 to	 alanine	 does	 not	 change	 polarity	 or	 size	 significantly	 and	
therefore,	these	differences	are	unlikely	to	affect	protein	function,	but	a	single	amino	acid	difference	






activity	dependent	manner,	 implying	a	 function	of	endogenous	BDNF	through	 local	activity	specific	




pre-	 and	 postsynaptic	 sites	 of	 neurons	 in	 an	 activity	 dependent	 fashion	 (Kohara	 et	 al.,	 2001;	
Kuczewski	 et	 al.,	 2008),	 while	 other	 studies	 report	 exclusive	 presynaptic	 localization	 (Dieni	 et	 al.,	
2012).	And	while	BDNF	mRNA	is	supposedly	absent	in	astrocytes	(Ernfors	et	al.,	1990),	released	BDNF	
can	be	taken	up	by	astrocytes	influence	their	morphology	(Ohira	et	al.,	2007;	Ohira	et	al.,	2005)	and	
possibly	even	be	 re-released	 (Bergami	et	al.,	2008),	 suggesting	a	bidirectional	 signaling	mechanism	
between	neurons	and	astrocytes.	Besides	all	 these	 interesting	 implications,	 the	release	of	BDNF	by	
neurons	and	subsequent	uptake	by	other	cells	has	to	our	knowledge	not	been	conclusively	shown	in	
any	 of	 these	 studies.	 They	mostly	 report	 release	 onto	 other	 cells,	 but	 not	 transfer	 (Kohara	 et	 al.,	
2001)	 or	 uptake	 of	 recombinant	 BDNF	 that	 has	 been	 added	 to	 the	medium	without	 the	 previous	
release	 (Bergami	 et	 al.,	 2008).	 These	 studies	 strongly	 suggests	 such	 a	 connection	between	 release	
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and	 uptake,	 but	 there	 are	 nevertheless	 many	 more	 open	 questions,	 including	 whether	 neuronal	
activity	affects	transfer,	whether	release	and	possible	uptake	occur	pre-	or	post-synaptically	or	both,	
and	 if	 there	 is	 bidirectional	 transfer	 and	 signaling	 between	 astrocytes	 and	 neurons	 or	 other	 cell	
types.	
During	the	course	of	this	project,	we	surprisingly	observed	a	strong	and	prominent	spread	of	
the	BDNF-mRFP1	signal	 in	 culture,	 labeling	many	more	cells	 than	can	be	 transfected	using	calcium	
phosphate.	 To	 investigate	 the	 possibility	 of	 cell-to-cell	 transfer	 and	 to	 identify	 BDNF-mRFP1	
producing	 cells,	 we	 combined	 the	 BDNF-mRFP1	 sequence	 with	 a	 P2A	 peptide	 sequence	 linked	 to	
either	 EGFP	 or	 ECFP	 and	 expressed	 it	 under	 the	 control	 of	 the	 CamKIIα	 promotor,	 specific	 for	
excitatory	 neurons.	 The	 P2A	 peptide	 sequence	 allows	 for	 the	 coding	 of	multiple	 peptides	 using	 a	




leading	 to	 local	 translation	 (Ridder	 et	 al.,	 2014).	 Although	 we	 were	 expressing	 our	
BDNF-mRFP1-P2A-EGFP	 construct	 under	 control	 of	 the	 CaMKIIα	 promotor,	 we	 still	 observed	 a	
remarkable	 spread	 of	mRFP1	 signal	 in	 neighboring	 cells	 around	 the	 EGFP	 positive	 cells.	We	were	
quite	surprised	that	 in	decades	of	BDNF	research	using	 fluorescently	 labeled	BDNF	overexpression,	
similar	observations	have	not	been	published,	and	set	out	 to	 investigate	 the	reason	 for	 this	and	 in	
parallel,	to	identify	the	cells	taking	up	the	overexpressed	and	released	BDNF-mRFP1.	
When	we	 performed	 standard	 ICC	 and	 compared	 the	 observed	 BDNF-mRFP1	 intensities	 in	
different	culture	and	treatment	conditions,	we	found	that	treatment	with	the	antimitotic	agent	AraC	
from	 DIV7	 onward,	 as	 well	 as	 fixation	 and	 permeabilization	 of	 the	 culture	 resulted	 in	 a	 dramatic	
reduction	 of	 BDNF-mRFP1	 fluorescence.	 Some	 mRFP1	 signal	 remains	 and	 can	 still	 be	 detected,	
however	the	largest	proportion	is	gone.	Interestingly,	in	initial	experiments	in	which	we	transfected	
BDNF-EGFP,	 the	 most	 commonly	 used	 BDNF-tagged	 fluorophore,	 we	 did	 not	 observe	 transfer	 to	
neighboring	cells.	By	using	25	mM	NH4Cl,	however,	we	could	show	that	the	previously	seen	absence	
of	 BDNF-EGFP	 signal	 is	 most	 likely	 because	 of	 acidic	 quenching	 in	 the	 subcellular	 compartments	
(Santi	 et	 al.,	 2006);	 addition	 of	 25	 mM	 NH4Cl	 to	 de-acidify	 internal	 compartments	 revealed	 an	
equivalent	amount	of	transfer	of	BDNF-EGFP	to	neighboring	cells,	compared	to	BDNF-mRFP1.	These	




We	 could	 show	 that	 indeed	 BDNF-mRFP1	 fluorescence	 co-occurs	 with	 other	 neurons	
identified	 by	 Map2	 immunoreactivity	 or	 synapsin	 promotor	 activity.	 We	 also	 found	 some	
BDNF-mRFP1	 in	 NG2	 immunoreactive	 cells,	 presumably	 polydendrocytes	 (Nishiyama	 et	 al.,	 2009),	
but	the	most	substantial	BDNF-mRFP1	signal	co-occurred	with	the	somata	of	GFAP	immunoreactive	
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cells,	 i.e.	 astrocytes.	We	 also	 tested	 Iba-1,	 for	 detection	 of	 microglia	 cells,	 but	 did	 not	 find	 Iba-1	
immunoreactive	cells	in	our	cultures.	It	is	unlikely	that	no	microglia	cells	are	present	in	these	cultures	
and	more	 likely	 that	 there	was	 a	 problem	with	 the	 ICC.	 To	 test	 this,	 different	 antibodies	 could	be	
tested.	
In	order	 to	 confirm	 the	actual	uptake	of	BDNF,	we	performed	 live-labeling	of	 the	GFP	and	
RFP	 fluorophore	 with	 preconjugated	 primary	 and	 secondary	 antibodies	 under	 non-permeabilizing	
conditions.	 Under	 these	 conditions	 antibodies	 detected	 the	 control	 epitope	 of	 Nrx,	 but	 failed	 to	
detect	 the	 large	 BDNF-mRFP1	 accumulations	 in	 the	 somata.	 We	 can	 therefore	 conclude	 that	
BDNF-mRFP1	is	internalized.	The	large	quantities	of	the	transferred	BDNF-mRFP1	suggest	some	sort	
of	regulated	uptake	using	target	receptors.	
Attaching	 224	 amino	 acid	 peptides	 (EGFP	or	mRFP1)	 via	 an	 11	 amino	 acid	 long	 linker	 to	 a	
249	amino	acid	ProBDNF	might	obscure	the	biological	functions	of	BDNF.	Fluorescently	tagged	BDNF	
has	 been	 reported	 to	 be	 physiologically	 active	 (Cubitt	 et	 al.,	 1995),	 and	 to	 behave	 in	 a	 manner	
indistinguishable	from	untagged	BDNF	(Haubensak	et	al.,	1998;	Kojima	et	al.,	2001).	Furthermore	the	
endocytosis	 of	 EYFP-tagged	 recombinant	 BDNF	 is	 reported	 not	 to	 differ	 from	 that	 of	 native	 BDNF	
(Santi	et	al.,	2006).	In	our	experiments,	untagged	BDNF	expressed	in	neurons	was	also	transferred	to	
astrocytes,	 in	 a	manner	 similar	 to	 fluorescently	 tagged	BDNF,	 thus	 confirming	 that	 the	 fluorescent	
tag	does	not	severely	affect	physiological	functions	of	BDNF.	
In	vitro	cultures	are	often	criticized	for	their	differences	to	physiological	in	vivo	conditions.	To	
verify	cell	 transfer	under	physiological	 conditions	and	address	 the	question	of	 release	and	 transfer	
directionality	 from	 neurons,	 we	 injected	 crude	 CaMKIIα-BDNF-mRFP1-P2A-ECFP	 AAV1/2	 extracts,	
produced	in	HEK293	cells,	into	the	CA3	or	CA1	region	of	organotypic	hippocampal	brain	slices.	With	
this	 approach,	 we	 hoped	 to	 determine	 transfer	 directionality	 from	 CA3	 to	 CA1	 (i.e.	 pre	 to	 post-
synaptic)	or	the	other	way	around.	To	our	surprise	in	this	system	the	ECFP	fluorophore	was	absent.	
We	therefore	swapped	the	ECFP	to	EGFP,	hoping	that	this	will	improve	the	strength	of	the	signal	and	
used	 constructs	 packed	 into	 professionally	 purified	 AAV6	 particles,	 which	 can	 presumably	 handle	
larger	 inserts,	 but	 again	 found	 an	 absence	 of	 the	 EGFP	 fluorophore,	 even	 though	 both	 constructs	
work	well	for	calcium	phosphate	transfection	of	dissociated	cultures.	A	possible	explanation	for	this	
could	be	that	during	the	packaging	process	of	constructs	that	are	too	large,	the	single	stranded	insert	





construct	was	 successfully	 transduced	and	expressed	with	high	efficiency,	we	can	exclude	 the	P2A	




of	 injection,	 including	 cells	 outside	 of	 the	 pyramidal	 cell	 layer.	 This	 demonstrates	 local	 release	 of	
BDNF-mRFP1	and	uptake	by	non-CaMKIIα	promotor	active	cells	in	a	physiological	context.	
To	quantify	the	differential	uptake	by	neurons	and	astrocytes	without	having	to	perform	ICC,	
potentially	 decreasing	 mRFP1	 fluorescence,	 we	 developed	 a	 four	 fluorophore-based	 live-labeling	
approach,	in	which	dissociated	neuronal	cultures	are	transfected	with	CaMKIIα	promotor	controlled	
BDNF-mRFP1-P2A-ECFP.	 Subsequently	 the	 culture	 is	 transduced	 with	 AAV1/2	 virions,	 labeling	
neurons	 and	 astrocytes	 by	 synapsin	 or	 GFAP2.2	 specific	 expression	 of	 the	 LSSmOrange	 or	 EGFP	
fluorophores,	 respectively.	 These	 fluorophores	 could	 easily	 be	 detected	 and	 separated	 using	
conventional	confocal	microscopy	and	image	analysis.	Using	ICC	for	the	detection	of	Map2	and	GFAP	
immunoreactive	 cells,	 we	 could	 confirm	 that	 AAV1/2	 transduction	 successfully	 labels	 80	-	90	%	 of	
astrocytes	and	neurons,	comparable	to	what	has	been	reported	in	the	literature	(Royo	et	al.,	2008).	




concentrations	 low	 and	 locally	 confined.	 However,	 BDNF	 is	 not	 without	 physiological	 function	 for	
astrocytes.	Astrocytes	express	the	p75	receptor	and	a	truncated	version	of	the	TrkB	receptor,	missing	
the	intracellular	tyrosine	kinase	domain	(Aroeira	et	al.,	2015;	Bergami	et	al.,	2008;	Rose	et	al.,	2003).	
Previous	work	 by	 others	 showed	 that	 exposure	 to	 brief	 BDNF	 application	 led	 to	 a	 rise	 of	 calcium	
concentrations	 in	 astrocytes	 (Rose	 et	 al.,	 2003).	 It	 can	 therefore	 be	 assumed,	 that	 the	 uptake	 of	
BDNF	 is	not	purely	buffering,	but	 also	has	physiological	 consequences	 for	 astrocytes.	 To	 study	 the	
fate	 of	 taken	 up	 BDNF-mRFP1	 in	 neurons	 and	 astrocytes,	 we	 used	 electroporation	 to	 transfect	
dissociated	neuronal	 cultures	before	plating	with	 fluorescently	 labeled	marker	proteins	 for	diverse	
subcellular	 compartments	 involved	 in	 protein	 degradation,	 sorting	 and	 processing,	 including	 the	
endosomal	 markers	 EEA1,	 Rab5	 and	 Rab7,	 the	 lysosomal	 marker	 Lamp1	 or	 the	 autophagosomal	
marker	LC3,	and	subsequently	transfected	them	with	our	BDNF	construct	using	calcium	phosphate.	
Because	overexpression	of	proteins	will	eventually	cause	accumulations	of	the	respective	proteins	in	
lysosomes,	 constructs	 were	 validated	 by	 ICC.	 There	 were	 no	 significant	 differences	 found	 in	 the	
localizations	 of	 the	 ICC	 staining	 and	 the	 fluorescent	 marker	 protein.	 Furthermore,	 if	 the	 marker	
proteins	would	eventually	end	up	in	the	same	compartments,	we	would	expect	similar	colocalization	
results	 for	 all	 different	 conditions,	 which	 was	 not	 the	 case.	 Endocytosed	 BDNF-mRFP1	 did	 not	
colocalize	with	the	early	endosomal	markers	EEA1	and	Rab5	(Huotari	and	Helenius,	2011;	Wilson	et	




at	 the	 peripheral	 cytoplasm,	 where	 they	 reside	 for	 approximately	 5	-	18	 min,	 while	 the	 early	






late	 endosomes	 to	 form	 larger	 bodies	 and	 eventually	 fuse	 with	 lysosomes,	 where	 most	 of	 the	
components	 of	 late	 endosomes	 will	 be	 degraded	 (Huotari	 and	 Helenius,	 2011).	 Autophagosomes	
engulf	cytoplasmic	components,	including	cytosolic	proteins	and	organelles	and	fuse	with	lysosomes	
to	 form	autolysosomes.	Our	data	suggest	 that	 the	 largest	proportion	of	endocytosed	BDNF-mRFP1	
goes	down	this	path	and	finally	ends	up	in	lysosomes,	where	it	is	degraded.	There	were	no	significant	
differences	 found	 between	 the	 colocalization	 of	 taken	 up	 BDNF-mRFP1	 between	 neurons	 and	
astrocytes	with	 specific	 compartments,	 suggesting	 that	 in	 both	 cell	 types	 uptake	may	occur	 partly	
through	similar	mechanisms.	Rab7	and	Lamp1	were	expected	to	colocalize	significantly	 (Humphries	
et	al.,	2011),	 something	 that	we	can	confirm	by	 their	 similar	 colocalization	with	BDNF-mRFP1.	The	
strong	 BDNF-mRFP1	 colocalization	 with	 marker	 proteins	 that	 represent	 the	 late	 endosomal	 to	
lysosomal	 stages,	 suggests	protein	degradation	 instead	of	 re-release.	However,	we	 cannot	exclude	
that	 uptake	 and	 subsequent	 re-release	 occurs	 as	 previously	 reported	 (Bergami	 et	 al.,	 2008).	 The	
experiments	 in	 which	 re-release	 has	 been	 observed	 comes	 from	 the	 application	 of	 recombinant	
ProBDNF	directly	to	the	culture,	under	the	assumption	that	BDNF	is	primarily	released	by	neurons	as	
ProBDNF,	 but	 the	 release	of	 ProBDNF	 is	 controversial.	Other	 than	 the	 TrkB	 receptor	 variants	 (full-
length	and	the	two	known	truncated	isoforms)	the	p75	receptor,	which	binds	ProBDNF,	is	reported	
to	 be	 expressed	 only	 weakly	 in	 the	 adult	 cortex	 or	 hippocampus	 and	 dissociated	 neuron	 and	
astrocytes	(Rudge	et	al.,	1994;	Yan	and	Johnson,	1988,	1989;	Yan	et	al.,	1997).	Further	experiments	
with	 the	 application	 of	 recombinant	 BDNF	 support	 the	 uptake	 by	 neurons	 mostly	 via	 the	 TrkB	
receptor	 (Santi	 et	 al.,	 2006).	 Indeed	 there	 is	 sufficient	 evidence	 to	 assume	 that	 BDNF	 is	 mostly	
processed	intracellular	and	released	in	its	mature	form	(Dieni	et	al.,	2012;	Matsumoto	et	al.,	2008).	
Release	of	ProBDNF	versus	mature	BDNF	and	physiological	consequences	for	astrocytes	
We	 confirmed	 the	 functional	 relevance	 of	 the	 overexpressed	 BDNF-mRFP1	 by	 demonstrating	 its	
ability	 to	 bind	 to	 the	 TrkB	 receptor.	 Because	 there	 was	 so	 much	 more	 BDNF-mRFP1	 found	 in	
astrocytes	than	in	neurons,	we	wondered	if	the	released	form	is	mostly	ProBDNF	binding	to	the	p75	
receptor	 on	 astrocytes	 or	 if	 neurons	 simply	 lack	 sufficient	 TrkB	 receptor	 levels	 to	 compete	 with	
astrocytes	 for	 available	 BDNF.	 We	 therefore	 overexpressed	 TrkB	 in	 neurons,	 which	 resulted	 in	 a	
dramatic	 increase	 of	 the	 BDNF-mRFP1	 found	 in	 neurons,	 from	 26	%	 to	 74	%	 of	 the	 total	
BDNF-mRFP1,	while	 at	 the	 same	 time	BDNF-mRFP1	 in	 astrocytes	 reduced	 from	58	%	 to	 11	%.	 This	
experiment	demonstrated	 that	 first,	BDNF-mRFP1	can	bind	 to	 its	native	 receptor	and	 second,	 that	












on	 differential	 uptake	 or	 abundance	 of	 individual	 cell	 types,	 the	 cLTP	 protocol	 led	 to	 a	 marked	
increase	 in	 released	 BDNF-mRFP1	 from	which	 only	 the	 astrocytic	 population	 appeared	 to	 benefit.	
While	 the	neuronal	population	 remained	 stable	 and	 took	up	 the	 same	amount	of	BDNF-mRFP1	as	
seen	 under	 control	 condition,	 there	was	 relatively	 less	 BDNF-mRFP1	 in	 astrocytes.	 In	 addition,	we	
found	 that	 astrocyte	 abundance	 was	 significantly	 increased,	 hence	 either	 cLTP	 or	 excess	 in	
BDNF-mRFP1	appears	to	stimulate	astrocyte	proliferation.	But	the	excess	astrocytes	had	decreased	
amounts	of	BDNF-mRFP1	taken	up	by	individual	cells.	In	separate	experiments	where	we	tested	for	
changes	 in	 GFAP	 immunoreactivity,	 10	mM	KCl	 or	 cLTP	 alone	 did	 not	 significantly	 increase	 the	
number	 of	 astrocytes.	 Only	 BDNF-mRFP1	 overexpression	 alone	 and	 in	 combination	 with	 the	 cLTP	
stimulation	 did.	 We	 also	 tested	 the	 effects	 of	 application	 of	 a	 TrkB	 Immunoglobulin	 G,	 which	
scavenges	free	BDNF,	overexpression	of	TrkB,	and	application	of	recombinant	BDNF.	None	of	these	
treatments	affected	GFAP	immunoreactivity.	It	is	expected	that	there	is	only	little	endogenous	BDNF	
available	 (Dieni	 et	 al.,	 2012);	 therefore	 it	 is	 not	 surprising,	 that	 the	 TrkB	 Immunoglobulin	 G	
application	and	the	TrkB	overexpression	under	normal	conditions	did	not	show	any	effect.	However,	
the	absence	of	an	effect	with	TrkB	overexpression	also	excludes	the	calcium	phosphate	transfection	
as	 a	 stimulating	 source	 of	 astrocytic	 proliferation.	 We	 also	 tried	 the	 application	 of	 the	 TrkB	
Immunoglobulin	G	on	BDNF-mRFP1	overexpressing	cultures,	where	 it	 led	to	a	decrease	of	released	
BDNF-mRFP1	by	about	60	%,	consequently	decreasing	the	signal	found	in	all	three	groups	(neurons,	
astrocytes	 and	 unassigned	 cells),	 but	 it	 did	 not	 appear	 to	 be	 significantly	 low	 enough	 to	 have	 an	
effect	on	any	cell	 type	abundance.	For	the	added	recombinant	BDNF,	 it	 is	possible	that	we	did	not	











synaptic	 neuronal	 activity	 by	 using	 optogenetics	 in	 combination	 with	 an	 illumination	 approach	




coilluminated	 area,	 therefore	 confining	 the	 region	 of	 activation.	 We	 identified	 suitable	 channel	
candidates	 and	 features	 that	 aid	 to	 reduce	 photocurrents	 under	 coillumination.	 Furthermore,	 we	
demonstrated	the	feasibility	of	both	approaches	for	the	stimulation	of	highly	focal	membrane	areas.	
But	 we	 also	 demonstrate	 that	 at	 present	 this	 application	 is	 not	 realistic,	 due	 to	 the	 weak	
conductances	 of	 the	 available	 channels.	 The	 knowledge	 from	 this	 work	 will	 be	 useful	 for	 future	
applications	 that	 make	 use	 of	 the	 investigated	 channel	 properties	 and	 different	 illumination	
approaches.	Nevertheless,	 the	 field	 of	 optogenetics	 is	 quickly	 progressing	 and	 it	 is	 very	 likely	 that	
stronger	conducting	variants	will	be	found	in	time.	It	could,	for	example,	be	interesting	to	focus	on	








out	 effects	 of	 light	 stimulation	 alone,	 in	 the	 absence	 of	 channelrhodopsins.	 Moreover,	 we	
demonstrated	 the	 transfer	 of	 neuronally	 expressed	 fluorescently	 labeled	 BDNF	 to	 nearby	 cells,	
something	 that	has	so	 far	only	been	 inferred,	but	not	demonstrated	and	showed	that	 in	 fact	most	
BDNF	 is	 being	 taken	 up	 by	 astrocytes.	 Consequently,	 we	 provide	 further	 evidence	 for	 the	





the	 uptake	 by	 astrocytes	 and	 the	 presence	 of	 Pro-	 or	 mature	 BDNF.	 A	 possible	 approach	 for	
removing	p75NTR	or	the	truncated	TrkB	variants	is	to	use	the	CRISPR/Cas9	system,	a	technique	that	
has	already	been	shown	to	work	efficiently	 in	postmitotic	neurons	(Incontro	et	al.,	2014;	Straub	et	
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